CleftGeneDB-Search

Gene: MMP9

Basic information

Tag	Content
Uniprot ID	P14780; B2R7V9; Q3LR70; Q8N725; Q9H4Z1; Q9UCJ9; Q9UCL1; Q9UDK2;
Entrez ID	4318
Genbank protein ID	ABA03169.1; BAG35956.1; AAA51539.1; BAA20967.1; AAH06093.1; AAM97934.1;
Genbank nucleotide ID	NM_004994.2
Ensembl protein ID	ENSP00000361405
Ensembl nucleotide ID	ENSG00000100985
Gene name	Matrix metalloproteinase-9
Gene symbol	MMP9
Organism	Homo sapiens
NCBI taxa ID	9606
Cleft type
Developmental stage
Data sources	Manually collected
Reference	21462296
Functional description	May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-\|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide.
Sequence	MSLWQPLVLV LLVLGCCFAA PRQRQSTLVL FPGDLRTNLT DRQLAEEYLY RYGYTRVAEM 60 RGESKSLGPA LLLLQKQLSL PETGELDSAT LKAMRTPRCG VPDLGRFQTF EGDLKWHHHN 120 ITYWIQNYSE DLPRAVIDDA FARAFALWSA VTPLTFTRVY SRDADIVIQF GVAEHGDGYP 180 FDGKDGLLAH AFPPGPGIQG DAHFDDDELW SLGKGVVVPT RFGNADGAAC HFPFIFEGRS 240 YSACTTDGRS DGLPWCSTTA NYDTDDRFGF CPSERLYTQD GNADGKPCQF PFIFQGQSYS 300 ACTTDGRSDG YRWCATTANY DRDKLFGFCP TRADSTVMGG NSAGELCVFP FTFLGKEYST 360 CTSEGRGDGR LWCATTSNFD SDKKWGFCPD QGYSLFLVAA HEFGHALGLD HSSVPEALMY 420 PMYRFTEGPP LHKDDVNGIR HLYGPRPEPE PRPPTTTTPQ PTAPPTVCPT GPPTVHPSER 480 PTAGPTGPPS AGPTGPPTAG PSTATTVPLS PVDDACNVNI FDAIAEIGNQ LYLFKDGKYW 540 RFSEGRGSRP QGPFLIADKW PALPRKLDSV FEERLSKKLF FFSGRQVWVY TGASVLGPRR 600 LDKLGLGADV AQVTGALRSG RGKMLLFSGR RLWRFDVKAQ MVDPRSASEV DRMFPGVPLD 660 THDVFQYREK AYFCQDRFYW RVSSRSELNQ VDQVGYVTYD ILQCPED 707

Abbreviation :
CLO : cleft lip only. CPO : cleft palate only. CLP : cleft lip and palate. CL/P : cleft lip with/without cleft palate.
For humans: CL/P, CLO, CPO, and CLP. For mice: CLO, CLP, and CPO.

Gene expression in different tissues (ENCODE)

Protein structural annotations

3D structure in PDB database

PDB ID
1GKC
1GKD
1ITV
1L6J
1LKG
2OVX
2OVZ
2OW0
2OW1
2OW2
4H1Q
4H2E
4H3X
4H82
4HMA
4JIJ
4JQG
4WZV
4XCT
5CUH
5I12
5TH6
5TH9
5UE3
5UE4
6ESM
1ITV
1L6J
4H2E
4JIJ
4WZV
4XCT
5UE3

Protein disorder information

Orthologous information

Relation	Gene symbol	Entrez ID	UniProt ID	Developmental stage	Species	Evidence	Details
1:1 ortholog	MMP9		F1P6A2		Canis lupus familiaris	Prediction	More>>
1:1 ortholog	MMP9		A0A452EYC3		Capra hircus	Prediction	More>>
1:1 ortholog	MMP9	4318	P14780		Homo sapiens	Publication	More>>
1:1 ortholog	Mmp9	17395	P41245	E12.5, E13.5, E14.5	Mus musculus	Prediction	More>>
1:1 ortholog	MMP9	458294	H2QKI0		Pan troglodytes	Prediction	More>>
1:1 ortholog	MMP9		A0A287AZD5		Sus scrofa	Prediction	More>>
1:1 ortholog	Mmp9		D3ZYK8		Rattus norvegicus	Prediction	More>>
1:1 ortholog	mmp9		F1QC76		Danio rerio	Prediction	More>>

Identified variants/mutations related to cleft phenotype

Gene symbol	Significant Variants/SNPS	Methods	PubMed ID
MMP9	rs17576A>G	Genotyping	21462296
MMP9	rs6094237A>T	Genotyping	21462296

Other genetic variants/mutations

ID	Variant	Type	Disease	Chromosome\Coordinate	Evidence
RCV000018642	p.Met1Lys	missense variant	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46008928T>A	ClinVar
rs1248852302	p.Leu3Pro	missense variant	-	NC_000020.11:g.46008934T>C	gnomAD
rs1416299149	p.Gln5Lys	missense variant	-	NC_000020.11:g.46008939C>A	TOPMed
rs749593366	p.Leu9Arg	missense variant	-	NC_000020.11:g.46008952T>G	ExAC,gnomAD
rs377557970	p.Val10Met	missense variant	-	NC_000020.11:g.46008954G>A	ESP,ExAC,gnomAD
rs1421030578	p.Leu11Phe	missense variant	-	NC_000020.11:g.46008957C>T	gnomAD
rs973255035	p.Val13Leu	missense variant	-	NC_000020.11:g.46008963G>C	TOPMed
rs1394084492	p.Leu14Met	missense variant	-	NC_000020.11:g.46008966C>A	gnomAD
rs775382644	p.Gly15Asp	missense variant	-	NC_000020.11:g.46008970G>A	ExAC,gnomAD
rs199986473	p.Cys17Tyr	missense variant	-	NC_000020.11:g.46008976G>A	ExAC,TOPMed,gnomAD
rs764157311	p.Cys17Gly	missense variant	-	NC_000020.11:g.46008975T>G	ExAC,gnomAD
rs1389114921	p.Phe18Val	missense variant	-	NC_000020.11:g.46008978T>G	gnomAD
NCI-TCGA novel	p.Ala19Ser	missense variant	-	NC_000020.11:g.46008981G>T	NCI-TCGA
rs1805088	p.Ala20Val	missense variant	-	NC_000020.11:g.46008985C>T	UniProt,dbSNP
VAR_013780	p.Ala20Val	missense variant	-	NC_000020.11:g.46008985C>T	UniProt
rs1805088	p.Ala20Val	missense variant	-	NC_000020.11:g.46008985C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs1805088	p.Ala20Gly	missense variant	-	NC_000020.11:g.46008985C>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000378591	p.Ala20Val	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46008985C>T	ClinVar
RCV000344813	p.Ala20Thr	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46008984G>A	ClinVar
rs886056714	p.Ala20Thr	missense variant	-	NC_000020.11:g.46008984G>A	-
COSM6093518	p.Pro21Leu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46008988C>T	NCI-TCGA Cosmic
rs144023823	p.Arg24Cys	missense variant	-	NC_000020.11:g.46008996C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs143089810	p.Arg24His	missense variant	-	NC_000020.11:g.46008997G>A	ESP
COSM3547157	p.Ser26Phe	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46009003C>T	NCI-TCGA Cosmic
rs201841087	p.Thr27Ile	missense variant	-	NC_000020.11:g.46009006C>T	1000Genomes,ExAC,TOPMed,gnomAD
rs777201664	p.Leu28Phe	missense variant	-	NC_000020.11:g.46009008C>T	ExAC,gnomAD
COSM269606	p.Leu28Pro	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46009009T>C	NCI-TCGA Cosmic
rs756942448	p.Pro32Thr	missense variant	-	NC_000020.11:g.46009020C>A	ExAC,gnomAD
rs1409224430	p.Gly33Arg	missense variant	-	NC_000020.11:g.46009023G>A	TOPMed,gnomAD
rs779227367	p.Leu35Val	missense variant	-	NC_000020.11:g.46009029C>G	ExAC,TOPMed,gnomAD
rs1311674897	p.Thr37Ala	missense variant	-	NC_000020.11:g.46009035A>G	TOPMed,gnomAD
rs761037128	p.Asn38Lys	missense variant	-	NC_000020.11:g.46009040T>A	TOPMed,gnomAD
rs41427445	p.Asn38Ser	missense variant	-	NC_000020.11:g.46009039A>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs41427445	p.Asn38Ser	missense variant	-	NC_000020.11:g.46009039A>G	UniProt,dbSNP
VAR_037004	p.Asn38Ser	missense variant	-	NC_000020.11:g.46009039A>G	UniProt
rs1357464329	p.Leu39Phe	missense variant	-	NC_000020.11:g.46009041C>T	TOPMed,gnomAD
rs1357464329	p.Leu39Ile	missense variant	-	NC_000020.11:g.46009041C>A	TOPMed,gnomAD
rs201595065	p.Asp41Asn	missense variant	-	NC_000020.11:g.46009047G>A	1000Genomes,ExAC,TOPMed,gnomAD
rs768767596	p.Arg42Lys	missense variant	-	NC_000020.11:g.46009051G>A	ExAC,gnomAD
rs142807270	p.Gln43His	missense variant	-	NC_000020.11:g.46009055G>T	ESP,ExAC,gnomAD
COSM6093517	p.Gln43His	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46009055G>C	NCI-TCGA Cosmic
rs1189873574	p.Ala45Val	missense variant	-	NC_000020.11:g.46009060C>T	gnomAD
rs1236078412	p.Glu47Gly	missense variant	-	NC_000020.11:g.46009867A>G	gnomAD
rs150576883	p.Glu47Lys	missense variant	-	NC_000020.11:g.46009866G>A	ESP,ExAC,gnomAD
rs1350125067	p.Tyr50His	missense variant	-	NC_000020.11:g.46009875T>C	gnomAD
rs139620474	p.Arg51Cys	missense variant	-	NC_000020.11:g.46009878C>T	ESP,ExAC,TOPMed,gnomAD
rs139620474	p.Arg51Ser	missense variant	-	NC_000020.11:g.46009878C>A	ESP,ExAC,TOPMed,gnomAD
rs1465166516	p.Arg51His	missense variant	-	NC_000020.11:g.46009879G>A	TOPMed,gnomAD
rs747548343	p.Tyr52Cys	missense variant	-	NC_000020.11:g.46009882A>G	ExAC,gnomAD
rs201920350	p.Thr55Ile	missense variant	-	NC_000020.11:g.46009891C>T	ExAC,gnomAD
rs1199504802	p.Thr55Ala	missense variant	-	NC_000020.11:g.46009890A>G	gnomAD
rs1468213676	p.Arg56Trp	missense variant	-	NC_000020.11:g.46009893C>T	gnomAD
rs1160886270	p.Arg56Gln	missense variant	-	NC_000020.11:g.46009894G>A	gnomAD
rs373331430	p.Ala58Val	missense variant	-	NC_000020.11:g.46009900C>T	ESP,ExAC,TOPMed,gnomAD
rs1460626188	p.Ala58Pro	missense variant	-	NC_000020.11:g.46009899G>C	gnomAD
rs199906203	p.Glu59Gln	missense variant	-	NC_000020.11:g.46009902G>C	ESP,ExAC,TOPMed,gnomAD
RCV000175795	p.Glu59Gln	missense variant	-	NC_000020.11:g.46009902G>C	ClinVar
rs1402945575	p.Met60Val	missense variant	-	NC_000020.11:g.46009905A>G	gnomAD
rs201069991	p.Arg61His	missense variant	-	NC_000020.11:g.46009909G>A	ExAC,TOPMed,gnomAD
rs370018925	p.Arg61Cys	missense variant	-	NC_000020.11:g.46009908C>T	ESP,TOPMed,gnomAD
rs201069991	p.Arg61Pro	missense variant	-	NC_000020.11:g.46009909G>C	ExAC,TOPMed,gnomAD
rs1208926409	p.Glu63Gly	missense variant	-	NC_000020.11:g.46009915A>G	TOPMed
rs1048809692	p.Ser64Ter	stop gained	-	NC_000020.11:g.46009918C>A	TOPMed,gnomAD
rs1237041404	p.Ser64Pro	missense variant	-	NC_000020.11:g.46009917T>C	gnomAD
rs1048809692	p.Ser64Leu	missense variant	-	NC_000020.11:g.46009918C>T	TOPMed,gnomAD
rs1232902097	p.Leu67Pro	missense variant	-	NC_000020.11:g.46009927T>C	gnomAD
rs1270974207	p.Gly68Arg	missense variant	-	NC_000020.11:g.46009929G>A	gnomAD
rs1489372682	p.Pro69Leu	missense variant	-	NC_000020.11:g.46009933C>T	TOPMed,gnomAD
rs1014494202	p.Ala70Val	missense variant	-	NC_000020.11:g.46009936C>T	TOPMed,gnomAD
rs1014494202	p.Ala70Glu	missense variant	-	NC_000020.11:g.46009936C>A	TOPMed,gnomAD
rs1435543367	p.Leu73Phe	missense variant	-	NC_000020.11:g.46009944C>T	TOPMed,gnomAD
rs1474644021	p.Lys76Asn	missense variant	-	NC_000020.11:g.46009955G>T	TOPMed,gnomAD
rs1162424705	p.Leu78Val	missense variant	-	NC_000020.11:g.46009959C>G	gnomAD
rs1805089	p.Glu82Lys	missense variant	-	NC_000020.11:g.46009971G>A	UniProt,dbSNP
VAR_013781	p.Glu82Lys	missense variant	-	NC_000020.11:g.46009971G>A	UniProt
rs1805089	p.Glu82Lys	missense variant	-	NC_000020.11:g.46009971G>A	ExAC,gnomAD
rs1805089	p.Glu82Gln	missense variant	-	NC_000020.11:g.46009971G>C	ExAC,gnomAD
rs143695450	p.Gly84Ser	missense variant	-	NC_000020.11:g.46009977G>A	1000Genomes,ExAC,TOPMed,gnomAD
rs143695450	p.Gly84Cys	missense variant	-	NC_000020.11:g.46009977G>T	1000Genomes,ExAC,TOPMed,gnomAD
rs1309853230	p.Glu85Gly	missense variant	-	NC_000020.11:g.46009981A>G	gnomAD
rs760637974	p.Leu86Arg	missense variant	-	NC_000020.11:g.46009984T>G	ExAC,gnomAD
rs764040727	p.Asp87Glu	missense variant	-	NC_000020.11:g.46009988T>G	ExAC,gnomAD
rs1323253154	p.Ser88Asn	missense variant	-	NC_000020.11:g.46009990G>A	gnomAD
rs1250570940	p.Ala89Thr	missense variant	-	NC_000020.11:g.46009992G>A	TOPMed,gnomAD
rs1485098105	p.Lys92Arg	missense variant	-	NC_000020.11:g.46010002A>G	gnomAD
rs1257898367	p.Ala93Thr	missense variant	-	NC_000020.11:g.46010004G>A	gnomAD
rs377251829	p.Arg95Ter	stop gained	-	NC_000020.11:g.46010010C>T	ESP,ExAC,TOPMed,gnomAD
rs562814692	p.Thr96Ser	missense variant	-	NC_000020.11:g.46010014C>G	1000Genomes,TOPMed,gnomAD
rs1171100463	p.Pro97Thr	missense variant	-	NC_000020.11:g.46010016C>A	gnomAD
rs140352541	p.Arg98Leu	missense variant	-	NC_000020.11:g.46010020G>T	ESP,TOPMed,gnomAD
rs1371238110	p.Arg98Trp	missense variant	-	NC_000020.11:g.46010019C>T	gnomAD
rs140352541	p.Arg98Gln	missense variant	-	NC_000020.11:g.46010020G>A	ESP,TOPMed,gnomAD
rs1301292849	p.Gly100Ala	missense variant	-	NC_000020.11:g.46010026G>C	gnomAD
rs1319751051	p.Gly100Trp	missense variant	-	NC_000020.11:g.46010025G>T	gnomAD
rs1244656505	p.Pro102Ala	missense variant	-	NC_000020.11:g.46010031C>G	TOPMed
rs996062494	p.Leu104Pro	missense variant	-	NC_000020.11:g.46010038T>C	TOPMed,gnomAD
rs1346496443	p.Gly105Ser	missense variant	-	NC_000020.11:g.46010040G>A	gnomAD
COSM1412130	p.Gln108Glu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010049C>G	NCI-TCGA Cosmic
rs200316960	p.Thr109Ile	missense variant	-	NC_000020.11:g.46010053C>T	TOPMed,gnomAD
rs1483332362	p.Gly112Ser	missense variant	-	NC_000020.11:g.46010061G>A	gnomAD
rs1201798763	p.Gly112Asp	missense variant	-	NC_000020.11:g.46010062G>A	gnomAD
rs976680437	p.Asp113Asn	missense variant	-	NC_000020.11:g.46010064G>A	gnomAD
rs202158739	p.Lys115Arg	missense variant	-	NC_000020.11:g.46010071A>G	ExAC,TOPMed,gnomAD
rs1448118597	p.Trp116Ter	stop gained	-	NC_000020.11:g.46010074G>A	TOPMed,gnomAD
rs1391377337	p.His119Tyr	missense variant	-	NC_000020.11:g.46010082C>T	gnomAD
rs1011983510	p.Asn120His	missense variant	-	NC_000020.11:g.46010085A>C	TOPMed,gnomAD
rs1173991915	p.Asn120Ser	missense variant	-	NC_000020.11:g.46010086A>G	TOPMed,gnomAD
rs1360980988	p.Ile121Phe	missense variant	-	NC_000020.11:g.46010088A>T	gnomAD
rs1042913543	p.Trp124Arg	missense variant	-	NC_000020.11:g.46010097T>C	TOPMed,gnomAD
rs1042913543	p.Trp124Arg	missense variant	-	NC_000020.11:g.46010097T>A	TOPMed,gnomAD
rs966535029	p.Gln126Arg	missense variant	-	NC_000020.11:g.46010488A>G	TOPMed
rs3918252	p.Asn127Lys	missense variant	-	NC_000020.11:g.46010492C>G	ESP,ExAC,TOPMed,gnomAD
rs756724622	p.Ser129Trp	missense variant	-	NC_000020.11:g.46010497C>G	ExAC,TOPMed,gnomAD
rs753247273	p.Ser129Ala	missense variant	-	NC_000020.11:g.46010496T>G	ExAC,gnomAD
rs1471912767	p.Glu130Gln	missense variant	-	NC_000020.11:g.46010499G>C	TOPMed
rs749347450	p.Pro133Leu	missense variant	-	NC_000020.11:g.46010509C>T	ExAC,TOPMed,gnomAD
rs193209205	p.Pro133Ser	missense variant	-	NC_000020.11:g.46010508C>T	1000Genomes,ExAC,TOPMed,gnomAD
rs200637345	p.Arg134Trp	missense variant	-	NC_000020.11:g.46010511C>T	-
rs1292338609	p.Arg134Gln	missense variant	-	NC_000020.11:g.46010512G>A	gnomAD
rs757458476	p.Ala135Val	missense variant	-	NC_000020.11:g.46010515C>T	ExAC,gnomAD
rs146456046	p.Asp138Gly	missense variant	-	NC_000020.11:g.46010524A>G	ESP,ExAC,gnomAD
COSM4098941	p.Asp139Asn	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010526G>A	NCI-TCGA Cosmic
rs746759681	p.Ala140Val	missense variant	-	NC_000020.11:g.46010530C>T	ExAC,gnomAD
rs768427160	p.Arg143Cys	missense variant	-	NC_000020.11:g.46010538C>T	ExAC,TOPMed,gnomAD
rs776477347	p.Arg143His	missense variant	-	NC_000020.11:g.46010539G>A	ExAC,gnomAD
rs370718441	p.Ala144Gly	missense variant	-	NC_000020.11:g.46010542C>G	ExAC,gnomAD
COSM262046	p.Ala144Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010541G>A	NCI-TCGA Cosmic
NCI-TCGA novel	p.Phe145Leu	missense variant	-	NC_000020.11:g.46010546C>A	NCI-TCGA
rs201130037	p.Ala146Val	missense variant	-	NC_000020.11:g.46010548C>T	ExAC,TOPMed,gnomAD
rs762404241	p.Trp148Arg	missense variant	-	NC_000020.11:g.46010553T>C	ExAC,gnomAD
rs201902138	p.Ser149Arg	missense variant	-	NC_000020.11:g.46010558C>G	ExAC,gnomAD
rs201902138	p.Ser149Arg	missense variant	-	NC_000020.11:g.46010558C>A	ExAC,gnomAD
rs770554685	p.Ser149Asn	missense variant	-	NC_000020.11:g.46010557G>A	ExAC,TOPMed,gnomAD
rs753159137	p.Val151Leu	missense variant	-	NC_000020.11:g.46010562G>C	ExAC,gnomAD
COSM270949	p.Thr152Met	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010566C>T	NCI-TCGA Cosmic
rs753889026	p.Pro153Gln	missense variant	-	NC_000020.11:g.46010569C>A	ExAC,TOPMed,gnomAD
rs764539138	p.Pro153Ser	missense variant	-	NC_000020.11:g.46010568C>T	ExAC,gnomAD
NCI-TCGA novel	p.Leu154Ile	missense variant	-	NC_000020.11:g.46010571C>A	NCI-TCGA
rs143024943	p.Thr155Ile	missense variant	-	NC_000020.11:g.46010575C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000286425	p.Thr155Ile	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46010575C>T	ClinVar
rs1344383872	p.Arg158His	missense variant	-	NC_000020.11:g.46010584G>A	gnomAD
rs1338781828	p.Val159Leu	missense variant	-	NC_000020.11:g.46010586G>T	TOPMed
rs1338781828	p.Val159Met	missense variant	-	NC_000020.11:g.46010586G>A	TOPMed
rs368247718	p.Tyr160His	missense variant	-	NC_000020.11:g.46010589T>C	ESP,ExAC,gnomAD
COSM4098945	p.Ala164Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010601G>A	NCI-TCGA Cosmic
rs8125581	p.Asp165Asn	missense variant	-	NC_000020.11:g.46010604G>A	ESP,ExAC,TOPMed,gnomAD
rs747962072	p.Val167Ala	missense variant	-	NC_000020.11:g.46010611T>C	ExAC,gnomAD
rs1237824635	p.Ile168Thr	missense variant	-	NC_000020.11:g.46010614T>C	gnomAD
rs1186571087	p.Gln169Arg	missense variant	-	NC_000020.11:g.46010617A>G	gnomAD
rs777580909	p.Ala173Thr	missense variant	-	NC_000020.11:g.46010628G>A	ExAC,gnomAD
rs202214757	p.Ala173Glu	missense variant	-	NC_000020.11:g.46010629C>A	ExAC,gnomAD
rs371298738	p.Glu174Gly	missense variant	-	NC_000020.11:g.46010922A>G	ESP,ExAC,gnomAD
rs775295226	p.Gly176Glu	missense variant	-	NC_000020.11:g.46010928G>A	ExAC,gnomAD
rs771781780	p.Gly176Arg	missense variant	-	NC_000020.11:g.46010927G>A	ExAC,gnomAD
rs768898768	p.Tyr179Cys	missense variant	-	NC_000020.11:g.46010937A>G	ExAC,gnomAD
rs141088574	p.Tyr179His	missense variant	-	NC_000020.11:g.46010936T>C	ESP,ExAC,TOPMed,gnomAD
rs199676062	p.Pro180Leu	missense variant	-	NC_000020.11:g.46010940C>T	TOPMed,gnomAD
rs1198905817	p.Pro180Ser	missense variant	-	NC_000020.11:g.46010939C>T	gnomAD
rs769270769	p.Asp182Tyr	missense variant	-	NC_000020.11:g.46010945G>T	gnomAD
NCI-TCGA novel	p.Asp182Asn	missense variant	-	NC_000020.11:g.46010945G>A	NCI-TCGA
rs762206194	p.Gly183Arg	missense variant	-	NC_000020.11:g.46010948G>A	ExAC,gnomAD
rs201932479	p.Gly183Ala	missense variant	-	NC_000020.11:g.46010949G>C	1000Genomes,ExAC,gnomAD
rs201932479	p.Gly183Glu	missense variant	-	NC_000020.11:g.46010949G>A	1000Genomes,ExAC,gnomAD
NCI-TCGA novel	p.Lys184Asn	missense variant	-	NC_000020.11:g.46010953G>T	NCI-TCGA
rs763027034	p.Asp185Glu	missense variant	-	NC_000020.11:g.46010956C>A	ExAC,gnomAD
rs751770581	p.Gly186Arg	missense variant	-	NC_000020.11:g.46010957G>A	ExAC,gnomAD
rs55789927	p.Leu187Val	missense variant	-	NC_000020.11:g.46010960C>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs55789927	p.Leu187Ile	missense variant	-	NC_000020.11:g.46010960C>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs55789927	p.Leu187Phe	missense variant	-	NC_000020.11:g.46010960C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
COSM1027369	p.Leu188Met	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010963C>A	NCI-TCGA Cosmic
rs778997562	p.His190Gln	missense variant	-	NC_000020.11:g.46010971C>A	ExAC,gnomAD
rs757099264	p.His190Leu	missense variant	-	NC_000020.11:g.46010970A>T	ExAC,gnomAD
NCI-TCGA novel	p.His190Tyr	missense variant	-	NC_000020.11:g.46010969C>T	NCI-TCGA
rs1263490093	p.Ala191Pro	missense variant	-	NC_000020.11:g.46010972G>C	TOPMed,gnomAD
rs1263490093	p.Ala191Thr	missense variant	-	NC_000020.11:g.46010972G>A	TOPMed,gnomAD
rs745316667	p.Pro193Leu	missense variant	-	NC_000020.11:g.46010979C>T	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Pro193Ser	missense variant	-	NC_000020.11:g.46010978C>T	NCI-TCGA
rs757968778	p.Pro194Ser	missense variant	-	NC_000020.11:g.46010981C>T	ExAC,gnomAD
COSM1027371	p.Pro194Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46010981C>A	NCI-TCGA Cosmic
rs746611387	p.Gly195Asp	missense variant	-	NC_000020.11:g.46010985G>A	ExAC,gnomAD
rs768405328	p.Pro196Thr	missense variant	-	NC_000020.11:g.46010987C>A	ExAC,gnomAD
rs768405328	p.Pro196Ser	missense variant	-	NC_000020.11:g.46010987C>T	ExAC,gnomAD
rs1326291859	p.Ile198Asn	missense variant	-	NC_000020.11:g.46010994T>A	TOPMed
rs748578814	p.Gln199His	missense variant	-	NC_000020.11:g.46010998G>C	ExAC,gnomAD
rs1367099843	p.Ala202Ser	missense variant	-	NC_000020.11:g.46011005G>T	gnomAD
COSM1027375	p.Ala202Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011005G>A	NCI-TCGA Cosmic
rs770222441	p.His203Tyr	missense variant	-	NC_000020.11:g.46011008C>T	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Asp205Asn	missense variant	-	NC_000020.11:g.46011014G>A	NCI-TCGA
rs139218878	p.Glu208Gln	missense variant	-	NC_000020.11:g.46011023G>C	ESP,ExAC,TOPMed,gnomAD
rs139218878	p.Glu208Lys	missense variant	-	NC_000020.11:g.46011023G>A	ESP,ExAC,TOPMed,gnomAD
rs200618210	p.Trp210Ter	stop gained	-	NC_000020.11:g.46011031G>A	ExAC,TOPMed,gnomAD
rs201775419	p.Leu212Val	missense variant	-	NC_000020.11:g.46011035C>G	TOPMed,gnomAD
rs199602749	p.Gly213Asp	missense variant	-	NC_000020.11:g.46011039G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs1246618527	p.Val216Leu	missense variant	-	NC_000020.11:g.46011047G>C	gnomAD
rs765092423	p.Val218Ala	missense variant	-	NC_000020.11:g.46011146T>C	ExAC,gnomAD
rs1454156823	p.Val218Leu	missense variant	-	NC_000020.11:g.46011145G>C	TOPMed
COSM3547159	p.Pro219Ser	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011148C>T	NCI-TCGA Cosmic
COSM1027377	p.Pro219Gln	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011149C>A	NCI-TCGA Cosmic
rs750293045	p.Thr220Ala	missense variant	-	NC_000020.11:g.46011151A>G	ExAC,gnomAD
rs762936205	p.Arg221Gln	missense variant	-	NC_000020.11:g.46011155G>A	ExAC,TOPMed,gnomAD
rs1382740469	p.Phe222Cys	missense variant	-	NC_000020.11:g.46011158T>G	TOPMed
rs143230916	p.Asn224Tyr	missense variant	-	NC_000020.11:g.46011163A>T	ESP
COSM1027379	p.Ala225Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011166G>A	NCI-TCGA Cosmic
rs750969696	p.Gly227Asp	missense variant	-	NC_000020.11:g.46011173G>A	ExAC,TOPMed,gnomAD
rs1386256475	p.Ala228Gly	missense variant	-	NC_000020.11:g.46011176C>G	TOPMed,gnomAD
rs1386256475	p.Ala228Val	missense variant	-	NC_000020.11:g.46011176C>T	TOPMed,gnomAD
COSM3405156	p.Ala228Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011175G>A	NCI-TCGA Cosmic
rs752393848	p.Ala229Pro	missense variant	-	NC_000020.11:g.46011178G>C	ExAC,gnomAD
rs1366255883	p.Ala229Asp	missense variant	-	NC_000020.11:g.46011179C>A	gnomAD
COSM3841164	p.His231Pro	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011185A>C	NCI-TCGA Cosmic
rs1302811072	p.Pro233Arg	missense variant	-	NC_000020.11:g.46011191C>G	gnomAD
rs1267880862	p.Phe234Cys	missense variant	-	NC_000020.11:g.46011194T>G	gnomAD
rs755807976	p.Phe234Val	missense variant	-	NC_000020.11:g.46011193T>G	ExAC,gnomAD
rs1422956340	p.Phe236Leu	missense variant	-	NC_000020.11:g.46011201C>A	TOPMed
rs28763886	p.Arg239His	missense variant	-	NC_000020.11:g.46011209G>A	UniProt,dbSNP
VAR_025165	p.Arg239His	missense variant	-	NC_000020.11:g.46011209G>A	UniProt
rs28763886	p.Arg239His	missense variant	-	NC_000020.11:g.46011209G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs200507335	p.Arg239Ser	missense variant	-	NC_000020.11:g.46011208C>A	TOPMed
RCV000397813	p.Arg239His	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46011209G>A	ClinVar
rs199564350	p.Ser240Cys	missense variant	-	NC_000020.11:g.46011212C>G	gnomAD
NCI-TCGA novel	p.Ser240Phe	missense variant	-	NC_000020.11:g.46011212C>T	NCI-TCGA
rs1350331916	p.Ser242Thr	missense variant	-	NC_000020.11:g.46011217T>A	TOPMed,gnomAD
rs749681548	p.Ala243Val	missense variant	-	NC_000020.11:g.46011221C>T	ExAC,gnomAD
rs1488453804	p.Ala243Thr	missense variant	-	NC_000020.11:g.46011220G>A	gnomAD
rs1265778843	p.Thr245Ile	missense variant	-	NC_000020.11:g.46011227C>T	TOPMed
rs771359021	p.Thr246Ile	missense variant	-	NC_000020.11:g.46011230C>T	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Thr246Asn	missense variant	-	NC_000020.11:g.46011230C>A	NCI-TCGA
rs200792951	p.Asp247Glu	missense variant	-	NC_000020.11:g.46011234C>A	ExAC,TOPMed,gnomAD
rs200792951	p.Asp247Glu	missense variant	-	NC_000020.11:g.46011234C>G	ExAC,TOPMed,gnomAD
rs746419143	p.Asp247Asn	missense variant	-	NC_000020.11:g.46011232G>A	ExAC
rs1247744387	p.Gly248Ser	missense variant	-	NC_000020.11:g.46011235G>A	TOPMed
NCI-TCGA novel	p.Asp251Asn	missense variant	-	NC_000020.11:g.46011244G>A	NCI-TCGA
rs760957320	p.Gly252Cys	missense variant	-	NC_000020.11:g.46011247G>T	ExAC,gnomAD
rs1389707993	p.Leu253Ter	stop gained	-	NC_000020.11:g.46011251T>A	gnomAD
rs1447099976	p.Leu253Phe	missense variant	-	NC_000020.11:g.46011252G>C	gnomAD
rs1349186420	p.Pro254Ser	missense variant	-	NC_000020.11:g.46011253C>T	gnomAD
rs1310933038	p.Pro254Arg	missense variant	-	NC_000020.11:g.46011254C>G	gnomAD
rs1294717327	p.Cys256Phe	missense variant	-	NC_000020.11:g.46011260G>T	gnomAD
rs1294717327	p.Cys256Tyr	missense variant	-	NC_000020.11:g.46011260G>A	gnomAD
rs773103169	p.Ser257Asn	missense variant	-	NC_000020.11:g.46011263G>A	ExAC,gnomAD
rs773103169	p.Ser257Thr	missense variant	-	NC_000020.11:g.46011263G>C	ExAC,gnomAD
rs1374029680	p.Ser257Gly	missense variant	-	NC_000020.11:g.46011262A>G	gnomAD
rs41529445	p.Thr258Ile	missense variant	-	NC_000020.11:g.46011266C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000764242	p.Thr258Ile	missense variant	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46011266C>T	ClinVar
RCV000725439	p.Thr258Ile	missense variant	-	NC_000020.11:g.46011266C>T	ClinVar
rs200516594	p.Thr259Met	missense variant	-	NC_000020.11:g.46011269C>T	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Thr259Lys	missense variant	-	NC_000020.11:g.46011269C>A	NCI-TCGA
rs144229833	p.Asn261Thr	missense variant	-	NC_000020.11:g.46011275A>C	ESP,ExAC,TOPMed,gnomAD
rs144229833	p.Asn261Ser	missense variant	-	NC_000020.11:g.46011275A>G	ESP,ExAC,TOPMed,gnomAD
rs767027217	p.Tyr262His	missense variant	-	NC_000020.11:g.46011277T>C	ExAC,gnomAD
rs148726595	p.Tyr262Cys	missense variant	-	NC_000020.11:g.46011278A>G	ESP,ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Asp263Gly	missense variant	-	NC_000020.11:g.46011281A>G	NCI-TCGA
NCI-TCGA novel	p.Asp263Asn	missense variant	-	NC_000020.11:g.46011280G>A	NCI-TCGA
COSM6093516	p.Thr264Asn	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011284C>A	NCI-TCGA Cosmic
rs1490544892	p.Asp265Tyr	missense variant	-	NC_000020.11:g.46011286G>T	gnomAD
rs1490544892	p.Asp265Asn	missense variant	-	NC_000020.11:g.46011286G>A	gnomAD
rs1181700308	p.Asp266Tyr	missense variant	-	NC_000020.11:g.46011289G>T	gnomAD
COSM724412	p.Arg267Pro	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011293G>C	NCI-TCGA Cosmic
rs1167468050	p.Cys271Tyr	missense variant	-	NC_000020.11:g.46011305G>A	TOPMed
rs1476025308	p.Pro272Leu	missense variant	-	NC_000020.11:g.46011308C>T	TOPMed
rs754141166	p.Ser273Ile	missense variant	-	NC_000020.11:g.46011311G>T	ExAC,gnomAD
NCI-TCGA novel	p.Ser273AlaPheSerTerUnkUnk	frameshift	-	NC_000020.11:g.46011306C>-	NCI-TCGA
COSM6093515	p.Ser273Cys	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011310A>T	NCI-TCGA Cosmic
rs141318648	p.Glu274Asp	missense variant	-	NC_000020.11:g.46011315G>C	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs367601348	p.Glu274Lys	missense variant	-	NC_000020.11:g.46011313G>A	ESP,ExAC,TOPMed,gnomAD
rs1004812364	p.Arg275Lys	missense variant	-	NC_000020.11:g.46011574G>A	TOPMed
rs745651268	p.Arg275Ser	missense variant	-	NC_000020.11:g.46011575A>T	ExAC,gnomAD
rs1465891923	p.Leu276His	missense variant	-	NC_000020.11:g.46011577T>A	TOPMed,gnomAD
rs1464375443	p.Tyr277Ter	stop gained	-	NC_000020.11:g.46011581C>A	gnomAD
rs1243534228	p.Tyr277His	missense variant	-	NC_000020.11:g.46011579T>C	gnomAD
RCV000299484	p.Gln279Arg	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46011586A>G	ClinVar
rs17576	p.Gln279Arg	missense variant	-	NC_000020.11:g.46011586A>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs201069467	p.Asp280Gly	missense variant	-	NC_000020.11:g.46011589A>G	1000Genomes,TOPMed,gnomAD
rs1239188179	p.Gly281Ala	missense variant	-	NC_000020.11:g.46011592G>C	TOPMed
rs1475483463	p.Asn282Lys	missense variant	-	NC_000020.11:g.46011596T>A	TOPMed,gnomAD
rs1302967594	p.Asn282Ser	missense variant	-	NC_000020.11:g.46011595A>G	TOPMed,gnomAD
rs760670157	p.Ala283Thr	missense variant	-	NC_000020.11:g.46011597G>A	ExAC,gnomAD
rs1380673980	p.Asp284Val	missense variant	-	NC_000020.11:g.46011601A>T	gnomAD
rs776166662	p.Lys286Asn	missense variant	-	NC_000020.11:g.46011608A>C	ExAC
rs761471689	p.Pro287His	missense variant	-	NC_000020.11:g.46011610C>A	ExAC,TOPMed,gnomAD
rs761471689	p.Pro287Arg	missense variant	-	NC_000020.11:g.46011610C>G	ExAC,TOPMed,gnomAD
rs764802271	p.Cys288Tyr	missense variant	-	NC_000020.11:g.46011613G>A	ExAC,gnomAD
COSM4835672	p.Pro291Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011621C>A	NCI-TCGA Cosmic
rs1319185514	p.Phe292Cys	missense variant	-	NC_000020.11:g.46011625T>G	gnomAD
RCV000729042	p.Ile293Asn	missense variant	-	NC_000020.11:g.46011628T>A	ClinVar
rs201975453	p.Ile293Asn	missense variant	-	NC_000020.11:g.46011628T>A	ESP,ExAC,TOPMed,gnomAD
RCV000338113	p.Ile293Asn	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46011628T>A	ClinVar
rs1274371041	p.Phe294Leu	missense variant	-	NC_000020.11:g.46011632C>G	gnomAD
rs766897916	p.Gln295Arg	missense variant	-	NC_000020.11:g.46011634A>G	ExAC,TOPMed,gnomAD
rs766897916	p.Gln295Pro	missense variant	-	NC_000020.11:g.46011634A>C	ExAC,TOPMed,gnomAD
rs144098289	p.Gly296Ser	missense variant	-	NC_000020.11:g.46011636G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000179448	p.Gly296Ser	missense variant	-	NC_000020.11:g.46011636G>A	ClinVar
rs1429246429	p.Gln297Arg	missense variant	-	NC_000020.11:g.46011640A>G	TOPMed
rs201130620	p.Ser298Cys	missense variant	-	NC_000020.11:g.46011643C>G	ExAC,gnomAD
rs1206717254	p.Tyr299Asp	missense variant	-	NC_000020.11:g.46011645T>G	gnomAD
COSM443923	p.Ala301Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011651G>A	NCI-TCGA Cosmic
rs146499495	p.Cys302Ter	stop gained	-	NC_000020.11:g.46011656C>A	ESP,ExAC,TOPMed,gnomAD
RCV000401593	p.Cys302Ter	nonsense	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46011656C>A	ClinVar
rs752834122	p.Asp305Asn	missense variant	-	NC_000020.11:g.46011663G>A	ExAC,gnomAD
rs201344509	p.Gly306Arg	missense variant	-	NC_000020.11:g.46011666G>C	ExAC,TOPMed,gnomAD
rs201344509	p.Gly306Cys	missense variant	-	NC_000020.11:g.46011666G>T	ExAC,TOPMed,gnomAD
rs1481207494	p.Ser308Phe	missense variant	-	NC_000020.11:g.46011673C>T	gnomAD
rs749575889	p.Gly310Arg	missense variant	-	NC_000020.11:g.46011678G>C	ExAC,TOPMed,gnomAD
rs749575889	p.Gly310Ser	missense variant	-	NC_000020.11:g.46011678G>A	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Trp313Arg	missense variant	-	NC_000020.11:g.46011687T>C	NCI-TCGA
rs771735711	p.Cys314Tyr	missense variant	-	NC_000020.11:g.46011691G>A	ExAC,gnomAD
rs746936147	p.Ala315Ser	missense variant	-	NC_000020.11:g.46011693G>T	ExAC,gnomAD
rs746936147	p.Ala315Thr	missense variant	-	NC_000020.11:g.46011693G>A	ExAC,gnomAD
rs968482034	p.Thr316Ile	missense variant	-	NC_000020.11:g.46011697C>T	TOPMed,gnomAD
rs776052269	p.Ala318Thr	missense variant	-	NC_000020.11:g.46011702G>A	ExAC,TOPMed,gnomAD
rs1284222372	p.Asn319Ser	missense variant	-	NC_000020.11:g.46011706A>G	gnomAD
rs202151407	p.Tyr320Asn	missense variant	-	NC_000020.11:g.46011708T>A	1000Genomes,ExAC,gnomAD
rs371340871	p.Asp321Tyr	missense variant	-	NC_000020.11:g.46011711G>T	ESP,ExAC,gnomAD
rs371340871	p.Asp321Asn	missense variant	-	NC_000020.11:g.46011711G>A	ESP,ExAC,gnomAD
rs959838806	p.Arg322Pro	missense variant	-	NC_000020.11:g.46011715G>C	TOPMed,gnomAD
rs200418910	p.Arg322Trp	missense variant	-	NC_000020.11:g.46011714C>T	TOPMed,gnomAD
COSM419368	p.Arg322Gln	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46011715G>A	NCI-TCGA Cosmic
rs762703999	p.Asp323Gly	missense variant	-	NC_000020.11:g.46011718A>G	ExAC,gnomAD
rs1287131775	p.Lys324Arg	missense variant	-	NC_000020.11:g.46011721A>G	TOPMed,gnomAD
rs769668671	p.Phe326Leu	missense variant	-	NC_000020.11:g.46011728C>A	ExAC,gnomAD
rs199569524	p.Gly327Ser	missense variant	-	NC_000020.11:g.46011729G>A	ExAC,TOPMed,gnomAD
rs752776370	p.Gly327Asp	missense variant	-	NC_000020.11:g.46011730G>A	ExAC
rs199569524	p.Gly327Arg	missense variant	-	NC_000020.11:g.46011729G>C	ExAC,TOPMed,gnomAD
rs756128837	p.Phe328Leu	missense variant	-	NC_000020.11:g.46011734C>A	ExAC,gnomAD
rs201503729	p.Pro330Leu	missense variant	-	NC_000020.11:g.46011739C>T	ESP,ExAC,TOPMed,gnomAD
rs201503729	p.Pro330Arg	missense variant	-	NC_000020.11:g.46011739C>G	ESP,ExAC,TOPMed,gnomAD
rs201503729	p.Pro330Gln	missense variant	-	NC_000020.11:g.46011739C>A	ESP,ExAC,TOPMed,gnomAD
rs777952347	p.Pro330Ser	missense variant	-	NC_000020.11:g.46011738C>T	ExAC,gnomAD
rs1167774814	p.Thr331Ile	missense variant	-	NC_000020.11:g.46011742C>T	TOPMed
rs1163227924	p.Arg332Gln	missense variant	-	NC_000020.11:g.46011745G>A	TOPMed,gnomAD
rs200477815	p.Arg332Ter	stop gained	-	NC_000020.11:g.46011744C>T	TOPMed
rs200477815	p.Arg332Gly	missense variant	-	NC_000020.11:g.46011744C>G	TOPMed
rs199860204	p.Ser335Trp	missense variant	-	NC_000020.11:g.46012143C>G	TOPMed,gnomAD
rs199860204	p.Ser335Leu	missense variant	-	NC_000020.11:g.46012143C>T	TOPMed,gnomAD
rs764068837	p.Thr336Met	missense variant	-	NC_000020.11:g.46012146C>T	ExAC,gnomAD
rs764068837	p.Thr336Arg	missense variant	-	NC_000020.11:g.46012146C>G	ExAC,gnomAD
rs199741040	p.Val337Ala	missense variant	-	NC_000020.11:g.46012149T>C	1000Genomes,ExAC,gnomAD
rs149701392	p.Val337Met	missense variant	-	NC_000020.11:g.46012148G>A	ESP,ExAC,TOPMed,gnomAD
rs149701392	p.Val337Leu	missense variant	-	NC_000020.11:g.46012148G>T	ESP,ExAC,TOPMed,gnomAD
rs1488602462	p.Gly339Arg	missense variant	-	NC_000020.11:g.46012154G>A	gnomAD
rs1343892427	p.Gly339Glu	missense variant	-	NC_000020.11:g.46012155G>A	gnomAD
rs1200165936	p.Gly340Ser	missense variant	-	NC_000020.11:g.46012157G>A	TOPMed,gnomAD
rs751305882	p.Asn341Asp	missense variant	-	NC_000020.11:g.46012160A>G	ExAC,gnomAD
rs754744380	p.Ser342Leu	missense variant	-	NC_000020.11:g.46012164C>T	ExAC,gnomAD
NCI-TCGA novel	p.Ser342Trp	missense variant	-	NC_000020.11:g.46012164C>G	NCI-TCGA
NCI-TCGA novel	p.Ala343Val	missense variant	-	NC_000020.11:g.46012167C>T	NCI-TCGA
rs748028096	p.Gly344Ala	missense variant	-	NC_000020.11:g.46012170G>C	ExAC,gnomAD
rs1028196273	p.Glu345Gly	missense variant	-	NC_000020.11:g.46012173A>G	gnomAD
rs770663427	p.Cys347Ter	stop gained	-	NC_000020.11:g.46012180C>A	ExAC,gnomAD
rs145450508	p.Cys347Tyr	missense variant	-	NC_000020.11:g.46012179G>A	ESP,ExAC,TOPMed
rs1408103367	p.Val348Phe	missense variant	-	NC_000020.11:g.46012181G>T	TOPMed,gnomAD
rs1408103367	p.Val348Ile	missense variant	-	NC_000020.11:g.46012181G>A	TOPMed,gnomAD
rs745558432	p.Pro350Leu	missense variant	-	NC_000020.11:g.46012188C>T	ExAC,gnomAD
rs774129053	p.Pro350Ser	missense variant	-	NC_000020.11:g.46012187C>T	ExAC,TOPMed,gnomAD
rs745558432	p.Pro350Arg	missense variant	-	NC_000020.11:g.46012188C>G	ExAC,gnomAD
COSM4098948	p.Pro350His	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012188C>A	NCI-TCGA Cosmic
rs775983105	p.Phe351Leu	missense variant	-	NC_000020.11:g.46012190T>C	ExAC,TOPMed,gnomAD
rs1403318320	p.Phe351Ser	missense variant	-	NC_000020.11:g.46012191T>C	TOPMed
rs1295678714	p.Phe351Leu	missense variant	-	NC_000020.11:g.46012192C>A	gnomAD
rs1261652427	p.Lys356Arg	missense variant	-	NC_000020.11:g.46012206A>G	TOPMed,gnomAD
NCI-TCGA novel	p.Lys356Ter	stop gained	-	NC_000020.11:g.46012205A>T	NCI-TCGA
rs200855672	p.Lys356Glu	missense variant	-	NC_000020.11:g.46012205A>G	ExAC,TOPMed,gnomAD
rs764667806	p.Tyr358Cys	missense variant	-	NC_000020.11:g.46012212A>G	ExAC,gnomAD
rs776534377	p.Ser359Trp	missense variant	-	NC_000020.11:g.46012215C>G	ExAC,gnomAD
rs201995611	p.Thr360Asn	missense variant	-	NC_000020.11:g.46012218C>A	ExAC,TOPMed,gnomAD
rs765350061	p.Thr362Ala	missense variant	-	NC_000020.11:g.46012223A>G	ExAC,TOPMed,gnomAD
rs1426221127	p.Ser363Arg	missense variant	-	NC_000020.11:g.46012228C>G	TOPMed
rs1262533864	p.Glu364Lys	missense variant	-	NC_000020.11:g.46012229G>A	gnomAD
rs750611219	p.Gly365Asp	missense variant	-	NC_000020.11:g.46012233G>A	ExAC,gnomAD
rs1432808686	p.Gly365Ser	missense variant	-	NC_000020.11:g.46012232G>A	gnomAD
rs1431124552	p.Arg366Gly	missense variant	-	NC_000020.11:g.46012235C>G	gnomAD
rs1197801989	p.Arg366His	missense variant	-	NC_000020.11:g.46012236G>A	TOPMed
rs758685219	p.Gly367Arg	missense variant	-	NC_000020.11:g.46012238G>C	ExAC,gnomAD
COSM266947	p.Gly367Arg	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012238G>A	NCI-TCGA Cosmic
NCI-TCGA novel	p.Gly369Trp	missense variant	-	NC_000020.11:g.46012244G>T	NCI-TCGA
NCI-TCGA novel	p.Gly369Val	missense variant	-	NC_000020.11:g.46012245G>T	NCI-TCGA
rs958279746	p.Arg370Cys	missense variant	-	NC_000020.11:g.46012247C>T	TOPMed,gnomAD
rs958279746	p.Arg370Ser	missense variant	-	NC_000020.11:g.46012247C>A	TOPMed,gnomAD
rs1455292512	p.Trp372Ter	stop gained	-	NC_000020.11:g.46012255G>A	gnomAD
rs752547204	p.Cys373Trp	missense variant	-	NC_000020.11:g.46012258C>G	ExAC
rs755934245	p.Ala374Ser	missense variant	-	NC_000020.11:g.46012259G>T	ExAC,TOPMed,gnomAD
rs755934245	p.Ala374Thr	missense variant	-	NC_000020.11:g.46012259G>A	ExAC,TOPMed,gnomAD
rs777794038	p.Thr376Asn	missense variant	-	NC_000020.11:g.46012266C>A	ExAC,TOPMed,gnomAD
rs777794038	p.Thr376Ile	missense variant	-	NC_000020.11:g.46012266C>T	ExAC,TOPMed,gnomAD
rs202242171	p.Ser377Leu	missense variant	-	NC_000020.11:g.46012269C>T	ESP,ExAC,TOPMed,gnomAD
rs745505081	p.Asn378Lys	missense variant	-	NC_000020.11:g.46012273C>A	ExAC,gnomAD
rs377610104	p.Ser381Thr	missense variant	-	NC_000020.11:g.46012281G>C	ESP,TOPMed
rs1412397989	p.Ser381Arg	missense variant	-	NC_000020.11:g.46012280A>C	gnomAD
COSM724411	p.Ser381Arg	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012282C>A	NCI-TCGA Cosmic
rs771771224	p.Asp382Val	missense variant	-	NC_000020.11:g.46012284A>T	ExAC,gnomAD
NCI-TCGA novel	p.Asp382His	missense variant	-	NC_000020.11:g.46012283G>C	NCI-TCGA
COSM1027389	p.Asp382Asn	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012283G>A	NCI-TCGA Cosmic
rs775650676	p.Lys383Arg	missense variant	-	NC_000020.11:g.46012287A>G	ExAC,TOPMed,gnomAD
rs1172538806	p.Trp385Ter	stop gained	-	NC_000020.11:g.46012294G>A	gnomAD
NCI-TCGA novel	p.Trp385Leu	missense variant	-	NC_000020.11:g.46012293G>T	NCI-TCGA
rs1490219180	p.Phe387Val	missense variant	-	NC_000020.11:g.46012298T>G	TOPMed,gnomAD
rs1220377464	p.Cys388Tyr	missense variant	-	NC_000020.11:g.46012302G>A	gnomAD
rs527613229	p.Pro389Leu	missense variant	-	NC_000020.11:g.46012305C>T	1000Genomes,ExAC,TOPMed,gnomAD
rs1275621092	p.Asp390Gly	missense variant	-	NC_000020.11:g.46012308A>G	TOPMed
rs201524123	p.Asp390Tyr	missense variant	-	NC_000020.11:g.46012307G>T	ExAC,gnomAD
rs1420799907	p.Gln391Glu	missense variant	-	NC_000020.11:g.46012310C>G	gnomAD
rs1159792100	p.Gln391Arg	missense variant	-	NC_000020.11:g.46012311A>G	gnomAD
rs1438885173	p.Gly392Arg	missense variant	-	NC_000020.11:g.46012313G>A	TOPMed
rs763938898	p.Gly392Glu	missense variant	-	NC_000020.11:g.46012427G>A	ExAC,gnomAD
rs757078351	p.TyrSer393Ter	stop gained	-	NC_000020.11:g.46012431_46012432del	ExAC,TOPMed,gnomAD
rs370515124	p.Ser394Thr	missense variant	-	NC_000020.11:g.46012433G>C	ESP,ExAC,TOPMed,gnomAD
rs761777308	p.Phe396Leu	missense variant	-	NC_000020.11:g.46012438T>C	ExAC,gnomAD
rs1301558887	p.Leu397Pro	missense variant	-	NC_000020.11:g.46012442T>C	TOPMed
rs765298650	p.Val398Glu	missense variant	-	NC_000020.11:g.46012445T>A	ExAC,TOPMed,gnomAD
rs1171543612	p.Val398Met	missense variant	-	NC_000020.11:g.46012444G>A	gnomAD
rs765298650	p.Val398Gly	missense variant	-	NC_000020.11:g.46012445T>G	ExAC,TOPMed,gnomAD
rs1171543612	p.Val398Leu	missense variant	-	NC_000020.11:g.46012444G>C	gnomAD
rs200590350	p.Ala399Val	missense variant	-	NC_000020.11:g.46012448C>T	TOPMed
NCI-TCGA novel	p.Ala400Thr	missense variant	-	NC_000020.11:g.46012450G>A	NCI-TCGA
NCI-TCGA novel	p.Ala400Glu	missense variant	-	NC_000020.11:g.46012451C>A	NCI-TCGA
rs1384211524	p.His401Leu	missense variant	-	NC_000020.11:g.46012454A>T	gnomAD
rs1398587848	p.His401Gln	missense variant	-	NC_000020.11:g.46012455T>G	TOPMed
rs1430059719	p.Glu402Gln	missense variant	-	NC_000020.11:g.46012456G>C	gnomAD
rs201417784	p.Phe403Tyr	missense variant	-	NC_000020.11:g.46012460T>A	1000Genomes,ExAC,TOPMed,gnomAD
rs751218589	p.Gly404Ser	missense variant	-	NC_000020.11:g.46012462G>A	ExAC,gnomAD
NCI-TCGA novel	p.Gly404Cys	missense variant	-	NC_000020.11:g.46012462G>T	NCI-TCGA
COSM4098952	p.Gly404Asp	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012463G>A	NCI-TCGA Cosmic
rs373663809	p.Ala406Thr	missense variant	-	NC_000020.11:g.46012468G>A	ESP,ExAC,TOPMed,gnomAD
rs748513980	p.Ala406Val	missense variant	-	NC_000020.11:g.46012469C>T	ExAC,gnomAD
rs1190321032	p.Leu407Arg	missense variant	-	NC_000020.11:g.46012472T>G	gnomAD
NCI-TCGA novel	p.Gly408Val	missense variant	-	NC_000020.11:g.46012475G>T	NCI-TCGA
rs1243400784	p.Asp410His	missense variant	-	NC_000020.11:g.46012480G>C	gnomAD
rs749803246	p.His411Arg	missense variant	-	NC_000020.11:g.46012484A>G	ExAC,TOPMed,gnomAD
rs1475532567	p.His411Asn	missense variant	-	NC_000020.11:g.46012483C>A	gnomAD
rs1014120184	p.His411Gln	missense variant	-	NC_000020.11:g.46012485T>G	TOPMed,gnomAD
rs1179069895	p.Ser413Leu	missense variant	-	NC_000020.11:g.46012490C>T	gnomAD
rs1479632722	p.Ser413Pro	missense variant	-	NC_000020.11:g.46012489T>C	gnomAD
rs771043300	p.Ala417Glu	missense variant	-	NC_000020.11:g.46012502C>A	ExAC,TOPMed,gnomAD
rs771043300	p.Ala417Val	missense variant	-	NC_000020.11:g.46012502C>T	ExAC,TOPMed,gnomAD
rs774355160	p.Met419Arg	missense variant	-	NC_000020.11:g.46012508T>G	ExAC,TOPMed,gnomAD
rs774355160	p.Met419Thr	missense variant	-	NC_000020.11:g.46012508T>C	ExAC,TOPMed,gnomAD
rs1347107674	p.Tyr420Cys	missense variant	-	NC_000020.11:g.46012511A>G	gnomAD
rs1285516259	p.Pro421Ser	missense variant	-	NC_000020.11:g.46012513C>T	TOPMed
rs201131366	p.Met422Arg	missense variant	-	NC_000020.11:g.46012517T>G	ExAC,TOPMed,gnomAD
rs201131366	p.Met422Thr	missense variant	-	NC_000020.11:g.46012517T>C	ExAC,TOPMed,gnomAD
rs201131366	p.Met422Lys	missense variant	-	NC_000020.11:g.46012517T>A	ExAC,TOPMed,gnomAD
rs1343899909	p.Met422Ile	missense variant	-	NC_000020.11:g.46012518G>A	gnomAD
COSM1027393	p.Met422Ile	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46012518G>T	NCI-TCGA Cosmic
rs1225079917	p.Tyr423Cys	missense variant	-	NC_000020.11:g.46012520A>G	TOPMed,gnomAD
rs776529410	p.Arg424His	missense variant	-	NC_000020.11:g.46012523G>A	ExAC,TOPMed,gnomAD
rs776529410	p.Arg424Leu	missense variant	-	NC_000020.11:g.46012523G>T	ExAC,TOPMed,gnomAD
rs371768001	p.Arg424Cys	missense variant	-	NC_000020.11:g.46012522C>T	ExAC,TOPMed,gnomAD
rs371768001	p.Arg424Gly	missense variant	-	NC_000020.11:g.46012522C>G	ExAC,TOPMed,gnomAD
rs761724001	p.Phe425Leu	missense variant	-	NC_000020.11:g.46012525T>C	ExAC
rs765173871	p.Glu427Lys	missense variant	-	NC_000020.11:g.46012531G>A	ExAC,gnomAD
rs773252323	p.Gly428Arg	missense variant	-	NC_000020.11:g.46012534G>A	ExAC
RCV000778632	p.Pro429Ter	frameshift	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46012536dup	ClinVar
rs146895638	p.Pro429His	missense variant	-	NC_000020.11:g.46012538C>A	ExAC,TOPMed,gnomAD
rs765897608	p.Pro429Ser	missense variant	-	NC_000020.11:g.46012537C>T	ExAC,gnomAD
rs765897608	p.Pro429Ala	missense variant	-	NC_000020.11:g.46012537C>G	ExAC,gnomAD
NCI-TCGA novel	p.Pro429Leu	missense variant	-	NC_000020.11:g.46012538C>T	NCI-TCGA
rs754588801	p.Pro430Ser	missense variant	-	NC_000020.11:g.46012540C>T	ExAC,gnomAD
rs1363158579	p.Leu431Met	missense variant	-	NC_000020.11:g.46012543T>A	TOPMed
NCI-TCGA novel	p.Leu431CysPheSerTerUnk	frameshift	-	NC_000020.11:g.46012533G>-	NCI-TCGA
COSM3294212	p.Leu431CysPheSerTerUnk	frameshift	Variant assessed as Somatic; HIGH impact.	NC_000020.11:g.46012537C>-	NCI-TCGA Cosmic
rs1157385301	p.His432Tyr	missense variant	-	NC_000020.11:g.46012546C>T	gnomAD
rs548050315	p.His432Arg	missense variant	-	NC_000020.11:g.46012547A>G	1000Genomes,ExAC
rs768099775	p.His432AlaPheSerTerUnk	frameshift	-	NC_000020.11:g.46012536_46012537insC	NCI-TCGA
rs1424297375	p.Asp434Glu	missense variant	-	NC_000020.11:g.46012554C>A	TOPMed
rs778180559	p.Asp434Ala	missense variant	-	NC_000020.11:g.46012553A>C	ExAC,gnomAD
rs199893610	p.Asp434His	missense variant	-	NC_000020.11:g.46012552G>C	ESP,ExAC,TOPMed,gnomAD
rs199893610	p.Asp434Asn	missense variant	-	NC_000020.11:g.46012552G>A	ESP,ExAC,TOPMed,gnomAD
rs201169008	p.Gly438Ala	missense variant	-	NC_000020.11:g.46012565G>C	ExAC,gnomAD
rs147960167	p.Arg440Gln	missense variant	-	NC_000020.11:g.46012571G>A	ESP,ExAC,TOPMed,gnomAD
rs141702644	p.His441Pro	missense variant	-	NC_000020.11:g.46012574A>C	ESP,ExAC,TOPMed,gnomAD
rs1334987603	p.His441Gln	missense variant	-	NC_000020.11:g.46012575C>G	TOPMed,gnomAD
rs141702644	p.His441Leu	missense variant	-	NC_000020.11:g.46012574A>T	ESP,ExAC,TOPMed,gnomAD
rs772372699	p.Tyr443Cys	missense variant	-	NC_000020.11:g.46012580A>G	ExAC,gnomAD
rs1389420574	p.Pro445Leu	missense variant	-	NC_000020.11:g.46013258C>T	gnomAD
rs754160543	p.Arg446Gly	missense variant	-	NC_000020.11:g.46013260C>G	ExAC,TOPMed,gnomAD
rs754160543	p.Arg446Cys	missense variant	-	NC_000020.11:g.46013260C>T	ExAC,TOPMed,gnomAD
rs968520149	p.Arg446His	missense variant	-	NC_000020.11:g.46013261G>A	TOPMed
rs201191171	p.Arg452Gln	missense variant	-	NC_000020.11:g.46013279G>A	ExAC,TOPMed,gnomAD
rs201191171	p.Arg452Pro	missense variant	-	NC_000020.11:g.46013279G>C	ExAC,TOPMed,gnomAD
rs368282794	p.Arg452Trp	missense variant	-	NC_000020.11:g.46013278C>T	ESP,ExAC,TOPMed,gnomAD
rs201191171	p.Arg452Leu	missense variant	-	NC_000020.11:g.46013279G>T	ExAC,TOPMed,gnomAD
rs747221038	p.Thr458Ile	missense variant	-	NC_000020.11:g.46013297C>T	ExAC,gnomAD
rs147087483	p.Pro459Ser	missense variant	-	NC_000020.11:g.46013299C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs200236055	p.Pro459Arg	missense variant	-	NC_000020.11:g.46013300C>G	ExAC,TOPMed,gnomAD
rs200236055	p.Pro459Leu	missense variant	-	NC_000020.11:g.46013300C>T	ExAC,TOPMed,gnomAD
rs1217684867	p.Pro461Ser	missense variant	-	NC_000020.11:g.46013305C>T	TOPMed
rs770850998	p.Pro461Leu	missense variant	-	NC_000020.11:g.46013306C>T	ExAC
COSM270850	p.Thr462Met	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013309C>T	NCI-TCGA Cosmic
rs759506867	p.Ala463Asp	missense variant	-	NC_000020.11:g.46013312C>A	ExAC,gnomAD
rs372797556	p.Ala463Ser	missense variant	-	NC_000020.11:g.46013311G>T	ESP,ExAC,gnomAD
rs374355049	p.Pro464Ser	missense variant	-	NC_000020.11:g.46013314C>T	ExAC,gnomAD
NCI-TCGA novel	p.Pro464His	missense variant	-	NC_000020.11:g.46013315C>A	NCI-TCGA
rs774999010	p.Pro465Leu	missense variant	-	NC_000020.11:g.46013318C>T	ExAC,gnomAD
NCI-TCGA novel	p.Pro465ArgPheSerTerUnkUnk	frameshift	-	NC_000020.11:g.46013314C>-	NCI-TCGA
rs760257077	p.Thr466Pro	missense variant	-	NC_000020.11:g.46013320A>C	ExAC,TOPMed,gnomAD
rs1291812181	p.Thr466Met	missense variant	-	NC_000020.11:g.46013321C>T	gnomAD
rs760257077	p.Thr466Ala	missense variant	-	NC_000020.11:g.46013320A>G	ExAC,TOPMed,gnomAD
rs1169417910	p.Val467Phe	missense variant	-	NC_000020.11:g.46013323G>T	TOPMed,gnomAD
rs1169417910	p.Val467Ile	missense variant	-	NC_000020.11:g.46013323G>A	TOPMed,gnomAD
rs201489145	p.Cys468Tyr	missense variant	-	NC_000020.11:g.46013327G>A	gnomAD
rs375741446	p.Thr470Ser	missense variant	-	NC_000020.11:g.46013333C>G	ESP,ExAC,TOPMed,gnomAD
rs1384941180	p.Thr470Pro	missense variant	-	NC_000020.11:g.46013332A>C	gnomAD
rs765674753	p.Gly471Arg	missense variant	-	NC_000020.11:g.46013335G>A	ExAC,gnomAD
rs148151404	p.Pro472Ala	missense variant	-	NC_000020.11:g.46013338C>G	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs148151404	p.Pro472Ser	missense variant	-	NC_000020.11:g.46013338C>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000300785	p.Pro472Ser	missense variant	-	NC_000020.11:g.46013338C>T	ClinVar
rs751692325	p.Pro473Thr	missense variant	-	NC_000020.11:g.46013341C>A	ExAC,gnomAD
rs755208384	p.Thr474Asn	missense variant	-	NC_000020.11:g.46013345C>A	ExAC,gnomAD
NCI-TCGA novel	p.Thr474LeuPheSerTerUnkUnk	frameshift	-	NC_000020.11:g.46013338C>-	NCI-TCGA
COSM3911471	p.Thr474Pro	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013344A>C	NCI-TCGA Cosmic
rs781290190	p.Val475Ile	missense variant	-	NC_000020.11:g.46013347G>A	ExAC,TOPMed,gnomAD
rs1201050035	p.His476Arg	missense variant	-	NC_000020.11:g.46013351A>G	TOPMed,gnomAD
rs748447770	p.Pro477Thr	missense variant	-	NC_000020.11:g.46013353C>A	ExAC,gnomAD
rs1379158945	p.Ser478Pro	missense variant	-	NC_000020.11:g.46013356T>C	TOPMed
rs1179114145	p.Arg480Cys	missense variant	-	NC_000020.11:g.46013362C>T	TOPMed
rs770597186	p.Arg480His	missense variant	-	NC_000020.11:g.46013363G>A	ExAC,TOPMed,gnomAD
rs770597186	p.Arg480Leu	missense variant	-	NC_000020.11:g.46013363G>T	ExAC,TOPMed,gnomAD
rs1238336258	p.Pro481Ser	missense variant	-	NC_000020.11:g.46013365C>T	TOPMed,gnomAD
rs745751136	p.Pro485Ala	missense variant	-	NC_000020.11:g.46013377C>G	ExAC
rs1479962170	p.Pro485Leu	missense variant	-	NC_000020.11:g.46013378C>T	gnomAD
rs200004905	p.Thr486Ile	missense variant	-	NC_000020.11:g.46013381C>T	1000Genomes,ExAC,gnomAD
rs760201819	p.Gly487Val	missense variant	-	NC_000020.11:g.46013384G>T	ExAC,gnomAD
rs774943876	p.Gly487Ser	missense variant	-	NC_000020.11:g.46013383G>A	ExAC,gnomAD
rs1281260321	p.Pro488Leu	missense variant	-	NC_000020.11:g.46013387C>T	TOPMed
rs776118546	p.Pro489Ala	missense variant	-	NC_000020.11:g.46013389C>G	ExAC,TOPMed,gnomAD
RCV000180611	p.Pro489Ala	missense variant	-	NC_000020.11:g.46013389C>G	ClinVar
rs201655080	p.Ser490Pro	missense variant	-	NC_000020.11:g.46013392T>C	1000Genomes,TOPMed
rs201655080	p.Ser490Thr	missense variant	-	NC_000020.11:g.46013392T>A	1000Genomes,TOPMed
NCI-TCGA novel	p.Ser490LeuPheSerTerUnkUnk	frameshift	-	NC_000020.11:g.46013385_46013386insC	NCI-TCGA
rs200619019	p.Gly495Val	missense variant	-	NC_000020.11:g.46013408G>T	-
NCI-TCGA novel	p.Pro496Ser	missense variant	-	NC_000020.11:g.46013410C>T	NCI-TCGA
rs767022971	p.Thr498Ser	missense variant	-	NC_000020.11:g.46013416A>T	ExAC,TOPMed,gnomAD
rs749041567	p.Thr503Arg	missense variant	-	NC_000020.11:g.46013432C>G	TOPMed,gnomAD
rs1490250349	p.Ala504Asp	missense variant	-	NC_000020.11:g.46013435C>A	gnomAD
rs1360140107	p.Thr505Ile	missense variant	-	NC_000020.11:g.46013438C>T	TOPMed
rs756375631	p.Pro508Ser	missense variant	-	NC_000020.11:g.46013446C>T	ExAC,gnomAD
rs778508016	p.Pro508Leu	missense variant	-	NC_000020.11:g.46013447C>T	ExAC,TOPMed,gnomAD
rs1417499614	p.Ser510Asn	missense variant	-	NC_000020.11:g.46013453G>A	TOPMed
rs1055327031	p.Pro511Leu	missense variant	-	NC_000020.11:g.46013456C>T	TOPMed
NCI-TCGA novel	p.Pro511Ser	missense variant	-	NC_000020.11:g.46013455C>T	NCI-TCGA
rs745697857	p.Asp513Glu	missense variant	-	NC_000020.11:g.46013463C>G	ExAC,gnomAD
rs368234910	p.Asp514Tyr	missense variant	-	NC_000020.11:g.46013464G>T	ESP,ExAC,TOPMed,gnomAD
rs368234910	p.Asp514Asn	missense variant	-	NC_000020.11:g.46013464G>A	ESP,ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Cys516Tyr	missense variant	-	NC_000020.11:g.46013471G>A	NCI-TCGA
rs1402353204	p.Asn519Ile	missense variant	-	NC_000020.11:g.46013480A>T	TOPMed
rs551960298	p.Ile520Leu	missense variant	-	NC_000020.11:g.46013482A>C	1000Genomes
rs1402779800	p.Ile520Met	missense variant	-	NC_000020.11:g.46013484C>G	gnomAD
rs1370233833	p.Asp522His	missense variant	-	NC_000020.11:g.46013488G>C	gnomAD
NCI-TCGA novel	p.Asp522Asn	missense variant	-	NC_000020.11:g.46013488G>A	NCI-TCGA
NCI-TCGA novel	p.Asp522Tyr	missense variant	-	NC_000020.11:g.46013488G>T	NCI-TCGA
COSM4940001	p.Asp522Glu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013490C>A	NCI-TCGA Cosmic
rs372299611	p.Ala523Val	missense variant	-	NC_000020.11:g.46013492C>T	ESP,ExAC,TOPMed,gnomAD
rs1473433072	p.Ala523Thr	missense variant	-	NC_000020.11:g.46013491G>A	gnomAD
rs1038064393	p.Ile524Thr	missense variant	-	NC_000020.11:g.46013495T>C	TOPMed
COSM4098955	p.Ala525Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013497G>A	NCI-TCGA Cosmic
rs747696251	p.Glu526Asp	missense variant	-	NC_000020.11:g.46013502G>T	ExAC,gnomAD
rs1190319835	p.Glu526Lys	missense variant	-	NC_000020.11:g.46013500G>A	TOPMed
rs1487471521	p.Ile527Phe	missense variant	-	NC_000020.11:g.46013503A>T	TOPMed
rs1248216978	p.Asn529Lys	missense variant	-	NC_000020.11:g.46013511C>G	gnomAD
rs769491153	p.Gln530Ter	stop gained	-	NC_000020.11:g.46013512C>T	ExAC,gnomAD
rs1248244568	p.Phe534Leu	missense variant	-	NC_000020.11:g.46013526C>G	gnomAD
COSM1027395	p.Lys535Asn	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013529G>T	NCI-TCGA Cosmic
rs1420821532	p.Gly537Glu	missense variant	-	NC_000020.11:g.46013534G>A	gnomAD
rs1332568935	p.Tyr539Cys	missense variant	-	NC_000020.11:g.46013662A>G	gnomAD
rs1382735555	p.Tyr539Ter	stop gained	-	NC_000020.11:g.46013663C>A	gnomAD
rs754955508	p.Arg541Gln	missense variant	-	NC_000020.11:g.46013668G>A	ExAC,gnomAD
rs780500313	p.Phe542Ser	missense variant	-	NC_000020.11:g.46013671T>C	ExAC,gnomAD
NCI-TCGA novel	p.Phe542Leu	missense variant	-	NC_000020.11:g.46013672C>A	NCI-TCGA
NCI-TCGA novel	p.Arg546Lys	missense variant	-	NC_000020.11:g.46013683G>A	NCI-TCGA
NCI-TCGA novel	p.Arg546Trp	missense variant	-	NC_000020.11:g.46013682A>T	NCI-TCGA
rs769280932	p.Arg549Trp	missense variant	-	NC_000020.11:g.46013691C>T	ExAC,gnomAD
NCI-TCGA novel	p.Arg549Gln	missense variant	-	NC_000020.11:g.46013692G>A	NCI-TCGA
rs772972610	p.Pro550Ser	missense variant	-	NC_000020.11:g.46013694C>T	ExAC,TOPMed,gnomAD
rs748984817	p.Gln551His	missense variant	-	NC_000020.11:g.46013699G>T	ExAC,TOPMed,gnomAD
rs1171325095	p.Pro553Ala	missense variant	-	NC_000020.11:g.46013703C>G	TOPMed
rs926968908	p.Pro553Leu	missense variant	-	NC_000020.11:g.46013704C>T	TOPMed,gnomAD
NCI-TCGA novel	p.Leu555Phe	missense variant	-	NC_000020.11:g.46013709C>T	NCI-TCGA
rs771415685	p.Ala557Asp	missense variant	-	NC_000020.11:g.46013716C>A	ExAC,gnomAD
rs150224695	p.Asp558Gly	missense variant	-	NC_000020.11:g.46013719A>G	ESP,ExAC,TOPMed,gnomAD
rs759896847	p.Asp558Asn	missense variant	-	NC_000020.11:g.46013718G>A	ExAC,gnomAD
rs775387047	p.Lys559Glu	missense variant	-	NC_000020.11:g.46013721A>G	ExAC,gnomAD
rs1478981807	p.Lys559Arg	missense variant	-	NC_000020.11:g.46013722A>G	gnomAD
rs138685704	p.Trp560Ter	stop gained	-	NC_000020.11:g.46013725G>A	ESP,ExAC,TOPMed,gnomAD
RCV000778633	p.Trp560Ter	nonsense	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46013725G>A	ClinVar
rs141966515	p.Pro561Ala	missense variant	-	NC_000020.11:g.46013727C>G	ESP,ExAC,gnomAD
rs141966515	p.Pro561Ser	missense variant	-	NC_000020.11:g.46013727C>T	ESP,ExAC,gnomAD
rs1468753367	p.Ala562Thr	missense variant	-	NC_000020.11:g.46013730G>A	gnomAD
NCI-TCGA novel	p.Leu563Val	missense variant	-	NC_000020.11:g.46013733C>G	NCI-TCGA
rs1336241913	p.Pro564Ser	missense variant	-	NC_000020.11:g.46013736C>T	gnomAD
rs1359858475	p.Pro564His	missense variant	-	NC_000020.11:g.46013737C>A	gnomAD
rs1359858475	p.Pro564Leu	missense variant	-	NC_000020.11:g.46013737C>T	gnomAD
rs543335411	p.Arg565His	missense variant	-	NC_000020.11:g.46013740G>A	1000Genomes,ExAC,TOPMed,gnomAD
rs543335411	p.Arg565Leu	missense variant	-	NC_000020.11:g.46013740G>T	1000Genomes,ExAC,TOPMed,gnomAD
rs1430252076	p.Arg565Gly	missense variant	-	NC_000020.11:g.46013739C>G	TOPMed,gnomAD
rs1342647321	p.Lys566Thr	missense variant	-	NC_000020.11:g.46013743A>C	gnomAD
NCI-TCGA novel	p.Lys566Arg	missense variant	-	NC_000020.11:g.46013743A>G	NCI-TCGA
rs1282416374	p.Asp568Asn	missense variant	-	NC_000020.11:g.46013748G>A	gnomAD
rs757535139	p.Ser569Trp	missense variant	-	NC_000020.11:g.46013752C>G	ExAC,TOPMed,gnomAD
rs757535139	p.Ser569Ter	stop gained	-	NC_000020.11:g.46013752C>A	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Val570Ala	missense variant	-	NC_000020.11:g.46013755T>C	NCI-TCGA
rs35691798	p.Phe571Val	missense variant	-	NC_000020.11:g.46013757T>G	ExAC,TOPMed,gnomAD
rs781210808	p.Glu573Asp	missense variant	-	NC_000020.11:g.46013765G>C	ExAC,gnomAD
rs754829019	p.Glu573Lys	missense variant	-	NC_000020.11:g.46013763G>A	ExAC,gnomAD
rs189827770	p.Arg574Gly	missense variant	-	NC_000020.11:g.46013766C>G	1000Genomes,ExAC,gnomAD
rs2250889	p.Arg574Pro	missense variant	-	NC_000020.11:g.46013767G>C	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000381191	p.Arg574Pro	missense variant	-	NC_000020.11:g.46013767G>C	ClinVar
rs2250889	p.Arg574Leu	missense variant	-	NC_000020.11:g.46013767G>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
RCV000270314	p.Arg574Pro	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46013767G>C	ClinVar
rs1194827897	p.Leu575Pro	missense variant	-	NC_000020.11:g.46013770T>C	gnomAD
rs201312492	p.Ser576Thr	missense variant	-	NC_000020.11:g.46013772T>A	gnomAD
rs1005636653	p.Ser576Cys	missense variant	-	NC_000020.11:g.46013773C>G	gnomAD
rs779383755	p.Lys577Glu	missense variant	-	NC_000020.11:g.46013775A>G	ExAC,TOPMed,gnomAD
rs1038500196	p.Lys577Arg	missense variant	-	NC_000020.11:g.46013776A>G	TOPMed,gnomAD
rs779383755	p.Lys577Ter	stop gained	-	NC_000020.11:g.46013775A>T	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Lys577Asn	missense variant	-	NC_000020.11:g.46013777G>T	NCI-TCGA
rs772374825	p.Phe580Cys	missense variant	-	NC_000020.11:g.46013785T>G	ExAC,gnomAD
COSM3841165	p.Phe581Leu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46013789C>A	NCI-TCGA Cosmic
rs1440345367	p.Gly584Glu	missense variant	-	NC_000020.11:g.46014124G>A	gnomAD
rs1302305656	p.Gly584Arg	missense variant	-	NC_000020.11:g.46013796G>C	gnomAD
rs1467654384	p.Gln586Ter	stop gained	-	NC_000020.11:g.46014129C>T	TOPMed
rs1163615651	p.Val587Leu	missense variant	-	NC_000020.11:g.46014132G>C	TOPMed,gnomAD
rs200746714	p.Trp588Ter	stop gained	-	NC_000020.11:g.46014137G>A	ExAC,TOPMed,gnomAD
RCV000778634	p.Trp588Ter	nonsense	Metaphyseal anadysplasia 2 (MANDP2)	NC_000020.11:g.46014137G>A	ClinVar
rs1463978877	p.Val589Met	missense variant	-	NC_000020.11:g.46014138G>A	gnomAD
rs777357774	p.Thr591Arg	missense variant	-	NC_000020.11:g.46014145C>G	ExAC,TOPMed,gnomAD
rs777357774	p.Thr591Ile	missense variant	-	NC_000020.11:g.46014145C>T	ExAC,TOPMed,gnomAD
rs1195441615	p.Ala593Glu	missense variant	-	NC_000020.11:g.46014151C>A	TOPMed
rs1400982177	p.Ala593Pro	missense variant	-	NC_000020.11:g.46014150G>C	gnomAD
rs753432923	p.Ser594Pro	missense variant	-	NC_000020.11:g.46014153T>C	ExAC,gnomAD
rs756923113	p.Val595Leu	missense variant	-	NC_000020.11:g.46014156G>T	ExAC,gnomAD
rs1340372819	p.Val595Gly	missense variant	-	NC_000020.11:g.46014157T>G	TOPMed
rs756923113	p.Val595Met	missense variant	-	NC_000020.11:g.46014156G>A	ExAC,gnomAD
COSM1412134	p.Pro598Thr	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46014165C>A	NCI-TCGA Cosmic
rs1285125500	p.Arg600Pro	missense variant	-	NC_000020.11:g.46014172G>C	gnomAD
rs1245154858	p.Arg600Cys	missense variant	-	NC_000020.11:g.46014171C>T	gnomAD
rs1285125500	p.Arg600His	missense variant	-	NC_000020.11:g.46014172G>A	gnomAD
rs527990566	p.Leu601Val	missense variant	-	NC_000020.11:g.46014174C>G	1000Genomes,ExAC,gnomAD
rs1197173954	p.Leu601Pro	missense variant	-	NC_000020.11:g.46014175T>C	gnomAD
rs576134436	p.Asp602His	missense variant	-	NC_000020.11:g.46014177G>C	1000Genomes,gnomAD
rs576134436	p.Asp602Asn	missense variant	-	NC_000020.11:g.46014177G>A	1000Genomes,gnomAD
rs1022229675	p.Leu604Met	missense variant	-	NC_000020.11:g.46014183C>A	gnomAD
rs1425748017	p.Gly605Ser	missense variant	-	NC_000020.11:g.46014186G>A	gnomAD
rs543571388	p.Gly607Ter	stop gained	-	NC_000020.11:g.46014192G>T	1000Genomes
rs1424180816	p.Ala608Thr	missense variant	-	NC_000020.11:g.46014195G>A	gnomAD
rs1300564395	p.Asp609Asn	missense variant	-	NC_000020.11:g.46014198G>A	gnomAD
rs765708300	p.Val610Leu	missense variant	-	NC_000020.11:g.46014201G>T	ExAC,gnomAD
rs765708300	p.Val610Leu	missense variant	-	NC_000020.11:g.46014201G>C	ExAC,gnomAD
rs1396232490	p.Ala611Asp	missense variant	-	NC_000020.11:g.46014205C>A	gnomAD
rs1338012680	p.Gln612Ter	stop gained	-	NC_000020.11:g.46014207C>T	gnomAD
rs1217117967	p.Gln612Leu	missense variant	-	NC_000020.11:g.46014208A>T	TOPMed,gnomAD
rs1217117967	p.Gln612Arg	missense variant	-	NC_000020.11:g.46014208A>G	TOPMed,gnomAD
rs1319203113	p.Val613Leu	missense variant	-	NC_000020.11:g.46014210G>C	gnomAD
rs1319203113	p.Val613Met	missense variant	-	NC_000020.11:g.46014210G>A	gnomAD
rs1254306737	p.Thr614Ala	missense variant	-	NC_000020.11:g.46014213A>G	gnomAD
rs1261219645	p.Gly615Glu	missense variant	-	NC_000020.11:g.46014217G>A	TOPMed,gnomAD
rs573936612	p.Gly615Trp	missense variant	-	NC_000020.11:g.46014216G>T	1000Genomes,TOPMed,gnomAD
rs573936612	p.Gly615Arg	missense variant	-	NC_000020.11:g.46014216G>A	1000Genomes,TOPMed,gnomAD
rs1261219645	p.Gly615Val	missense variant	-	NC_000020.11:g.46014217G>T	TOPMed,gnomAD
rs1485659654	p.Ala616Val	missense variant	-	NC_000020.11:g.46014220C>T	gnomAD
rs1487439307	p.Ala616Thr	missense variant	-	NC_000020.11:g.46014219G>A	gnomAD
rs1487439307	p.Ala616Ser	missense variant	-	NC_000020.11:g.46014219G>T	gnomAD
rs541487643	p.Leu617His	missense variant	-	NC_000020.11:g.46014223T>A	1000Genomes,TOPMed,gnomAD
rs541487643	p.Leu617Pro	missense variant	-	NC_000020.11:g.46014223T>C	1000Genomes,TOPMed,gnomAD
rs960442345	p.Arg618Trp	missense variant	-	NC_000020.11:g.46014225C>T	gnomAD
rs761902475	p.Arg618Gln	missense variant	-	NC_000020.11:g.46014226G>A	ExAC,gnomAD
rs1173928961	p.Ser619Asn	missense variant	-	NC_000020.11:g.46014229G>A	gnomAD
rs990563451	p.Gly620Asp	missense variant	-	NC_000020.11:g.46014232G>A	gnomAD
rs990563451	p.Gly620Val	missense variant	-	NC_000020.11:g.46014232G>T	gnomAD
rs1466072965	p.Arg621Gly	missense variant	-	NC_000020.11:g.46014234A>G	gnomAD
rs1466072965	p.Arg621Trp	missense variant	-	NC_000020.11:g.46014234A>T	gnomAD
rs6104428	p.Arg621Lys	missense variant	-	NC_000020.11:g.46014235G>A	ExAC,TOPMed,gnomAD
rs6104428	p.Arg621Thr	missense variant	-	NC_000020.11:g.46014235G>C	ExAC,TOPMed,gnomAD
rs773448293	p.Gly622Arg	missense variant	-	NC_000020.11:g.46014237G>C	ExAC,TOPMed,gnomAD
rs1300400001	p.Met624Ile	missense variant	-	NC_000020.11:g.46014245G>A	gnomAD
rs1341573154	p.Phe627Leu	missense variant	-	NC_000020.11:g.46014254C>G	gnomAD
rs767327895	p.Ser628Asn	missense variant	-	NC_000020.11:g.46014256G>A	ExAC
rs1299768724	p.Gly629Ala	missense variant	-	NC_000020.11:g.46014259G>C	gnomAD
rs559776843	p.Gly629Arg	missense variant	-	NC_000020.11:g.46014258G>C	1000Genomes,ExAC,TOPMed,gnomAD
rs559776843	p.Gly629Arg	missense variant	-	NC_000020.11:g.46014258G>A	1000Genomes,ExAC,TOPMed,gnomAD
rs1233986311	p.Arg630Trp	missense variant	-	NC_000020.11:g.46014261C>T	TOPMed,gnomAD
rs201280938	p.Arg631Ser	missense variant	-	NC_000020.11:g.46014264C>A	1000Genomes,ExAC,TOPMed,gnomAD
rs1351778542	p.Arg631His	missense variant	-	NC_000020.11:g.46014265G>A	TOPMed,gnomAD
rs201280938	p.Arg631Cys	missense variant	-	NC_000020.11:g.46014264C>T	1000Genomes,ExAC,TOPMed,gnomAD
RCV000384681	p.Arg631Ser	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46014264C>A	ClinVar
RCV000733684	p.Arg631Ser	missense variant	-	NC_000020.11:g.46014264C>A	ClinVar
rs1275331861	p.Leu632Phe	missense variant	-	NC_000020.11:g.46014267C>T	TOPMed
rs1490112187	p.Trp633Ter	stop gained	-	NC_000020.11:g.46014270_46014271insA	TOPMed,gnomAD
rs753879807	p.Arg634Lys	missense variant	-	NC_000020.11:g.46014274G>A	ExAC,gnomAD
rs1449008686	p.Val637Met	missense variant	-	NC_000020.11:g.46014378G>A	gnomAD
rs1449008686	p.Val637Leu	missense variant	-	NC_000020.11:g.46014378G>C	gnomAD
rs1378687282	p.Ala639Val	missense variant	-	NC_000020.11:g.46014385C>T	TOPMed,gnomAD
rs1322040806	p.Asp643Asn	missense variant	-	NC_000020.11:g.46014396G>A	gnomAD
rs1197786653	p.Pro644Arg	missense variant	-	NC_000020.11:g.46014400C>G	gnomAD
rs1197786653	p.Pro644His	missense variant	-	NC_000020.11:g.46014400C>A	gnomAD
rs1039833998	p.Arg645Gln	missense variant	-	NC_000020.11:g.46014403G>A	TOPMed
rs1256036447	p.Arg645Trp	missense variant	-	NC_000020.11:g.46014402C>T	gnomAD
rs1198701842	p.Ser646Gly	missense variant	-	NC_000020.11:g.46014405A>G	gnomAD
rs748693804	p.Ser646Arg	missense variant	-	NC_000020.11:g.46014407C>G	ExAC,gnomAD
rs1236427613	p.Ser646Asn	missense variant	-	NC_000020.11:g.46014406G>A	gnomAD
rs1183294686	p.Ala647Thr	missense variant	-	NC_000020.11:g.46014408G>A	gnomAD
rs201553146	p.Ser648Arg	missense variant	-	NC_000020.11:g.46014413C>A	gnomAD
rs1424689310	p.Asp651Asn	missense variant	-	NC_000020.11:g.46014420G>A	gnomAD
rs199533749	p.Arg652Trp	missense variant	-	NC_000020.11:g.46014423C>T	gnomAD
rs905276176	p.Arg652Gln	missense variant	-	NC_000020.11:g.46014424G>A	TOPMed,gnomAD
rs1358717510	p.Pro655Ser	missense variant	-	NC_000020.11:g.46014432C>T	gnomAD
rs531026399	p.Pro655Leu	missense variant	-	NC_000020.11:g.46014433C>T	1000Genomes,gnomAD
rs1304741777	p.Gly656Glu	missense variant	-	NC_000020.11:g.46014436G>A	gnomAD
rs200684686	p.Val657Ala	missense variant	-	NC_000020.11:g.46014439T>C	gnomAD
rs1276124546	p.Thr661Ala	missense variant	-	NC_000020.11:g.46014450A>G	gnomAD
rs1219244909	p.His662Gln	missense variant	-	NC_000020.11:g.46014455C>A	TOPMed,gnomAD
rs1319874415	p.His662Tyr	missense variant	-	NC_000020.11:g.46014453C>T	gnomAD
rs1277278430	p.Val664Ile	missense variant	-	NC_000020.11:g.46014459G>A	gnomAD
rs1309871164	p.Gln666His	missense variant	-	NC_000020.11:g.46014467G>T	gnomAD
rs17577	p.Arg668Gln	missense variant	-	NC_000020.11:g.46014472G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs902431501	p.Arg668Gly	missense variant	-	NC_000020.11:g.46014471C>G	TOPMed,gnomAD
RCV000728386	p.Arg668Gln	missense variant	-	NC_000020.11:g.46014472G>A	ClinVar
RCV000271562	p.Arg668Gln	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46014472G>A	ClinVar
RCV000592237	p.Arg668Gly	missense variant	-	NC_000020.11:g.46014471C>G	ClinVar
rs17577	p.Arg668Pro	missense variant	-	NC_000020.11:g.46014472G>C	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs902431501	p.Arg668Ter	stop gained	-	NC_000020.11:g.46014471C>T	TOPMed,gnomAD
rs1487768526	p.Glu669Lys	missense variant	-	NC_000020.11:g.46014474G>A	gnomAD
COSM1027399	p.Glu669Asp	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46016251G>T	NCI-TCGA Cosmic
rs201258058	p.Tyr672Phe	missense variant	-	NC_000020.11:g.46016259A>T	1000Genomes,ExAC,TOPMed,gnomAD
rs748636725	p.Phe673Leu	missense variant	-	NC_000020.11:g.46016263C>A	ExAC,gnomAD
rs1206068410	p.Cys674Tyr	missense variant	-	NC_000020.11:g.46016265G>A	gnomAD
rs756588901	p.Cys674Gly	missense variant	-	NC_000020.11:g.46016264T>G	ExAC,TOPMed,gnomAD
rs1450391556	p.Asp676Asn	missense variant	-	NC_000020.11:g.46016270G>A	gnomAD
rs202215075	p.Arg677Ser	missense variant	-	NC_000020.11:g.46016273C>A	ExAC,TOPMed,gnomAD
rs202215075	p.Arg677Cys	missense variant	-	NC_000020.11:g.46016273C>T	ExAC,TOPMed,gnomAD
rs200118434	p.Arg677His	missense variant	-	NC_000020.11:g.46016274G>A	-
COSM4098958	p.Trp680Ter	stop gained	Variant assessed as Somatic; HIGH impact.	NC_000020.11:g.46016284G>A	NCI-TCGA Cosmic
rs771094559	p.Arg681Gly	missense variant	-	NC_000020.11:g.46016285C>G	ExAC,TOPMed,gnomAD
rs774687719	p.Arg681His	missense variant	-	NC_000020.11:g.46016286G>A	ExAC,TOPMed,gnomAD
RCV000321690	p.Arg681His	missense variant	Metaphyseal anadysplasia	NC_000020.11:g.46016286G>A	ClinVar
rs771094559	p.Arg681Cys	missense variant	-	NC_000020.11:g.46016285C>T	ExAC,TOPMed,gnomAD
rs137904662	p.Val682Met	missense variant	-	NC_000020.11:g.46016288G>A	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs137904662	p.Val682Leu	missense variant	-	NC_000020.11:g.46016288G>T	1000Genomes,ESP,ExAC,TOPMed,gnomAD
rs1369630811	p.Ser683Thr	missense variant	-	NC_000020.11:g.46016292G>C	gnomAD
rs765120002	p.Arg685Trp	missense variant	-	NC_000020.11:g.46016297C>T	ExAC,TOPMed,gnomAD
rs772727216	p.Arg685Gln	missense variant	-	NC_000020.11:g.46016298G>A	ExAC,TOPMed,gnomAD
rs151173908	p.Ser686Asn	missense variant	-	NC_000020.11:g.46016301G>A	ESP,ExAC,TOPMed,gnomAD
rs374780254	p.Glu687Gln	missense variant	-	NC_000020.11:g.46016303G>C	ESP,ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Glu687Lys	missense variant	-	NC_000020.11:g.46016303G>A	NCI-TCGA
rs751208103	p.Leu688Ser	missense variant	-	NC_000020.11:g.46016307T>C	ExAC,gnomAD
rs759241136	p.Asn689Ile	missense variant	-	NC_000020.11:g.46016310A>T	ExAC,gnomAD
rs767808980	p.Val691Met	missense variant	-	NC_000020.11:g.46016315G>A	ExAC,TOPMed,gnomAD
rs767808980	p.Val691Leu	missense variant	-	NC_000020.11:g.46016315G>C	ExAC,TOPMed,gnomAD
rs201112388	p.Val691Ala	missense variant	-	NC_000020.11:g.46016316T>C	ExAC,TOPMed,gnomAD
rs756600684	p.Asp692His	missense variant	-	NC_000020.11:g.46016318G>C	ExAC,gnomAD
rs778121963	p.Gln693Arg	missense variant	-	NC_000020.11:g.46016322A>G	ExAC,gnomAD
rs111366278	p.Val697Met	missense variant	-	NC_000020.11:g.46016333G>A	ExAC,TOPMed,gnomAD
NCI-TCGA novel	p.Asp700Val	missense variant	-	NC_000020.11:g.46016343A>T	NCI-TCGA
rs199677423	p.Gln703Lys	missense variant	-	NC_000020.11:g.46016351C>A	ExAC,TOPMed,gnomAD
rs1240143691	p.Gln703His	missense variant	-	NC_000020.11:g.46016353G>T	gnomAD
NCI-TCGA novel	p.Gln703His	missense variant	-	NC_000020.11:g.46016353G>C	NCI-TCGA
NCI-TCGA novel	p.Cys704Phe	missense variant	-	NC_000020.11:g.46016355G>T	NCI-TCGA
NCI-TCGA novel	p.Asp707Asn	missense variant	-	NC_000020.11:g.46016363G>A	NCI-TCGA
COSM724406	p.Asp707Glu	missense variant	Variant assessed as Somatic; MODERATE impact.	NC_000020.11:g.46016365C>A	NCI-TCGA Cosmic

Disease or phenotype associated information

Disease ID	Disease Name	Disease Type	Source
C0000887	Acantholysis	phenotype	LHGDN
C0001175	Acquired Immunodeficiency Syndrome	group	BEFREE
C0001342	Acute periodontitis	disease	BEFREE
C0001418	Adenocarcinoma	group	BEFREE;LHGDN
C0001430	Adenoma	group	BEFREE
C0001849	AIDS Dementia Complex	disease	BEFREE
C0001973	Alcoholic Intoxication, Chronic	disease	BEFREE;PSYGENET
C0002152	Alloxan Diabetes	disease	CTD_human
C0002395	Alzheimer's Disease	disease	BEFREE
C0002448	Ameloblastoma	disease	BEFREE
C0002726	Amyloidosis	disease	BEFREE
C0002736	Amyotrophic Lateral Sclerosis	disease	BEFREE;LHGDN
C0002793	Anaplasia	disease	BEFREE
C0002893	Refractory anemias	disease	BEFREE
C0002940	Aneurysm	phenotype	BEFREE;LHGDN
C0002949	Aneurysm, Dissecting	disease	BEFREE
C0003130	Anoxia	phenotype	LHGDN
C0003486	Aortic Aneurysm	disease	BEFREE;CTD_human;LHGDN
C0003493	Aortic Diseases	group	CTD_human
C0003496	Aortic Rupture	disease	CTD_human
C0003504	Aortic Valve Insufficiency	disease	BEFREE
C0003507	Aortic Valve Stenosis	disease	BEFREE
C0003838	Arterial Occlusive Diseases	group	BEFREE
C0003850	Arteriosclerosis	disease	BEFREE;RGD
C0003855	Arteriovenous fistula	phenotype	BEFREE
C0003862	Arthralgia	phenotype	BEFREE
C0003864	Arthritis	disease	BEFREE
C0003868	Arthritis, Gouty	disease	LHGDN
C0003873	Rheumatoid Arthritis	disease	BEFREE;LHGDN
C0003962	Ascites	phenotype	LHGDN
C0004031	Aspergillosis, Allergic Bronchopulmonary	disease	BEFREE
C0004096	Asthma	disease	BEFREE;CTD_human;LHGDN;RGD
C0004114	Astrocytoma	disease	BEFREE;CTD_human;LHGDN
C0004135	Ataxia Telangiectasia	disease	BEFREE
C0004153	Atherosclerosis	disease	BEFREE;LHGDN
C0004238	Atrial Fibrillation	disease	BEFREE
C0004364	Autoimmune Diseases	group	BEFREE;LHGDN
C0004565	Melanoma, B16	disease	BEFREE
C0004623	Bacterial Infections	group	BEFREE
C0004943	Behcet Syndrome	disease	BEFREE
C0005398	Cholestasis, Extrahepatic	disease	CTD_human
C0005586	Bipolar Disorder	disease	BEFREE;PSYGENET
C0005684	Malignant neoplasm of urinary bladder	disease	BEFREE
C0005695	Bladder Neoplasm	group	BEFREE;LHGDN
C0005699	Blast Phase	disease	BEFREE
C0005940	Bone Diseases	group	BEFREE
C0005967	Bone neoplasms	group	BEFREE;CTD_human
C0006114	Cerebral Edema	disease	CTD_human
C0006118	Brain Neoplasms	group	BEFREE;LHGDN
C0006142	Malignant neoplasm of breast	disease	BEFREE;CTD_human
C0006145	Breast Diseases	group	BEFREE
C0006267	Bronchiectasis	disease	BEFREE
C0006272	Bronchiolitis Obliterans	disease	LHGDN
C0006287	Bronchopulmonary Dysplasia	disease	BEFREE;LHGDN
C0006663	Calcinosis	phenotype	CTD_human
C0006826	Malignant Neoplasms	group	BEFREE
C0007102	Malignant tumor of colon	disease	BEFREE;CTD_human
C0007103	Malignant neoplasm of endometrium	disease	BEFREE
C0007107	Malignant neoplasm of larynx	disease	BEFREE
C0007112	Adenocarcinoma of prostate	disease	BEFREE
C0007113	Rectal Carcinoma	disease	BEFREE
C0007114	Malignant neoplasm of skin	disease	BEFREE;CTD_human
C0007115	Malignant neoplasm of thyroid	disease	BEFREE
C0007124	Noninfiltrating Intraductal Carcinoma	disease	BEFREE
C0007131	Non-Small Cell Lung Carcinoma	disease	BEFREE;CTD_human
C0007134	Renal Cell Carcinoma	disease	BEFREE;LHGDN
C0007137	Squamous cell carcinoma	disease	BEFREE;CTD_human;LHGDN
C0007138	Carcinoma, Transitional Cell	disease	BEFREE
C0007193	Cardiomyopathy, Dilated	group	LHGDN
C0007222	Cardiovascular Diseases	group	BEFREE;LHGDN
C0007273	Carotid Artery Diseases	group	LHGDN
C0007282	Carotid Stenosis	disease	LHGDN
C0007286	Carpal Tunnel Syndrome	disease	BEFREE
C0007621	Neoplastic Cell Transformation	phenotype	CTD_human
C0007766	Intracranial Aneurysm	disease	BEFREE;RGD
C0007785	Cerebral Infarction	disease	BEFREE
C0007786	Brain Ischemia	disease	CTD_human;LHGDN;RGD
C0007787	Transient Ischemic Attack	disease	BEFREE;RGD
C0007820	Cerebrovascular Disorders	group	BEFREE
C0007847	Malignant tumor of cervix	disease	BEFREE
C0007867	Cervix Diseases	group	BEFREE
C0007873	Uterine Cervical Neoplasm	disease	LHGDN
C0008312	Primary biliary cirrhosis	disease	RGD
C0008350	Cholelithiasis	disease	BEFREE
C0008354	Cholera	disease	BEFREE
C0008479	Chondrosarcoma	disease	BEFREE
C0008497	Choriocarcinoma	disease	BEFREE
C0008728	Eosinophilic granulomatosis with polyangiitis	disease	BEFREE
C0008924	Cleft upper lip	disease	LHGDN
C0009319	Colitis	disease	BEFREE
C0009324	Ulcerative Colitis	disease	BEFREE;CTD_human
C0009375	Colonic Neoplasms	group	BEFREE;CTD_human;LHGDN
C0009402	Colorectal Carcinoma	disease	BEFREE
C0009404	Colorectal Neoplasms	group	BEFREE;LHGDN
C0009952	Febrile Convulsions	disease	BEFREE;LHGDN
C0010043	Corneal Ulcer	disease	LHGDN
C0010051	Coronary Aneurysm	disease	BEFREE;LHGDN
C0010054	Coronary Arteriosclerosis	disease	BEFREE;RGD
C0010068	Coronary heart disease	disease	BEFREE;LHGDN;RGD
C0010072	Coronary Thrombosis	disease	BEFREE
C0010200	Coughing	phenotype	BEFREE
C0010278	Craniosynostosis	disease	BEFREE
C0010346	Crohn Disease	disease	BEFREE
C0010414	Infection by Cryptococcus neoformans	disease	BEFREE
C0010495	Cutis Laxa	disease	BEFREE
C0010606	Adenoid Cystic Carcinoma	disease	BEFREE;LHGDN
C0010674	Cystic Fibrosis	disease	BEFREE;LHGDN
C0010701	Phyllodes Tumor	disease	BEFREE
C0010709	Cyst	phenotype	BEFREE
C0011269	Dementia, Vascular	disease	BEFREE
C0011603	Dermatitis	disease	BEFREE;LHGDN
C0011633	Dermatomyositis	disease	BEFREE;LHGDN
C0011847	Diabetes	disease	BEFREE
C0011849	Diabetes Mellitus	group	BEFREE
C0011853	Diabetes Mellitus, Experimental	disease	CTD_human
C0011854	Diabetes Mellitus, Insulin-Dependent	disease	BEFREE
C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	BEFREE;RGD
C0011880	Diabetic Ketoacidosis	disease	BEFREE
C0011881	Diabetic Nephropathy	disease	BEFREE;LHGDN
C0011882	Diabetic Neuropathies	group	CTD_human
C0011884	Diabetic Retinopathy	disease	BEFREE
C0012359	Pathological Dilatation	phenotype	LHGDN
C0012736	Dissecting aortic aneurysm	disease	BEFREE
C0013238	Dry Eye Syndromes	group	BEFREE
C0013264	Muscular Dystrophy, Duchenne	disease	BEFREE
C0013537	Eclampsia	disease	BEFREE
C0013604	Edema	phenotype	LHGDN
C0014038	Encephalitis	disease	BEFREE
C0014118	Endocarditis	disease	BEFREE
C0014170	Endometrial Neoplasms	group	LHGDN
C0014175	Endometriosis	disease	BEFREE;LHGDN;RGD
C0014547	Epilepsies, Partial	disease	RGD
C0014553	Absence Epilepsy	disease	RGD
C0014740	Erythema Chronicum Migrans	disease	BEFREE
C0014859	Esophageal Neoplasms	group	BEFREE;LHGDN
C0015230	Exanthema	phenotype	BEFREE
C0015625	Fanconi Anemia	disease	BEFREE
C0015695	Fatty Liver	disease	BEFREE
C0015934	Fetal Growth Retardation	phenotype	LHGDN
C0016034	Breast Fibrocystic Disease	disease	BEFREE
C0016057	Fibrosarcoma	disease	BEFREE;LHGDN
C0016169	pathologic fistula	phenotype	BEFREE
C0016667	Fragile X Syndrome	disease	BEFREE
C0017152	Gastritis	disease	BEFREE
C0017525	Giant Cell Tumors	group	BEFREE
C0017605	Angle Closure Glaucoma	disease	LHGDN
C0017636	Glioblastoma	disease	BEFREE;CTD_human;LHGDN
C0017638	Glioma	disease	BEFREE;LHGDN
C0017658	Glomerulonephritis	disease	BEFREE;LHGDN
C0017661	IGA Glomerulonephritis	disease	BEFREE;LHGDN
C0017665	Membranous glomerulonephritis	disease	RGD
C0017668	Focal glomerulosclerosis	disease	BEFREE;RGD
C0017677	Glossitis, Benign Migratory	disease	BEFREE
C0018188	Granuloma	phenotype	LHGDN
C0018378	Guillain-Barre Syndrome	disease	BEFREE
C0018799	Heart Diseases	group	BEFREE
C0018801	Heart failure	disease	BEFREE;LHGDN;RGD
C0018802	Congestive heart failure	disease	BEFREE;RGD
C0018923	Hemangiosarcoma	disease	BEFREE
C0018989	Hemiparesis	phenotype	BEFREE
C0019080	Hemorrhage	phenotype	LHGDN
C0019156	Hepatic Veno-Occlusive Disease	disease	RGD
C0019163	Hepatitis B	disease	BEFREE
C0019189	Hepatitis, Chronic	disease	BEFREE
C0019196	Hepatitis C	disease	BEFREE
C0019693	HIV Infections	group	BEFREE
C0019829	Hodgkin Disease	disease	BEFREE;LHGDN
C0020097	HTLV-I Infections	group	BEFREE
C0020179	Huntington Disease	disease	BEFREE;RGD
C0020443	Hypercholesterolemia	disease	BEFREE
C0020445	Hypercholesterolemia, Familial	disease	BEFREE;LHGDN
C0020456	Hyperglycemia	disease	BEFREE;RGD
C0020507	Hyperplasia	phenotype	CTD_human;LHGDN
C0020538	Hypertensive disease	group	BEFREE;CTD_human;LHGDN;RGD
C0020542	Pulmonary Hypertension	phenotype	RGD
C0020544	Renal hypertension	disease	RGD
C0021051	Immunologic Deficiency Syndromes	group	BEFREE
C0021368	Inflammation	phenotype	CTD_human;LHGDN
C0021390	Inflammatory Bowel Diseases	group	BEFREE;LHGDN
C0021400	Influenza	disease	BEFREE
C0022116	Ischemia	phenotype	LHGDN
C0022408	Arthropathy	group	BEFREE
C0022548	Keloid	phenotype	BEFREE
C0022572	keratoacanthoma	disease	BEFREE
C0022575	Keratoconjunctivitis Sicca	disease	BEFREE
C0022578	Keratoconus	disease	BEFREE
C0022650	Kidney Calculi	disease	BEFREE
C0022658	Kidney Diseases	group	BEFREE;LHGDN;RGD
C0022661	Kidney Failure, Chronic	disease	BEFREE
C0022665	Kidney Neoplasm	disease	BEFREE
C0023176	Lead Poisoning	disease	CTD_human
C0023223	Leg Ulcer	disease	BEFREE
C0023267	Fibroid Tumor	group	BEFREE
C0023418	leukemia	disease	BEFREE;LHGDN
C0023434	Chronic Lymphocytic Leukemia	disease	BEFREE;LHGDN
C0023449	Acute lymphocytic leukemia	disease	BEFREE
C0023452	Childhood Acute Lymphoblastic Leukemia	disease	BEFREE
C0023467	Leukemia, Myelocytic, Acute	disease	BEFREE;LHGDN
C0023470	Myeloid Leukemia	disease	BEFREE
C0023473	Myeloid Leukemia, Chronic	disease	BEFREE
C0023487	Acute Promyelocytic Leukemia	disease	BEFREE
C0023492	Leukemia, T-Cell	disease	BEFREE
C0023493	Adult T-Cell Lymphoma/Leukemia	disease	BEFREE;LHGDN
C0023518	Leukocytosis	disease	LHGDN
C0023646	Lichen Planus	disease	LHGDN
C0023652	Lichen Sclerosus et Atrophicus	disease	BEFREE
C0023795	Lipoid Proteinosis of Urbach and Wiethe	disease	BEFREE
C0023890	Liver Cirrhosis	disease	BEFREE
C0023892	Biliary cirrhosis	disease	RGD
C0023893	Liver Cirrhosis, Experimental	disease	CTD_human
C0023895	Liver diseases	group	BEFREE;CTD_human;LHGDN
C0023903	Liver neoplasms	group	BEFREE
C0024115	Lung diseases	group	BEFREE;LHGDN;RGD
C0024117	Chronic Obstructive Airway Disease	disease	BEFREE;CTD_human;LHGDN;RGD
C0024121	Lung Neoplasms	group	BEFREE;LHGDN
C0024141	Lupus Erythematosus, Systemic	disease	BEFREE;LHGDN
C0024143	Lupus Nephritis	disease	CTD_human
C0024198	Lyme Disease	disease	BEFREE;LHGDN
C0024232	Lymphatic Metastasis	disease	BEFREE
C0024299	Lymphoma	group	BEFREE;LHGDN
C0024301	Lymphoma, Follicular	disease	BEFREE
C0024305	Lymphoma, Non-Hodgkin	disease	BEFREE
C0024449	Mycetoma	disease	BEFREE
C0024530	Malaria	disease	BEFREE
C0024535	Malaria, Falciparum	disease	BEFREE
C0024623	Malignant neoplasm of stomach	disease	BEFREE;RGD
C0024668	Mammary Neoplasms, Experimental	group	CTD_human
C0024796	Marfan Syndrome	disease	CTD_human
C0024897	Mastocytoma	disease	BEFREE
C0025149	Medulloblastoma	disease	BEFREE
C0025202	melanoma	disease	BEFREE;LHGDN
C0025267	Multiple Endocrine Neoplasia Type 1	disease	BEFREE
C0025286	Meningioma	disease	BEFREE;LHGDN
C0025289	Meningitis	disease	BEFREE
C0025294	Meningococcal meningitis	disease	BEFREE;RGD
C0025295	Meningitis, Pneumococcal	disease	LHGDN
C0025297	Viral meningitis	disease	BEFREE;LHGDN
C0025500	Mesothelioma	disease	BEFREE;LHGDN
C0025568	Metaplasia	phenotype	LHGDN
C0026277	Mixed Salivary Gland Tumor	disease	BEFREE
C0026552	Morphine Dependence	disease	CTD_human
C0026640	Mouth Neoplasms	group	LHGDN
C0026691	Mucocutaneous Lymph Node Syndrome	disease	BEFREE;LHGDN
C0026764	Multiple Myeloma	disease	BEFREE
C0026766	Multiple Organ Failure	phenotype	CTD_human
C0026769	Multiple Sclerosis	disease	BEFREE;LHGDN
C0026848	Myopathy	group	BEFREE
C0026850	Muscular Dystrophy	disease	BEFREE
C0026918	Mycobacterium Infections	group	LHGDN
C0026948	Mycosis Fungoides	group	BEFREE
C0027051	Myocardial Infarction	disease	BEFREE;CTD_human;LHGDN;RGD
C0027059	Myocarditis	disease	BEFREE;LHGDN
C0027070	Myoepithelioma	disease	BEFREE
C0027092	Myopia	disease	BEFREE
C0027121	Myositis	disease	LHGDN
C0027430	Nasal Polyps	disease	BEFREE;LHGDN
C0027547	Necrotizing Scleritis	disease	BEFREE
C0027626	Neoplasm Invasiveness	phenotype	CTD_human;LHGDN
C0027627	Neoplasm Metastasis	phenotype	BEFREE;CTD_human;LHGDN
C0027651	Neoplasms	group	BEFREE
C0027819	Neuroblastoma	group	BEFREE
C0027868	Neuromuscular Diseases	group	LHGDN
C0027873	Neuromyelitis Optica	disease	BEFREE
C0028754	Obesity	disease	BEFREE;CTD_human
C0028840	Ocular Hypertension	disease	RGD
C0029118	Opportunistic Infections	group	BEFREE
C0029134	Optic Neuritis	disease	BEFREE
C0029172	Oral Submucous Fibrosis	disease	BEFREE;CTD_human
C0029408	Degenerative polyarthritis	disease	BEFREE
C0029410	Osteoarthritis of hip	disease	BEFREE
C0029434	Osteogenesis Imperfecta	disease	GENOMICS_ENGLAND
C0029463	Osteosarcoma	disease	BEFREE;LHGDN
C0029883	Otitis Media with Effusion	disease	LHGDN
C0029925	Ovarian Carcinoma	disease	BEFREE
C0029927	Ovarian Cysts	disease	BEFREE
C0030193	Pain	phenotype	BEFREE
C0030297	Pancreatic Neoplasm	disease	BEFREE;CTD_human;LHGDN
C0030354	Papilloma	disease	BEFREE
C0030481	Tropical Spastic Paraparesis	disease	BEFREE
C0030499	Parasitic Diseases	group	BEFREE
C0030567	Parkinson Disease	disease	BEFREE
C0030583	Parotitis	disease	LHGDN
C0030805	Bullous pemphigoid	disease	BEFREE
C0030807	Pemphigus	disease	LHGDN
C0030809	Pemphigus Vulgaris	disease	BEFREE
C0031051	Pericementitis	disease	CTD_human
C0031099	Periodontitis	disease	BEFREE;CTD_human
C0031106	Periodontitis, Juvenile	disease	BEFREE
C0031117	Peripheral Neuropathy	group	LHGDN
C0032000	Pituitary Adenoma	disease	BEFREE
C0032019	Pituitary Neoplasms	group	BEFREE;LHGDN
C0032227	Pleural effusion disorder	group	BEFREE;LHGDN
C0032285	Pneumonia	disease	BEFREE;LHGDN
C0032460	Polycystic Ovary Syndrome	disease	LHGDN
C0032580	Adenomatous Polyposis Coli	disease	BEFREE
C0032584	polyps	phenotype	BEFREE;LHGDN
C0032914	Pre-Eclampsia	phenotype	LHGDN
C0032927	Precancerous Conditions	group	BEFREE
C0033377	Ptosis	disease	BEFREE
C0033578	Prostatic Neoplasms	group	BEFREE;CTD_human;LHGDN
C0033847	Pseudoxanthoma Elasticum	disease	BEFREE
C0033860	Psoriasis	disease	BEFREE
C0033975	Psychotic Disorders	group	BEFREE
C0033999	Pterygium	disease	BEFREE
C0034065	Pulmonary Embolism	disease	RGD
C0034067	Pulmonary Emphysema	disease	BEFREE;CTD_human;LHGDN
C0034069	Pulmonary Fibrosis	disease	BEFREE;CTD_human;RGD
C0034150	Purpura	disease	LHGDN
C0034186	Pyelonephritis	disease	LHGDN
C0034189	Pyemia	phenotype	CTD_human
C0034951	Refractive Errors	group	BEFREE
C0035078	Kidney Failure	disease	BEFREE
C0035126	Reperfusion Injury	disease	CTD_human;LHGDN
C0035220	Respiratory Distress Syndrome, Newborn	disease	BEFREE
C0035309	Retinal Diseases	group	BEFREE;CTD_human
C0035335	Retinoblastoma	disease	BEFREE
C0035412	Rhabdomyosarcoma	disease	BEFREE
C0035439	Rheumatic Heart Disease	disease	BEFREE
C0036341	Schizophrenia	disease	BEFREE;PSYGENET
C0036421	Systemic Scleroderma	disease	BEFREE;LHGDN
C0036572	Seizures	phenotype	BEFREE
C0036690	Septicemia	disease	BEFREE;CTD_human
C0037274	Dermatologic disorders	group	BEFREE
C0037286	Skin Neoplasms	group	CTD_human;LHGDN
C0037928	Spinal Cord Diseases	group	LHGDN
C0038220	Status Epilepticus	disease	BEFREE;RGD
C0038325	Stevens-Johnson Syndrome	disease	LHGDN
C0038356	Stomach Neoplasms	group	BEFREE;LHGDN;RGD
C0038358	Gastric ulcer	disease	BEFREE;CTD_human;RGD
C0038433	Streptozotocin Diabetes	disease	CTD_human
C0038454	Cerebrovascular accident	group	BEFREE
C0038522	Subacute Sclerosing Panencephalitis	disease	LHGDN
C0038525	Subarachnoid Hemorrhage	disease	BEFREE
C0038587	Substance Withdrawal Syndrome	disease	CTD_human
C0039101	synovial sarcoma	disease	BEFREE
C0039106	Pigmented villonodular synovitis	disease	BEFREE;LHGDN
C0039263	Takayasu Arteritis	disease	LHGDN
C0039483	Giant Cell Arteritis	disease	BEFREE;LHGDN
C0039685	Tetralogy of Fallot	disease	BEFREE
C0040136	Thyroid Neoplasm	disease	LHGDN
C0041234	Chagas Disease	disease	BEFREE
C0041296	Tuberculosis	disease	BEFREE;LHGDN
C0041318	Tuberculosis, Meningeal	disease	BEFREE
C0041327	Tuberculosis, Pulmonary	disease	BEFREE
C0041408	Turner Syndrome	disease	BEFREE
C0041582	Ulcer	disease	BEFREE;LHGDN
C0042133	Uterine Fibroids	group	BEFREE
C0042134	Uterine hemorrhage	phenotype	LHGDN
C0042344	Varicose Ulcer	disease	BEFREE
C0042345	Varicosity	disease	LHGDN
C0042373	Vascular Diseases	group	BEFREE
C0042384	Vasculitis	group	BEFREE
C0042769	Virus Diseases	group	BEFREE
C0043144	Wheezing	phenotype	BEFREE
C0079298	Epidermolysis Bullosa Simplex	disease	BEFREE
C0079474	Hallopeau-Siemens Disease	disease	BEFREE
C0079588	Ichthyosis, X-Linked	disease	BEFREE
C0079731	B-Cell Lymphomas	group	BEFREE
C0079740	High Grade Lymphoma (neoplasm)	disease	BEFREE
C0080032	Pleural Effusion, Malignant	disease	BEFREE;LHGDN
C0085096	Peripheral Vascular Diseases	group	BEFREE
C0085215	Ovarian Failure, Premature	disease	BEFREE
C0085220	Cerebral Amyloid Angiopathy	disease	BEFREE
C0085437	Meningitis, Bacterial	group	BEFREE;LHGDN
C0085580	Essential Hypertension	disease	BEFREE
C0085655	Polymyositis	disease	BEFREE;LHGDN
C0085742	Injuries, Acute Brain	group	CTD_human
C0085762	Alcohol abuse	disease	BEFREE;RGD
C0085786	Hamman-Rich syndrome	disease	BEFREE;CTD_human
C0086132	Depressive Symptoms	phenotype	BEFREE;PSYGENET
C0086189	Drug Withdrawal Symptoms	phenotype	CTD_human
C0086543	Cataract	disease	BEFREE
C0086565	Liver Dysfunction	phenotype	CTD_human
C0087169	Withdrawal Symptoms	phenotype	CTD_human
C0149516	Chronic sinusitis	disease	BEFREE
C0149630	Bicuspid aortic valve	disease	BEFREE
C0149678	Epstein-Barr Virus Infections	group	BEFREE
C0149721	Left Ventricular Hypertrophy	disease	BEFREE
C0149782	Squamous cell carcinoma of lung	disease	BEFREE
C0149871	Deep Vein Thrombosis	disease	BEFREE
C0149925	Small cell carcinoma of lung	disease	BEFREE
C0149931	Migraine Disorders	group	BEFREE
C0149939	Obstructive nephropathy	disease	BEFREE
C0149940	Sciatic Neuropathy	disease	RGD
C0151449	Primary Sj?gren's syndrome	disease	BEFREE
C0151468	Thyroid Gland Follicular Adenoma	disease	BEFREE
C0151526	Premature Birth	phenotype	CTD_human
C0151546	Oral Cavity Carcinoma	disease	BEFREE
C0151650	Renal fibrosis	disease	RGD
C0151744	Myocardial Ischemia	disease	LHGDN;RGD
C0152013	Adenocarcinoma of lung (disorder)	disease	BEFREE
C0152018	Esophageal carcinoma	disease	BEFREE
C0152105	Hypertensive heart disease	disease	BEFREE
C0152164	Cyclical vomiting syndrome (disorder)	disease	BEFREE
C0153381	Malignant neoplasm of mouth	disease	BEFREE
C0153392	Malignant neoplasm of nasopharynx	disease	BEFREE
C0153421	Malignant neoplasm of body of stomach	disease	RGD
C0153422	Malignant tumor of lesser curve of stomach	disease	RGD
C0153423	Malignant tumor of greater curve of stomach	disease	RGD
C0153452	Malignant neoplasm of gallbladder	disease	BEFREE
C0153676	Secondary malignant neoplasm of lung	disease	BEFREE
C0153690	Secondary malignant neoplasm of bone	disease	BEFREE
C0154830	Proliferative diabetic retinopathy	disease	BEFREE
C0155094	Corneal pannus	disease	BEFREE
C0155626	Acute myocardial infarction	disease	BEFREE
C0155728	Other specified transient cerebral ischemias	disease	RGD
C0155877	Allergic asthma	disease	BEFREE
C0162291	Retinal ischemia	disease	RGD
C0162298	Joint stiffness	phenotype	HPO
C0162529	Colitis, Ischemic	disease	BEFREE;LHGDN
C0162820	Dermatitis, Allergic Contact	disease	RGD
C0162871	Aortic Aneurysm, Abdominal	disease	BEFREE;CTD_human;LHGDN;RGD
C0162872	Aortic Aneurysm, Thoracic	disease	BEFREE;CTD_human;RGD
C0175697	Van der Woude syndrome	disease	BEFREE
C0175754	Agenesis of corpus callosum	disease	BEFREE
C0178664	Glomerulosclerosis (disorder)	disease	RGD
C0178874	Tumor Progression	phenotype	BEFREE
C0205647	Follicular adenoma	disease	BEFREE
C0205697	Carcinoma, Spindle-Cell	disease	BEFREE
C0205768	Subependymal Giant Cell Astrocytoma	disease	CTD_human
C0206172	Diabetic Foot	disease	BEFREE
C0206245	Amyloid Neuropathies, Familial	group	BEFREE
C0206638	Giant Cell Tumor of Bone	disease	BEFREE
C0206664	Teratocarcinoma	disease	BEFREE
C0206677	Adenomatous Polyps	disease	BEFREE;LHGDN
C0206682	Follicular thyroid carcinoma	disease	BEFREE
C0206692	Carcinoma, Lobular	disease	LHGDN
C0206698	Cholangiocarcinoma	disease	BEFREE;LHGDN;RGD
C0206702	Klatskin Tumor	disease	BEFREE
C0206708	Cervical Intraepithelial Neoplasia	disease	BEFREE
C0206726	gliosarcoma	disease	BEFREE
C0206731	Angiofibroma	disease	BEFREE
C0220620	Gastrointestinal Carcinoid Tumor	disease	BEFREE
C0220641	Lip and Oral Cavity Carcinoma	disease	BEFREE
C0220650	Metastatic malignant neoplasm to brain	disease	BEFREE
C0221056	Adult type dermatomyositis	disease	BEFREE
C0221227	Centriacinar Emphysema	disease	CTD_human
C0231341	Premature aging syndrome	disease	BEFREE
C0232197	Fibrillation	disease	BEFREE
C0233532	Maladaptive behavior associated with physical illness	phenotype	BEFREE
C0235782	Gallbladder Carcinoma	disease	BEFREE
C0235974	Pancreatic carcinoma	disease	BEFREE
C0238033	Carcinoma of Male Breast	disease	BEFREE
C0238067	Colitis, Collagenous	disease	BEFREE
C0238190	Inclusion Body Myositis (disorder)	disease	BEFREE
C0238281	Middle Cerebral Artery Syndrome	disease	CTD_human
C0238301	Cancer of Nasopharynx	disease	BEFREE
C0238463	Papillary thyroid carcinoma	disease	BEFREE
C0238790	bone destruction	disease	BEFREE
C0239946	Fibrosis, Liver	disease	BEFREE
C0240066	Iron deficiency	disease	BEFREE
C0242172	Pelvic Inflammatory Disease	group	BEFREE
C0242379	Malignant neoplasm of lung	disease	BEFREE
C0242383	Age related macular degeneration	disease	BEFREE
C0242787	Malignant neoplasm of male breast	disease	BEFREE
C0243026	Sepsis	disease	BEFREE;CTD_human;LHGDN
C0243038	Carcinoma, Lewis Lung	disease	BEFREE
C0259785	Malignant Meningioma	disease	BEFREE
C0259786	Rhabdoid meningioma	disease	BEFREE
C0262929	Myxoma of the Endocardium	disease	BEFREE
C0263628	Tumoral calcinosis	disease	CTD_human
C0263641	Epithelial hyperplasia of skin	disease	BEFREE
C0264393	Panacinar Emphysema	disease	CTD_human
C0264408	Childhood asthma	disease	BEFREE
C0264694	Chronic myocardial ischemia	disease	RGD
C0265110	Cerebral Vasospasm	disease	BEFREE
C0265338	Coffin-Siris syndrome	disease	BEFREE
C0266526	Norrie disease	disease	BEFREE
C0266929	Chronic Periodontitis	disease	BEFREE;LHGDN
C0267187	Intestinal metaplasia of gastric mucosa	disease	BEFREE
C0268398	Familial lichen amyloidosis	disease	BEFREE
C0269102	Endometrioma	disease	BEFREE
C0270611	Brain Injuries	group	CTD_human
C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	CTD_human
C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	CTD_human
C0271678	Diabetic Mononeuropathy	disease	CTD_human
C0271680	Diabetic Polyneuropathies	group	CTD_human
C0271685	Diabetic Amyotrophy	disease	CTD_human
C0271686	Diabetic Autonomic Neuropathy	disease	CTD_human
C0272945	Brain Lacerations	disease	CTD_human
C0275544	Congenital infectious disease	group	BEFREE
C0275904	Tuberculosis, Central Nervous System	disease	BEFREE
C0278488	Carcinoma breast stage IV	disease	BEFREE
C0278498	Malignant neoplasm of stomach stage IV	disease	BEFREE
C0278512	Metastatic osteosarcoma	disease	BEFREE
C0278701	Gastric Adenocarcinoma	disease	BEFREE
C0278828	Stage IV Bladder Cancer AJCC v6	disease	BEFREE
C0278883	Metastatic melanoma	disease	BEFREE
C0278987	Non-small cell lung cancer metastatic	disease	BEFREE
C0278996	Malignant Head and Neck Neoplasm	disease	BEFREE
C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	disease	BEFREE
C0279530	Malignant Bone Neoplasm	disease	CTD_human
C0279563	Lobular carcinoma in situ of breast	disease	BEFREE
C0279626	Squamous cell carcinoma of esophagus	disease	BEFREE
C0279628	Adenocarcinoma Of Esophagus	disease	BEFREE
C0279671	Cervical Squamous Cell Carcinoma	disease	BEFREE
C0279680	Transitional cell carcinoma of bladder	disease	BEFREE
C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	BEFREE
C0280100	Solid Neoplasm	phenotype	BEFREE
C0280232	stage, cervical cancer	phenotype	BEFREE
C0280313	Squamous cell carcinoma of oropharynx	disease	BEFREE
C0280324	Laryngeal Squamous Cell Carcinoma	disease	BEFREE
C0280631	Leiomyosarcoma of uterus	disease	BEFREE
C0280725	Adult Cholangiocarcinoma	disease	RGD
C0280783	Juvenile Pilocytic Astrocytoma	disease	CTD_human
C0280785	Diffuse Astrocytoma	disease	CTD_human
C0281361	Adenocarcinoma of pancreas	disease	BEFREE
C0282160	Aplasia Cutis Congenita	disease	BEFREE
C0302592	Cervix carcinoma	disease	BEFREE
C0314719	Dryness of eye	phenotype	BEFREE
C0333186	Restenosis	phenotype	BEFREE
C0333293	Healing ulcer	phenotype	BEFREE
C0333307	Superficial ulcer	phenotype	BEFREE
C0333463	Senile Plaques	phenotype	BEFREE
C0334381	Non-infiltrating lobular carcinoma	disease	BEFREE
C0334576	Gliomatosis cerebri	disease	BEFREE
C0334579	Anaplastic astrocytoma	disease	BEFREE;CTD_human
C0334580	Protoplasmic astrocytoma	disease	CTD_human
C0334581	Gemistocytic astrocytoma	disease	CTD_human
C0334582	Fibrillary Astrocytoma	disease	CTD_human
C0334583	Pilocytic Astrocytoma	disease	CTD_human
C0334588	Giant Cell Glioblastoma	disease	CTD_human
C0334664	Mast Cell Neoplasm	disease	BEFREE
C0338070	Childhood Cerebral Astrocytoma	disease	CTD_human
C0338430	Limbic Encephalitis	disease	BEFREE
C0338831	Manic	disease	BEFREE;PSYGENET
C0339573	Glaucoma, Primary Open Angle	disease	BEFREE
C0340288	Stable angina	disease	BEFREE;CTD_human
C0340629	Aortic aneurysm without mention of rupture NOS	disease	BEFREE
C0340630	Aortic Aneurysm, Thoracoabdominal	disease	CTD_human
C0340643	Dissection of aorta	disease	BEFREE
C0341439	Chronic liver disease	group	BEFREE
C0341858	Endometriosis of uterus	disease	BEFREE
C0345904	Malignant neoplasm of liver	disease	BEFREE
C0345905	Intrahepatic Cholangiocarcinoma	disease	BEFREE
C0345967	Malignant mesothelioma	disease	BEFREE
C0346627	Intestinal Cancer	group	BEFREE
C0346629	Malignant neoplasm of large intestine	disease	BEFREE
C0346647	Malignant neoplasm of pancreas	disease	BEFREE;CTD_human
C0346957	Disseminated Malignant Neoplasm	phenotype	BEFREE
C0349530	Early gastric cancer	disease	BEFREE
C0349566	Squamous cell carcinoma of tongue	disease	BEFREE
C0349588	Short stature	phenotype	HPO
C0376358	Malignant neoplasm of prostate	disease	BEFREE;CTD_human
C0392525	Nephrolithiasis	disease	BEFREE
C0393665	Multiple Sclerosis, Chronic Progressive	disease	LHGDN
C0393819	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	disease	BEFREE
C0393835	Diabetic Asymmetric Polyneuropathy	disease	CTD_human
C0394006	Dysequilibrium syndrome	disease	BEFREE
C0399440	Hereditary gingival fibromatosis	disease	BEFREE
C0403416	Idiopathic crescentic glomerulonephritis	disease	RGD
C0409959	Osteoarthritis, Knee	disease	LHGDN
C0424295	Hyperactive behavior	phenotype	BEFREE
C0428791	Aortic valve calcification	disease	BEFREE
C0432226	Metaphyseal anadysplasia	disease	BEFREE;ORPHANET
C0432291	Mandibuloacral dysostosis	disease	BEFREE;CTD_human
C0442874	Neuropathy	group	BEFREE
C0452047	Brain Injuries, Focal	group	CTD_human
C0458219	Complex Regional Pain Syndromes	disease	BEFREE
C0472387	Vasogenic Cerebral Edema	phenotype	CTD_human
C0472388	Cytotoxic Cerebral Edema	phenotype	CTD_human
C0473583	Nevus elasticus	disease	BEFREE
C0476089	Endometrial Carcinoma	disease	BEFREE
C0494165	Secondary malignant neoplasm of liver	disease	BEFREE
C0497406	Overweight	phenotype	BEFREE
C0520575	Acute pyelonephritis	disease	BEFREE
C0520679	Sleep Apnea, Obstructive	disease	BEFREE
C0521158	Recurrent tumor	phenotype	BEFREE
C0521174	Microcalcification	phenotype	CTD_human
C0524620	Metabolic Syndrome X	disease	BEFREE
C0524909	Hepatitis B, Chronic	disease	LHGDN
C0524910	Hepatitis C, Chronic	disease	BEFREE
C0543822	Atherosclerotic occlusive disease	disease	BEFREE
C0543982	Glaucoma, primary	disease	BEFREE
C0544755	Genu varum	phenotype	HPO
C0546837	Malignant neoplasm of esophagus	disease	BEFREE
C0547065	Mixed oligoastrocytoma	disease	CTD_human
C0549473	Thyroid carcinoma	disease	BEFREE
C0553548	Necrotizing Arteritis	disease	BEFREE
C0555198	Malignant Glioma	disease	BEFREE
C0566602	Primary sclerosing cholangitis	disease	BEFREE
C0577631	Carotid Atherosclerosis	disease	BEFREE
C0585442	Osteosarcoma of bone	disease	BEFREE
C0595989	Carcinoma of larynx	disease	BEFREE
C0596263	Carcinogenesis	phenotype	BEFREE
C0598608	Hyperhomocysteinemia	disease	BEFREE
C0600139	Prostate carcinoma	disease	BEFREE
C0600272	Morphine Abuse	disease	CTD_human
C0677886	Epithelial ovarian cancer	disease	BEFREE
C0677932	Progressive Neoplastic Disease	phenotype	BEFREE
C0677950	Stage IV Colorectal Cancer	disease	BEFREE
C0678222	Breast Carcinoma	disease	BEFREE;CTD_human
C0679401	Vascular rupture	disease	BEFREE
C0684249	Carcinoma of lung	disease	BEFREE
C0685889	Splenic Hypoplasia	disease	BEFREE
C0686619	Secondary malignant neoplasm of lymph node	disease	BEFREE
C0694549	Community acquired pneumonia	disease	BEFREE
C0699790	Colon Carcinoma	disease	BEFREE
C0699791	Stomach Carcinoma	disease	BEFREE
C0699885	Carcinoma of bladder	disease	BEFREE
C0700095	Central neuroblastoma	disease	BEFREE
C0729353	Subfertility	disease	BEFREE
C0729552	Genital infection	group	BEFREE
C0740376	Middle Cerebral Artery Thrombosis	disease	CTD_human
C0740391	Middle Cerebral Artery Occlusion	phenotype	CTD_human
C0740392	Infarction, Middle Cerebral Artery	disease	CTD_human;RGD
C0740457	Malignant neoplasm of kidney	disease	BEFREE
C0741160	Aortic Aneurysm, Ruptured	disease	CTD_human
C0745103	Hyperlipoproteinemia Type IIa	disease	BEFREE
C0747845	early pregnancy	phenotype	BEFREE
C0750935	Cerebral Astrocytoma	disease	CTD_human
C0750936	Intracranial Astrocytoma	disease	CTD_human
C0750969	Vasogenic Brain Edema	phenotype	CTD_human
C0750970	Cytotoxic Brain Edema	phenotype	CTD_human
C0751074	Diabetic Neuralgia	disease	CTD_human
C0751583	Encephalitis, West Nile Fever	disease	BEFREE
C0751688	Malignant Squamous Cell Neoplasm	disease	BEFREE
C0751845	Middle Cerebral Artery Embolus	disease	CTD_human
C0751846	Left Middle Cerebral Artery Infarction	disease	CTD_human
C0751847	Embolic Infarction, Middle Cerebral Artery	disease	CTD_human
C0751848	Thrombotic Infarction, Middle Cerebral Artery	disease	CTD_human
C0751849	Right Middle Cerebral Artery Infarction	disease	CTD_human
C0751967	Multiple Sclerosis, Relapsing-Remitting	disease	LHGDN
C0752347	Lewy Body Disease	disease	BEFREE
C0812413	Malignant Pleural Mesothelioma	disease	BEFREE
C0850666	Infection caused by Helicobacter pylori	disease	BEFREE
C0852036	Pregnancy associated hypertension	disease	LHGDN
C0853879	Invasive carcinoma of breast	disease	BEFREE
C0856169	Endothelial dysfunction	phenotype	BEFREE
C0856742	Post MI	phenotype	BEFREE
C0858252	Breast adenocarcinoma	disease	BEFREE
C0877015	Pelvic Organ Prolapse	disease	BEFREE
C0877430	Asthma chronic	disease	BEFREE
C0878693	Conjunctivochalasis	disease	BEFREE
C0879615	Stromal Neoplasm	disease	BEFREE
C0917798	Cerebral Ischemia	disease	BEFREE;CTD_human
C0917996	Cerebral Aneurysm	disease	BEFREE
C0919267	ovarian neoplasm	disease	BEFREE;LHGDN
C0936223	Metastatic Prostate Carcinoma	disease	BEFREE
C0940937	precancerous lesions	phenotype	BEFREE
C0947622	Cholecystolithiasis	disease	BEFREE
C0947751	Vascular inflammations	phenotype	BEFREE
C0948008	Ischemic stroke	disease	BEFREE
C0948089	Acute Coronary Syndrome	disease	BEFREE;CTD_human;LHGDN
C0948163	Leukoaraiosis	phenotype	LHGDN
C0948192	Primary infection NOS	phenotype	BEFREE
C0948380	Colorectal cancer metastatic	disease	BEFREE
C1096086	Deformity of lower limb	group	HPO
C1096184	West Nile viral infection	disease	BEFREE
C1112768	Anterior subcapsular cataract	disease	BEFREE
C1134719	Invasive Ductal Breast Carcinoma	disease	BEFREE
C1135745	Meningitis, Meningococcal, Serogroup A	disease	RGD
C1135746	Meningitis, Meningococcal, Serogroup B	disease	RGD
C1135747	Meningitis, Meningococcal, Serogroup C	disease	RGD
C1136209	Meningitis, Meningococcal, Serogroup Y	disease	RGD
C1136210	Meningitis, Meningococcal, Serogroup W-135	disease	RGD
C1140680	Malignant neoplasm of ovary	disease	BEFREE
C1141926	Abdominal sepsis	disease	BEFREE
C1168305	Corneal melt	disease	BEFREE
C1168401	Squamous cell carcinoma of the head and neck	disease	BEFREE
C1257931	Mammary Neoplasms, Human	group	CTD_human
C1258215	Ileus	disease	RGD
C1261287	Stenosis	phenotype	LHGDN
C1261473	Sarcoma	group	BEFREE;LHGDN
C1278797	Postnatal infection	disease	BEFREE
C1282496	Metastasis from malignant tumor of prostate	disease	BEFREE
C1290398	Cerebral arterial aneurysm	disease	BEFREE
C1304300	Skin Nodular Basal Cell Carcinoma	disease	BEFREE
C1306459	Primary malignant neoplasm	group	BEFREE
C1306460	Primary malignant neoplasm of lung	disease	BEFREE
C1306557	Chronic venous insufficiency	disease	BEFREE
C1332225	Aggressive Non-Hodgkin Lymphoma	disease	BEFREE
C1334274	Invasive Carcinoma	phenotype	BEFREE
C1334455	Pulmonary Sclerosing Hemangioma	disease	LHGDN
C1334699	Mesenchymal Cell Neoplasm	disease	BEFREE
C1335302	Pancreatic Ductal Adenocarcinoma	disease	BEFREE
C1335392	Pericytic Neoplasm	disease	BEFREE
C1336745	Thymic Lymphoma	disease	BEFREE
C1368683	Epithelioma	disease	BEFREE
C1378703	Renal carcinoma	disease	BEFREE
C1397307	Cardiac fibrosis	disease	BEFREE
C1402315	Vascular lesions	disease	BEFREE
C1449563	Cardiomyopathy, Familial Idiopathic	disease	BEFREE
C1456868	Diabetic foot ulcer	disease	BEFREE
C1458155	Mammary Neoplasms	group	BEFREE;CTD_human;LHGDN
C1510472	Drug Dependence	phenotype	BEFREE
C1510885	Angiogenic Switch	disease	BEFREE
C1511789	Desmoplastic	disease	BEFREE
C1514422	Glioblastoma, IDH-Wildtype	disease	BEFREE
C1519346	Skin Carcinogenesis	disease	BEFREE
C1519670	Tumor Angiogenesis	phenotype	BEFREE
C1527249	Colorectal Cancer	disease	BEFREE
C1527303	Chronic Airflow Obstruction	disease	CTD_human
C1527311	Brain Edema	disease	CTD_human;RGD
C1527336	Sjogren's Syndrome	disease	BEFREE
C1527390	Neoplasms, Intracranial	group	BEFREE
C1536220	ST segment elevation myocardial infarction	disease	BEFREE
C1561643	Chronic Kidney Diseases	group	BEFREE
C1565489	Renal Insufficiency	disease	BEFREE
C1567741	Alport Syndrome	disease	BEFREE
C1568272	Tendinopathy	disease	BEFREE
C1611184	Calcification of coronary artery	phenotype	GWASDB
C1621958	Glioblastoma Multiforme	disease	BEFREE;CTD_human
C1623038	Cirrhosis	disease	BEFREE
C1654637	androgen independent prostate cancer	disease	BEFREE
C1658953	tumor vasculature	phenotype	BEFREE
C1704230	Grade I Astrocytoma	disease	CTD_human
C1704272	Benign Prostatic Hyperplasia	disease	BEFREE
C1704356	Enchondroma	disease	BEFREE
C1719495	Aggressive periodontitis, generalized	disease	BEFREE
C1719498	Generalized chronic periodontitis	disease	BEFREE
C1719672	Severe Sepsis	disease	CTD_human
C1762616	Meningioma, benign, no ICD-O subtype	disease	BEFREE
C1800706	Idiopathic Pulmonary Fibrosis	disease	BEFREE
C1836184	Short femoral neck	phenotype	HPO
C1838662	Metaphyseal irregularity	phenotype	HPO
C1842937	AURAL ATRESIA, CONGENITAL	disease	BEFREE
C1849039	Metaphyseal widening	phenotype	HPO
C1855179	CATARACT, ANTERIOR POLAR	disease	BEFREE
C1855340	Bowing of the long bones	phenotype	HPO
C1855739	Indifference to Pain, Congenital, Autosomal Recessive	disease	BEFREE
C1861305	TARSAL-CARPAL COALITION SYNDROME	disease	BEFREE
C1863340	PITUITARY ADENOMA PREDISPOSITION (disorder)	phenotype	BEFREE
C1866956	Aortic root dilation	disease	BEFREE
C1867743	Premature coronary artery disease	phenotype	BEFREE
C1868193	PNEUMOTHORAX, PRIMARY SPONTANEOUS	disease	BEFREE
C1883486	Uterine Corpus Cancer	disease	BEFREE
C1956346	Coronary Artery Disease	disease	BEFREE;LHGDN
C1959587	Ventricular Free Wall Rupture	disease	BEFREE
C1959635	Parvovirus B19 (disease)	disease	BEFREE
C1959859	Acute lyme disease	disease	BEFREE
C1960546	Myxoma of heart	disease	BEFREE
C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	BEFREE
C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	LHGDN
C2076600	Influenza due to Influenza A virus subtype H1N1	disease	GWASCAT
C2112532	Postmenopausal endometrium	disease	BEFREE
C2145472	Urothelial Carcinoma	disease	BEFREE
C2239176	Liver carcinoma	disease	BEFREE;CTD_human;LHGDN
C2242987	Benign Mastocytoma	disease	BEFREE
C2316810	Chronic kidney disease stage 5	disease	BEFREE
C2350878	Focal Emphysema	disease	CTD_human
C2362324	Pediatric Obesity	disease	BEFREE
C2607914	Allergic rhinitis (disorder)	disease	BEFREE
C2711227	Steatohepatitis	disease	BEFREE
C2717836	Steroid Sulfatase Deficiency Disease	disease	BEFREE
C2718067	Alcoholic Steatohepatitis	disease	BEFREE
C2749463	Aplasia/Hypoplasia of the radius	phenotype	HPO
C2751322	Metaphyseal Anadysplasia 2	disease	CLINVAR;CTD_human
C2751492	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	disease	BEFREE
C2931073	Collagenopathy, type 2 alpha 1	disease	BEFREE
C2931822	Nasopharyngeal carcinoma	disease	BEFREE
C2936179	Obesity, Visceral	phenotype	BEFREE
C2936258	Peri-Implantitis	disease	BEFREE
C2936349	Plaque, Amyloid	phenotype	BEFREE
C2936380	Neointima	phenotype	CTD_human
C2936381	Neointima Formation	phenotype	CTD_human
C2937358	Cerebral Hemorrhage	phenotype	CTD_human
C2937421	Prostatic Hyperplasia	disease	BEFREE
C2939419	Secondary Neoplasm	group	BEFREE
C2939420	Metastatic Neoplasm	phenotype	BEFREE
C2945759	aggressive cancer	phenotype	BEFREE
C3146251	Stage IV Colorectal Cancer AJCC v7	disease	BEFREE
C3163622	Papillary Meningioma	disease	BEFREE
C3203102	Idiopathic pulmonary arterial hypertension	disease	BEFREE
C3258293	Valvular disease	disease	BEFREE
C3463824	MYELODYSPLASTIC SYNDROME	group	BEFREE;LHGDN
C3469521	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	disease	BEFREE
C3539781	Progressive cGVHD	disease	BEFREE
C3539878	Triple Negative Breast Neoplasms	disease	BEFREE
C3642345	Luminal A Breast Carcinoma	disease	BEFREE
C3642346	Luminal B Breast Carcinoma	disease	BEFREE
C3665444	Neutrophilia (disorder)	disease	BEFREE
C3695127	Astrocytoma of brain	disease	BEFREE
C3714514	Infection	group	LHGDN
C3714524	Fibromyxosarcoma	disease	BEFREE
C3714636	Pneumonitis	disease	BEFREE
C3714948	PACHYONYCHIA CONGENITA 3	disease	BEFREE
C3811653	Experimental Organism Basal Cell Carcinoma	phenotype	BEFREE
C3850141	Acute-On-Chronic Liver Failure	disease	BEFREE
C3875321	Inflammatory dermatosis	group	BEFREE
C3887461	Head and Neck Carcinoma	disease	BEFREE
C3887486	Interstitial lung fibrosis	phenotype	BEFREE
C3899278	Early Rheumatoid Arthritis	disease	BEFREE
C4021611	Abnormality of epiphysis morphology	phenotype	HPO
C4025424	Abnormality of ulnar metaphysis	phenotype	HPO
C4048328	cervical cancer	disease	BEFREE
C4049343	Combined pulmonary fibrosis and emphysema	disease	BEFREE
C4083056	Basal cell carcinoma, nodular	disease	BEFREE
C4255010	Non-ST Elevated Myocardial Infarction	disease	BEFREE
C4302111	Familial M?ni?re disease	disease	GENOMICS_ENGLAND

Gene Ontology (GO)/biological pathways

GO:Molecular Function

GO ID	GO Term	Evidence
GO:0004175	endopeptidase activity	IDA
GO:0004222	metalloendopeptidase activity	IDA
GO:0004222	metalloendopeptidase activity	IBA
GO:0004222	metalloendopeptidase activity	TAS
GO:0004252	serine-type endopeptidase activity	EXP
GO:0005515	protein binding	IPI
GO:0005518	collagen binding	TAS
GO:0008233	peptidase activity	IDA
GO:0008237	metallopeptidase activity	IDA
GO:0008270	zinc ion binding	TAS
GO:0042802	identical protein binding	IPI

GO:Biological Process

GO ID	GO Term	Evidence
GO:0001501	skeletal system development	IEA
GO:0001934	positive regulation of protein phosphorylation	IMP
GO:0006508	proteolysis	IDA
GO:0007566	embryo implantation	IEA
GO:0019221	cytokine-mediated signaling pathway	TAS
GO:0022617	extracellular matrix disassembly	TAS
GO:0030198	extracellular matrix organization	IBA
GO:0030225	macrophage differentiation	TAS
GO:0030335	positive regulation of cell migration	TAS
GO:0030335	positive regulation of cell migration	IGI
GO:0030574	collagen catabolic process	IBA
GO:0030574	collagen catabolic process	TAS
GO:0034614	cellular response to reactive oxygen species	IDA
GO:0035987	endodermal cell differentiation	IEP
GO:0043066	negative regulation of apoptotic process	IMP
GO:0043312	neutrophil degranulation	TAS
GO:0043388	positive regulation of DNA binding	IDA
GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	IMP
GO:0048013	ephrin receptor signaling pathway	TAS
GO:0051549	positive regulation of keratinocyte migration	IMP
GO:0071276	cellular response to cadmium ion	IDA
GO:0090200	positive regulation of release of cytochrome c from mitochondria	IMP
GO:0150077	regulation of neuroinflammatory response	TAS
GO:1900122	positive regulation of receptor binding	IDA
GO:1904645	response to amyloid-beta	ISS
GO:1904707	positive regulation of vascular smooth muscle cell proliferation	IMP
GO:2000697	negative regulation of epithelial cell differentiation involved in kidney development	ISS
GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	IMP
GO:2001258	negative regulation of cation channel activity	IDA
GO:2001268	negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	IMP

GO:Cellular Component

GO ID	GO Term	Evidence
GO:0005576	extracellular region	HDA
GO:0005576	extracellular region	TAS
GO:0005615	extracellular space	IBA
GO:0005615	extracellular space	IDA
GO:0062023	collagen-containing extracellular matrix	HDA
GO:0070062	extracellular exosome	HDA
GO:1904724	tertiary granule lumen	TAS
GO:1904813	ficolin-1-rich granule lumen	TAS

Reactome Pathway

Reactome ID	Reactome Term	Evidence
R-HSA-1266738	Developmental Biology	TAS
R-HSA-1280215	Cytokine Signaling in Immune system	TAS
R-HSA-1433557	Signaling by SCF-KIT	TAS
R-HSA-1442490	Collagen degradation	IEA
R-HSA-1442490	Collagen degradation	TAS
R-HSA-1474228	Degradation of the extracellular matrix	TAS
R-HSA-1474228	Degradation of the extracellular matrix	IEA
R-HSA-1474244	Extracellular matrix organization	TAS
R-HSA-1474244	Extracellular matrix organization	IEA
R-HSA-1474290	Collagen formation	TAS
R-HSA-1592389	Activation of Matrix Metalloproteinases	TAS
R-HSA-162582	Signal Transduction	TAS
R-HSA-168249	Innate Immune System	TAS
R-HSA-168256	Immune System	TAS
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	TAS
R-HSA-2682334	EPH-Ephrin signaling	TAS
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	TAS
R-HSA-422475	Axon guidance	TAS
R-HSA-449147	Signaling by Interleukins	TAS
R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	TAS
R-HSA-6798695	Neutrophil degranulation	TAS
R-HSA-8939211	ESR-mediated signaling	TAS
R-HSA-9006931	Signaling by Nuclear Receptors	TAS
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	TAS
R-HSA-9009391	Extra-nuclear estrogen signaling	TAS

Drugs and compounds information

ID	Drug Name	Action	PubMed
C521487	10-nitro-oleic acid	10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21454668
C521487	10-nitro-oleic acid	10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21454668
C521487	10-nitro-oleic acid	10-nitro-oleic acid results in increased activity of MMP9 protein	21454668
C521487	10-nitro-oleic acid	2-chloro-5-nitrobenzanilide inhibits the reaction [10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	21454668
C521487	10-nitro-oleic acid	10-nitro-oleic acid results in decreased expression of MMP9 protein	21454668
C025205	1,10-phenanthroline	1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein]	20177776
C025205	1,10-phenanthroline	1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
C435044	1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol	1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	22936809
C504897	12-(3-adamantan-1-ylureido)dodecanoic acid	12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]	28694203
C504897	12-(3-adamantan-1-ylureido)dodecanoic acid	12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28694203
C009536	1,2,3-trichloropropane	1,2,3-trichloropropane results in increased expression of MMP9 mRNA	22952646
C009536	1,2,3-trichloropropane	1,2,3-trichloropropane results in increased expression of MMP9 protein	22952646
C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
C070379	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
C070379	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20590612
C569107	1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one	1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in decreased activity of MMP9 protein	23826121
C517232	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of MMP9 mRNA	23958786
D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
C063609	1,2-dimethyl-4-nitrobenzene	1,2-dimethyl-4-nitrobenzene results in decreased expression of MMP9 mRNA	19784758
D019813	1,2-Dimethylhydrazine	1,2-Dimethylhydrazine results in increased expression of MMP9 protein	29031619
D019813	1,2-Dimethylhydrazine	Artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein]	29031619
D019813	1,2-Dimethylhydrazine	Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein]	29031619
C031763	1,3-butadiene	1,3-butadiene results in decreased expression of MMP9 mRNA	29038090
C517943	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased activity of MMP9 protein	31468104
C517943	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased activity of MMP9 protein]	31468104
C097240	15-deoxy-delta(12,14)-prostaglandin J2	15-deoxy-delta(12,14)-prostaglandin J2 results in decreased activity of and results in decreased expression of MMP9 protein	19997048
C097240	15-deoxy-delta(12,14)-prostaglandin J2	15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of MMP9 mRNA	19997048
C097240	15-deoxy-delta(12,14)-prostaglandin J2	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased activity of and results in decreased expression of MMP9 protein]	19997048
C097240	15-deoxy-delta(12,14)-prostaglandin J2	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of MMP9 mRNA]	19997048
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]	19880272
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased secretion of MMP9 protein]	19880272
C447621	16-(4-fluorophenoxy)lipoxin A4	16-(4-fluorophenoxy)lipoxin A4 inhibits the reaction [VEGFA results in increased expression of and results in increased activity of MMP9 protein]	18193074
C072581	16-hydroxycleroda-3,13(14)-dien-15,16-olide	16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased activity of MMP9 protein	23628706
C119129	18alpha-glycyrrhetinic acid	18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	24613819
C119129	18alpha-glycyrrhetinic acid	18alpha-glycyrrhetinic acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	24613819
C047948	1'-acetoxychavicol acetate	1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	15905586
D020001	1-Butanol	1-Butanol inhibits the reaction [Phenylephrine results in increased activity of MMP9 protein]	18539131
C506325	1-hydroxy-1-norresistomycin	1-hydroxy-1-norresistomycin results in decreased expression of MMP9 mRNA	29596799
C506325	1-hydroxy-1-norresistomycin	1-hydroxy-1-norresistomycin results in decreased expression of MMP9 protein	29596799
C105351	1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene	1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in decreased activity of MMP9 protein	18424783
C105351	1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene	1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in decreased expression of MMP9 mRNA	18424783
D015056	1-Methyl-3-isobutylxanthine	TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA]	23503329
D015056	1-Methyl-3-isobutylxanthine	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA	23503329
D015655	1-Methyl-4-phenylpyridinium	1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA	19962414
D015655	1-Methyl-4-phenylpyridinium	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]	19962414
D015655	1-Methyl-4-phenylpyridinium	Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]	19962414
D015058	1-Naphthylisothiocyanate	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MMP9 mRNA	27344345
C581572	1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea	[Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in decreased expression of MMP9 mRNA	25827057
C494665	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C494665	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
C552888	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C548651	2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased activity of MMP9 protein	24469321
C548651	2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	MMP1 protein affects the reaction [2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased activity of MMP9 protein]	24469321
C574037	2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one	2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in decreased expression of MMP9	24300195
C005849	2,2,2-trichloroethanol	2,2,2-trichloroethanol results in increased activity of MMP9 protein	21741468
C005849	2,2,2-trichloroethanol	2,2,2-trichloroethanol results in increased expression of MMP9 mRNA	21741468
C005849	2,2,2-trichloroethanol	2,2,2-trichloroethanol results in increased expression of MMP9 protein	21741468
C541131	2,2',3,3',4,4',5-heptachlorobiphenyl	2,2',3,3',4,4',5-heptachlorobiphenyl results in decreased expression of MMP9 mRNA	26238599
C511295	2,2',4,4'-tetrabromodiphenyl ether	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MMP9 mRNA	25614096
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with AG 1879] inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	24997338; 25312822;
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	24997338
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [HGF results in increased expression of MMP9]	11981761
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]	15728660
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein]	19765281
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]	28722351
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859; 19804834;
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248; 23288142;
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19804834; 25656647;
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093; 15728660; 21354279;
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	22926441
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF results in increased expression of MMP9 mRNA]	17560598
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [VEGFA protein results in increased activity of MMP9 protein]	22270366
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA	19501039
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein]	19837106
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]	19837106
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]	19837106
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein	15657063
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA	15657063
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased expression of and results in increased secretion of MMP9 protein]	23811825
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
C019273	2,2-bis(4-glycidyloxyphenyl)propane	2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]]	27274199
D015082	2,2'-Dipyridyl	2,2'-Dipyridyl results in increased activity of MMP9 protein	18674879
D015082	2,2'-Dipyridyl	2,2'-Dipyridyl results in increased expression of MMP9 mRNA	18674879
D015082	2,2'-Dipyridyl	Resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein]	18674879
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]	16378139
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	16378139
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	16683234
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	2,2'-(hydroxynitrosohydrazono)bis-ethanamine promotes the reaction [HNRNPD protein binds to MMP9 3' UTR]	16683234
C094210	2,2'-(hydroxynitrosohydrazono)bis-ethanamine	HNRNPD mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]]	16683234
C111118	2',3,3',4',5-pentachloro-4-hydroxybiphenyl	2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MMP9 mRNA	19114083
C061282	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased activity of MMP9 protein	16783407
C061282	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in decreased expression of MMP9 mRNA	16783407
C010914	2,4-diaminotoluene	2,4-diaminotoluene results in increased expression of MMP9 mRNA	20713471
C044563	24-hydroxycholesterol	24-hydroxycholesterol results in increased expression of MMP9 mRNA	24802026
C044563	24-hydroxycholesterol	Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of MMP9 mRNA]	24802026
C490707	2-(4-isobutylphenyl)propionylmethanesulfonamide	2-(4-isobutylphenyl)propionylmethanesulfonamide inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15652230
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]	19956873
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	19956873; 24997338;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 mRNA]	19956873
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 protein]	19956873
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131; 27634460;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in decreased expression of MMP9 mRNA]	19956873
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in decreased expression of MMP9 protein]	19956873
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	24997338
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859; 25866363;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25656647
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	24613819
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	24613819
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF results in increased expression of MMP9 mRNA]	17560598
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [VEGFA protein results in increased activity of MMP9 protein]	22270366
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [leptin (116-130) results in decreased expression of MMP9 mRNA]	31499123
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in increased expression of and results in increased activity of MMP9 protein]	23229870
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA	23566884
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 protein	18424783
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]	19962414
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	19401153
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of MMP9 protein	19393235; 22326785;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of MMP9 mRNA	19393235; 22326785;
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EGF protein results in increased secretion of MMP9 protein]	21942447
C076996	27-hydroxycholesterol	27-hydroxycholesterol results in increased expression of MMP9 mRNA	24802026
C076996	27-hydroxycholesterol	Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of MMP9 mRNA]	24802026
D015073	2-Acetylaminofluorene	2-Acetylaminofluorene results in increased expression of MMP9 mRNA	18678246
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MMP9 protein	22307971
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased secretion of MMP9 protein	20951759
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	U 0126 inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MMP9 protein]	22307971
C087594	2-amino-5-nitrophenol	2-amino-5-nitrophenol results in increased expression of MMP9 mRNA	22952646
C087594	2-amino-5-nitrophenol	2-amino-5-nitrophenol results in increased expression of MMP9 protein	22952646
C012177	2-aminofluorene	2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased activity of MMP9 protein]	19052882
C012177	2-aminofluorene	2-aminofluorene results in increased activity of MMP9 protein	19052882
C012177	2-aminofluorene	[Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of MMP9 protein	19052882
C012796	2-butenal	2-butenal results in increased expression of MMP9 mRNA	28947239
C012796	2-butenal	2-butenal results in increased secretion of MMP9 protein	28947239
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	21454668
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol affects the expression of MMP9 protein]	17007354
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased activity of and results in decreased expression of MMP9 protein]	19997048
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of MMP9 mRNA]	19997048
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein]	17531121
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]	24192212
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in increased expression of MMP9 protein]	24192212
C457499	2-chloro-5-nitrobenzanilide	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]]	24192212
C457499	2-chloro-5-nitrobenzanilide	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in increased expression of MMP9 protein]]	24192212
C031278	2-chloroethyl ethyl sulfide	2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C031278	2-chloroethyl ethyl sulfide	2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein	21722719; 29535050;
C031278	2-chloroethyl ethyl sulfide	A 967079 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C031278	2-chloroethyl ethyl sulfide	Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	21722719
C031278	2-chloroethyl ethyl sulfide	MK-8825 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C028145	2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine	[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of MMP9 protein	20348013
C096118	2-methoxy-1,4-naphthoquinone	2-methoxy-1,4-naphthoquinone results in decreased activity of MMP9 protein	24291160
C560356	(2S,4R)-methyl-1-acetyl-4-(N-(4-bromophenyl)sulfamoyloxy)pyrrolidine-2-carboxylate	(2S,4R)-methyl-1-acetyl-4-(N-(4-bromophenyl)sulfamoyloxy)pyrrolidine-2-carboxylate results in increased secretion of and results in increased activity of MMP9 protein	21349324
C041525	3,3',4,5'-tetrahydroxystilbene	3,3',4,5'-tetrahydroxystilbene inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	12444159
C041525	3,3',4,5'-tetrahydroxystilbene	3,3',4,5'-tetrahydroxystilbene inhibits the reaction [TNF protein results in increased secretion of MMP9 protein]	19631264
C016392	3,3'-diindolylmethane	3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein]	25794856
C016392	3,3'-diindolylmethane	3,3'-diindolylmethane analog results in decreased expression of and results in decreased activity of MMP9 protein	25794856
C016392	3,3'-diindolylmethane	3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	28844962
C016392	3,3'-diindolylmethane	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	28844962
C016392	3,3'-diindolylmethane	3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP9 protein]	28844962
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MMP9 mRNA	28973690
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl affects the expression of MMP9 mRNA	21703328
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MMP9 mRNA	27663891
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 protein]	28973532
C023035	3,4,5,3',4'-pentachlorobiphenyl	3,4,5,3',4'-pentachlorobiphenyl results in increased secretion of MMP9 protein	27663891
C005975	3,4-dihydroxyphenylethanol	3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22595400
C005975	3,4-dihydroxyphenylethanol	3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]	28390675
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein]	28390675
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [AGT protein modified form results in increased expression of MMP9 mRNA]	30354818
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C434003	3-(4-methylphenylsulfonyl)-2-propenenitrile	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C544671	3-caffeoyl-4-dihydrocaffeoylquinic acid	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20599481
C544671	3-caffeoyl-4-dihydrocaffeoylquinic acid	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20599481
C544671	3-caffeoyl-4-dihydrocaffeoylquinic acid	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20599481
C544671	3-caffeoyl-4-dihydrocaffeoylquinic acid	3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
C544671	3-caffeoyl-4-dihydrocaffeoylquinic acid	Curcumin promotes the reaction [3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
C554289	3-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester	3-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester results in decreased secretion of and results in decreased expression of MMP9 protein	20670616
C025946	3-methyladenine	3-methyladenine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
C532757	4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide	4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide results in decreased activity of MMP9 protein	23611293
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein]	19765281
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 mRNA]	30081051
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 protein]	30081051
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole results in decreased activity of MMP9 protein	15657063
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C090942	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C583074	4,4'-hexafluorisopropylidene diphenol	4,4'-hexafluorisopropylidene diphenol results in decreased expression of MMP9 mRNA	30675821
C568862	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone results in increased activity of MMP9 protein]	31468104
C568862	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	25312822
C568862	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
C568862	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [Estradiol results in increased activity of MMP9 protein]	31468104
C108123	4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine	4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	22936809
C041338	4-aminobenzamide	4-aminobenzamide inhibits the reaction [Capsaicin results in increased activity of MMP9 protein]	21310942
C095170	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	15131573
C095170	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein]	15131573
C010024	4-aminophenylmercuriacetate	[Zymosan co-treated with 4-aminophenylmercuriacetate] results in increased activity of MMP9 protein	18557954
C010024	4-aminophenylmercuriacetate	Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]	17015178
C010024	4-aminophenylmercuriacetate	Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]	17015178
C010024	4-aminophenylmercuriacetate	4-aminophenylmercuriacetate results in increased secretion of MMP9 protein	23525277
C010024	4-aminophenylmercuriacetate	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [4-aminophenylmercuriacetate results in increased secretion of MMP9 protein]	23525277
C400084	4-chlorobenzyltetrahydroberberine	4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	23270704
C400084	4-chlorobenzyltetrahydroberberine	4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	23270704
C045934	4-hydroxy-2-hexenal	4-hydroxy-2-hexenal results in increased expression of MMP9 mRNA	28760545
C045934	4-hydroxy-2-hexenal	4-hydroxy-2-hexenal results in increased expression of MMP9 protein	28760545
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in decreased expression of MMP9 mRNA	19191707
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased activity of MMP9 protein	19837106
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased expression of MMP9 mRNA	19191707
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased expression of MMP9 protein	19191707; 19837106;
C027576	4-hydroxy-2-nonenal	ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C027576	4-hydroxy-2-nonenal	alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C027576	4-hydroxy-2-nonenal	MK-886 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C027576	4-hydroxy-2-nonenal	U 75302 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C406734	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid inhibits the reaction [TGFB1 protein results in increased expression of MMP9 protein]	30930231
C570020	4-methylesculetin	4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of and results in increased activity of MMP9 protein]	24960061
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 mRNA]	24960061; 29753068;
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 protein]	29753068
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819; 21354279;
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20152819; 21354279;
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
C549066	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
D015112	4-Nitroquinoline-1-oxide	4-Nitroquinoline-1-oxide results in increased expression of MMP9 mRNA	22561872
C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of MMP9 mRNA	21167638
C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA	21167638
C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	22245252
C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of MMP9 mRNA	22245252
C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of MMP9 protein	22245252
C489251	5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone	5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
C558286	6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose	6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose analog results in decreased expression of MMP9 protein	25148938
C584755	6-bromo-8-ethoxy-3-nitro-2H-chromene	6-bromo-8-ethoxy-3-nitro-2H-chromene results in decreased expression of and results in decreased activity of MMP9 protein	30125547
C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
C003001	7-ketocholesterol	7-ketocholesterol results in increased expression of MMP9 protein	24895526
C003001	7-ketocholesterol	Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of MMP9 protein]	24895526
C003001	7-ketocholesterol	7-ketocholesterol results in increased expression of MMP9 mRNA	20466046
C080122	7-nitroindazole	[7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein]	20519536
C557120	8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene	8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene results in decreased expression of and results in decreased activity of MMP9 protein	30125547
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA	21294050; 22485181;
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein	21294050; 22485181;
D015127	9,10-Dimethyl-1,2-benzanthracene	chlorophyllin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	22485181
D015127	9,10-Dimethyl-1,2-benzanthracene	chlorophyllin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	22485181
D015127	9,10-Dimethyl-1,2-benzanthracene	Ellagic Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	22485181
D015127	9,10-Dimethyl-1,2-benzanthracene	Ellagic Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	22485181
D015127	9,10-Dimethyl-1,2-benzanthracene	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	21294050
D015127	9,10-Dimethyl-1,2-benzanthracene	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	21294050
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene affects the expression of MMP9 mRNA	21785161
D015127	9,10-Dimethyl-1,2-benzanthracene	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein	12208745
D015127	9,10-Dimethyl-1,2-benzanthracene	Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	12208745
C507011	A-83-01	[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of MMP9 mRNA	31023824
C560402	A 967079	A 967079 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C106538	abacavir	abacavir results in increased expression of MMP9 protein	19891054
C496492	abrine	abrine results in increased expression of MMP9 mRNA	31054353
C496492	abrine	abrine results in increased expression of MMP9 mRNA	22595364
D000079	Acetaldehyde	Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein	19110045
D000079	Acetaldehyde	Acetaldehyde results in increased expression of MMP9 mRNA	19110045
D000079	Acetaldehyde	Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein]	19110045
D000079	Acetaldehyde	Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA]	19110045
D000082	Acetaminophen	Acetaminophen results in decreased expression of MMP9 mRNA	26690555
D000082	Acetaminophen	Acetaminophen affects the expression of MMP9 mRNA	17562736
D000082	Acetaminophen	Acetaminophen results in increased expression of MMP9 mRNA	12392966; 14550746; 21135413; 22461450;
D000082	Acetaminophen	Acetaminophen results in increased expression of MMP9 protein	21135413
D000082	Acetaminophen	FLT1 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA]	21135413
D000082	Acetaminophen	FLT1 protein affects the reaction [Acetaminophen results in increased expression of MMP9 protein]	21135413
D000082	Acetaminophen	LGALS3 protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA]	22461450
D000082	Acetaminophen	TNFRSF1A protein affects the reaction [Acetaminophen results in increased expression of MMP9 mRNA]	14550746
D000082	Acetaminophen	Acetaminophen affects the expression of MMP9 mRNA	19784758
D000082	Acetaminophen	Acetaminophen results in decreased expression of MMP9 mRNA	19784758
D000082	Acetaminophen	Acetaminophen results in increased expression of MMP9 mRNA	19784758
D019342	Acetic Acid	Acetic Acid results in increased expression of MMP9 mRNA	23933360
D019342	Acetic Acid	[Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA]	23933360
C056165	acetovanillone	acetovanillone inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
C056165	acetovanillone	acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	23270704
C056165	acetovanillone	acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	23270704
C056165	acetovanillone	acetovanillone inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
C056165	acetovanillone	acetovanillone inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C056165	acetovanillone	acetovanillone inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C094432	acetyl-11-ketoboswellic acid	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein	21078271
C094432	acetyl-11-ketoboswellic acid	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA	21078271
C094432	acetyl-11-ketoboswellic acid	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of MMP9 protein	21078271
D000109	Acetylcholine	MMP9 protein affects the susceptibility to Acetylcholine	16979597
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]	17015178
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]	19350554
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP9 protein]	15962302
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
D000111	Acetylcysteine	Acetylcysteine results in decreased activity of MMP9 protein	18930813
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MMP9 mRNA]	19962414
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
D000111	Acetylcysteine	Acetylcysteine results in decreased activity of MMP9 protein	15451797
D000111	Acetylcysteine	[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA	21051528
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [SOD2 protein results in increased expression of MMP9]	21749277
D000171	Acrolein	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000171	Acrolein	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000171	Acrolein	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
D000171	Acrolein	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000171	Acrolein	Acrolein affects the secretion of MMP9 protein	28947239
D000171	Acrolein	Acrolein results in increased activity of MMP9 protein	15531749; 18006877;
D000171	Acrolein	Acrolein results in increased cleavage of MMP9 protein	18006877
D000171	Acrolein	Acrolein results in increased expression of and results in increased secretion of MMP9 protein	19371603
D000171	Acrolein	Acrolein results in increased expression of MMP9 mRNA	15531749; 18006877;
D000171	Acrolein	Acrolein results in increased expression of MMP9 protein	15531749
D000171	Acrolein	Acrolein results in increased secretion of MMP9 protein	15531749
D000171	Acrolein	Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000171	Acrolein	MMP9 protein promotes the reaction [Acrolein results in increased expression of MUC5AC mRNA]	15531749
D000171	Acrolein	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
D000171	Acrolein	Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D000171	Acrolein	RTKI cpd inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
D000171	Acrolein	Acrolein results in increased activity of MMP9 protein	17950725; 18006877;
D000171	Acrolein	Acrolein results in increased expression of and results in increased activity of MMP9 protein	20153347
D000171	Acrolein	Acrolein results in increased expression of MMP9 mRNA	18006877
D000171	Acrolein	Acrolein results in increased expression of MMP9 protein	18006877
D000171	Acrolein	CD8A gene mutant form inhibits the reaction [Acrolein results in increased activity of MMP9 protein]	17950725
D000171	Acrolein	MMP9 gene mutant form inhibits the reaction [Acrolein results in increased expression of MUC5AC mRNA]	18006877
D020106	Acrylamide	Acrylamide results in increased expression of MMP9 mRNA	30807115
D000255	Adenosine Triphosphate	Adenosine Triphosphate results in increased activity of MMP9 protein	26522449
D000255	Adenosine Triphosphate	azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of MMP9 protein]	26522449
D000255	Adenosine Triphosphate	1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
D000255	Adenosine Triphosphate	Adenosine Triphosphate results in increased activity of MMP9 protein	20195827
D000255	Adenosine Triphosphate	Adenosine Triphosphate results in increased secretion of MMP9 protein	20195827
D000255	Adenosine Triphosphate	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
D000255	Adenosine Triphosphate	SB 3CT compound inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
D000255	Adenosine Triphosphate	Wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
D000319	Adrenergic beta-Antagonists	[Adrenergic beta-Antagonists co-treated with Angiotensin-Converting Enzyme Inhibitors] results in decreased expression of MMP9 protein	21697605
D000319	Adrenergic beta-Antagonists	[Adrenergic beta-Antagonists co-treated with Angiotensin Receptor Antagonists] results in decreased expression of MMP9 protein	21697605
D000336	Aerosols	Aerosols results in increased expression of MMP9 mRNA	29505817
D016604	Aflatoxin B1	Aflatoxin B1 results in decreased methylation of MMP9 gene	27153756
C412373	AG 1879	[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with AG 1879] inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
C412373	AG 1879	[AG 1879 co-treated with chelerythrine] inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
C412373	AG 1879	AG 1879 inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131
C482289	Ageladine A	Ageladine A results in decreased activity of MMP9 protein	21413800
C031143	AICA ribonucleotide	AICA ribonucleotide results in decreased activity of MMP9 protein	20590612
D000393	Air Pollutants	Air Pollutants results in increased activity of MMP9 protein	26179980
D000393	Air Pollutants	Air Pollutants results in increased expression of MMP9 mRNA	26179980
D000393	Air Pollutants	Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]	26179980
D000393	Air Pollutants	Glucose promotes the reaction [Air Pollutants results in increased expression of MMP9 mRNA]	26179980
D000393	Air Pollutants	SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]]	26179980
D000393	Air Pollutants	Air Pollutants results in increased expression of MMP9 protein	30641074
D000395	Air Pollutants, Occupational	Air Pollutants, Occupational results in increased expression of MMP9	18409814
C000188	alachlor	alachlor results in increased expression of MMP9 mRNA	12419858
D000487	Allethrins	Allethrins results in increased expression of MMP9 protein	24055895
D000493	Allopurinol	Allopurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
C038491	allyl sulfide	allyl sulfide affects the expression of MMP9 protein	21695758
C038491	allyl sulfide	allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	23656969
C109682	alpha-benzoylamino-1,4-naphthoquinone	alpha-benzoylamino-1,4-naphthoquinone results in decreased secretion of MMP9 protein	15962302
C095512	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
C011512	alpha-naphthoflavone	alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein]	23462309
C011512	alpha-naphthoflavone	alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	19022365
C049740	alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol	alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
D000535	Aluminum	Aluminum results in increased expression of MMP9 protein	16052892
D000537	Aluminum Oxide	Aluminum Oxide results in increased expression of MMP9 mRNA	16488289
C453459	AMD 6221	AMD 6221 results in decreased activity of MMP9 protein	12658210
C557933	AMG 837	AMG 837 results in increased expression of MMP9 mRNA	30243991
D000640	Amitrole	Amitrole inhibits the reaction [Fluvastatin results in decreased expression of MMP9 mRNA]	24964743
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of MMP9 mRNA	16483693
C088115	anacardic acid	anacardic acid inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	18349320
C088115	anacardic acid	anacardic acid binds to and results in decreased activity of MMP9 protein	22745359
C583175	anagliptin	anagliptin inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	31586451
C078814	anandamide	anandamide results in increased expression of MMP9 mRNA	16330497
C078814	anandamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA]	16330497
D000728	Androgens	Androgens affects the activity of MMP9 protein	17607299
C006578	anethole	anethole results in decreased activity of MMP9 protein	21212515
C006578	anethole	anethole results in decreased expression of MMP9 mRNA	21212515
D000806	Angiotensin-Converting Enzyme Inhibitors	[Adrenergic beta-Antagonists co-treated with Angiotensin-Converting Enzyme Inhibitors] results in decreased expression of MMP9 protein	21697605
D057911	Angiotensin Receptor Antagonists	[Adrenergic beta-Antagonists co-treated with Angiotensin Receptor Antagonists] results in decreased expression of MMP9 protein	21697605
D000872	Anthocyanins	Anthocyanins inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein]	30056145
D018501	Antirheumatic Agents	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 mRNA	23146660
D018501	Antirheumatic Agents	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 protein	23146660
D018501	Antirheumatic Agents	Antirheumatic Agents results in decreased expression of MMP9 mRNA	17696278
C545357	antroquinonol	antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25656647
C545357	antroquinonol	antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
D047310	Apigenin	Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	22634262
D047310	Apigenin	Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22634262
D047310	Apigenin	Apigenin inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	21679050
D052157	Aptamers, Nucleotide	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D052157	Aptamers, Nucleotide	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Protein Synthesis Inhibitors binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D016718	Arachidonic Acid	Arachidonic Acid results in increased expression of MMP9 mRNA	16185265
D016718	Arachidonic Acid	Arachidonic Acid results in increased secretion of MMP9 protein	16185265
D016718	Arachidonic Acid	Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA]	16185265
D016718	Arachidonic Acid	Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein]	16185265
D034341	Aristolochic Acids	Aristolochic Acids inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	21453692
D034341	Aristolochic Acids	Aristolochic Acids inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	21453692
D034341	Aristolochic Acids	Aristolochic Acids inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	21453692
D001151	Arsenic	Arsenic results in increased expression of and results in increased activity of MMP9 protein	18539681
D001151	Arsenic	Arsenic results in increased expression of and results in increased secretion of MMP9 protein	23232971; 26637202;
D001151	Arsenic	[Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in decreased abundance of Cholesterol, HDL	26637202
D001151	Arsenic	[Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in increased expression of ICAM1 protein	26637202
D001151	Arsenic	[Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in increased expression of VCAM1 protein	26637202
D001151	Arsenic	Arsenic results in increased expression of MMP9 protein	26721309
D001151	Arsenic	Arsenic results in increased secretion of MMP9 protein	25273566
D001151	Arsenic	KRAS affects the reaction [Arsenic results in increased secretion of MMP9 protein]	25273566
D001151	Arsenic	MIR143 mRNA inhibits the reaction [Arsenic results in increased expression of MMP9 protein]	26721309
D001151	Arsenic	Arsenic results in increased expression of MMP9 mRNA	19654921
C058317	arsenic disulfide	arsenic disulfide analog results in decreased expression of MMP9 protein	30320388
D000077237	Arsenic Trioxide	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein	21078271
D000077237	Arsenic Trioxide	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA	21078271
D000077237	Arsenic Trioxide	[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of MMP9 protein	21078271
D000077237	Arsenic Trioxide	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]	19350554
D000077237	Arsenic Trioxide	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP9 protein]	15962302
D000077237	Arsenic Trioxide	[Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP9 mRNA	21969006
D000077237	Arsenic Trioxide	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	23253724
D000077237	Arsenic Trioxide	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	23253724
D000077237	Arsenic Trioxide	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15962302
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased activity of MMP9 protein	21969006; 23851143; 24680928; 27039805;
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of and results in decreased secretion of MMP9 protein	15962302
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 mRNA	15962302; 16624393; 19128835; 19350554; 19804631; 20471514; 21969006; 23253724; 23851143; 24680928; 26238599; 26705709; 27039805;
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 protein	16624393; 19236750; 20592496;
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of and affects the localization of and results in decreased secretion of MMP9 protein	24956101
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of MMP9	15949266
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of MMP9 mRNA	24956101; 27829220;
D000077237	Arsenic Trioxide	Arsenic Trioxide results in increased expression of MMP9 protein	25728215; 27829220;
D000077237	Arsenic Trioxide	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of MMP9 protein]	24956101
D000077237	Arsenic Trioxide	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	24956101
D000077237	Arsenic Trioxide	Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	24956101
D000077237	Arsenic Trioxide	[Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA	29274334
D000077237	Arsenic Trioxide	GH1 protein promotes the reaction [Arsenic Trioxide results in decreased activity of MMP9 protein]	23851143
D000077237	Arsenic Trioxide	GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]	23851143
D000077237	Arsenic Trioxide	HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
D000077237	Arsenic Trioxide	HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
D000077237	Arsenic Trioxide	JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
D000077237	Arsenic Trioxide	JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
D000077237	Arsenic Trioxide	MIR491 mRNA affects the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]	24680928
D000077237	Arsenic Trioxide	MMP9 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]]	24956101
D000077237	Arsenic Trioxide	MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]	24956101
D000077237	Arsenic Trioxide	MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]	24956101
D000077237	Arsenic Trioxide	MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]	24956101
D000077237	Arsenic Trioxide	MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2L11 protein]	24956101
D000077237	Arsenic Trioxide	MMP9 protein results in decreased susceptibility to Arsenic Trioxide	24956101
D000077237	Arsenic Trioxide	SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
D000077237	Arsenic Trioxide	SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
D000077237	Arsenic Trioxide	[Silybin co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein	21969006
D000077237	Arsenic Trioxide	SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
D000077237	Arsenic Trioxide	SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
D000077237	Arsenic Trioxide	zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 mRNA	23210436
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 protein	23210436
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 mRNA	16648906
D000077237	Arsenic Trioxide	Arsenic Trioxide results in decreased expression of MMP9 protein	16648906
C015001	arsenite	arsenite results in increased expression of MMP9 protein	12488483
C015001	arsenite	arsenite results in increased methylation of MMP9 promoter	23974009
C015001	arsenite	arsenite results in increased secretion of MMP9 protein	22011395
C015001	arsenite	arsenite affects the expression of MMP9 mRNA	15738583
C015001	arsenite	arsenite results in decreased expression of MMP9 mRNA	18929588
C015001	arsenite	arsenite results in increased expression of MMP9 mRNA	18296743
C015001	arsenite	Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA]	18296743
C015001	arsenite	TRP53 protein affects the reaction [arsenite results in decreased expression of MMP9 mRNA]	18929588
D000077332	Artesunate	Artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein]	29031619
D017638	Asbestos, Crocidolite	Asbestos, Crocidolite results in increased expression of MMP9 protein	16966607
D017638	Asbestos, Crocidolite	Asbestos, Crocidolite results in increased expression of MMP9 protein	16574944
D017632	Asbestos, Serpentine	Asbestos, Serpentine results in increased secretion of MMP9 protein	26685284
D017632	Asbestos, Serpentine	Asbestos, Serpentine results in increased activity of MMP9 protein	16571779
D017632	Asbestos, Serpentine	Asbestos, Serpentine results in increased expression of MMP9	19105532
D017632	Asbestos, Serpentine	Asbestos, Serpentine results in increased expression of MMP9 mRNA	18039278
D001205	Ascorbic Acid	[juglone co-treated with Ascorbic Acid] results in decreased expression of MMP9 mRNA	29992683
D001241	Aspirin	Aspirin inhibits the reaction [HGF results in increased expression of MMP9]	11981761
D001241	Aspirin	Aspirin results in decreased activity of MMP9 protein	20137092
D001241	Aspirin	Aspirin results in decreased expression of MMP9	18971601
D001241	Aspirin	Aspirin results in decreased expression of MMP9 mRNA	15928584; 19880272; 20137092;
D001241	Aspirin	Aspirin results in decreased secretion of MMP9 protein	18971601; 19880272;
D001241	Aspirin	Aspirin results in decreased expression of MMP9 mRNA	19462226
D001241	Aspirin	Aspirin results in decreased secretion of MMP9 protein	19462226
D001241	Aspirin	Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein]	29031619
D000069059	Atorvastatin	Atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
D000069059	Atorvastatin	Atorvastatin results in increased activity of MMP9 protein	23831763
D001374	Azacitidine	metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9]	19148494
C082735	azetidine	azetidine analog inhibits the reaction [Adenosine Triphosphate results in increased expression of MMP9 protein]	26522449
C547126	AZM551248	AZM551248 results in decreased activity of MMP9 protein	22323515
C547126	AZM551248	AZM551248 results in increased expression of MMP9 mRNA	22323515
D001397	Azoxymethane	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA	29950665
D001397	Azoxymethane	Azoxymethane affects the expression of MMP9 protein	22467055
D001397	Azoxymethane	Glucose affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D001397	Azoxymethane	Linoleic Acid affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D001397	Azoxymethane	[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
C087670	azoxystrobin	azoxystrobin results in increased expression of MMP9 mRNA	20825990
C500175	bacoside A	bacoside A inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein]	20084675
C006680	baicalein	baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
C006680	baicalein	baicalein results in decreased activity of MMP9 protein	21803068
C006680	baicalein	baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	22369883
C416282	BAY 11-7085	BAY 11-7085 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C416282	BAY 11-7085	BAY 11-7085 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C416282	BAY 11-7085	BAY 11-7085 inhibits the reaction [TNF protein results in increased secretion of MMP9 protein]	16606632
D001507	Beclomethasone	Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	10455257
D001507	Beclomethasone	Beclomethasone results in decreased expression of MMP9 protein	10452757
D001514	Bee Venoms	Bee Venoms inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19969058
C044946	benazepril	benazepril results in decreased expression of MMP9 protein	20981132
C044946	benazepril	benazepril results in increased activity of MMP9 protein	15339989
C044946	benazepril	benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]	19357873
C044946	benazepril	benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]	19357873
D001542	Benomyl	Benomyl results in decreased expression of MMP9 mRNA	25530041
D001542	Benomyl	Benomyl results in decreased expression of MMP9 protein	10026946
D001548	Benzalkonium Compounds	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MMP9 mRNA	30171875
C037689	benzamide	benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MMP9 mRNA]	29935282
C012768	benzanthrone	benzanthrone results in increased expression of MMP9 protein	28495615
D001554	Benzene	Benzene affects the expression of MMP9 mRNA	31154059
D001554	Benzene	Benzene results in increased expression of MMP9 mRNA	19162166
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 mRNA	22209252
D001564	Benzo(a)pyrene	Benzo(a)pyrene affects the expression of MMP9 mRNA	31154059
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of MMP9 mRNA	20106945; 30659931;
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased activity of MMP9 protein	15922868
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 mRNA	15922868; 25724548;
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 protein	26359795
D001564	Benzo(a)pyrene	U 0126 inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	25724548
D001564	Benzo(a)pyrene	baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	22369883
D001564	Benzo(a)pyrene	Benzo(a)pyrene affects the expression of MMP9 mRNA	22342234
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of MMP9 mRNA	20713471
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 mRNA	22369883
D001564	Benzo(a)pyrene	alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	19022365
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 mRNA	19022365
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of MMP9 protein	21467743
D001572	Benzofurans	Benzofurans analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30696844
C046412	benzyl acetate	benzyl acetate results in increased expression of MMP9 mRNA	22952646
C046412	benzyl acetate	benzyl acetate results in increased expression of MMP9 protein	22952646
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]	15728660
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	24613819
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	24613819
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C103712	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of MMP9 protein]	24956101
C103712	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane	benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	24956101
C006741	bergenin	[TNFSF11 protein co-treated with Pyruvaldehyde co-treated with bergenin] results in decreased expression of MMP9 mRNA	31369791
C023888	beta-hexachlorocyclohexane	beta-hexachlorocyclohexane results in increased expression of MMP9 protein	12948864
C002070	betulinic acid	betulinic acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP9 protein]	24463094
C004541	biochanin A	biochanin A results in decreased activity of MMP9 protein	16598420
C034786	bis(4-hydroxycinnamoyl)methane	bis(4-hydroxycinnamoyl)methane results in decreased secretion of and results in decreased activity of MMP9 protein	18495463
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in decreased expression of MMP9 mRNA	30265984
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of MMP9 mRNA	28806546
C543008	bis(4-hydroxyphenyl)sulfone	[Pam(3)CSK(4) peptide co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MMP9 mRNA	28806546
C543008	bis(4-hydroxyphenyl)sulfone	[Poly I-C co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MMP9 mRNA	28806546
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein	28903498
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of MMP9 mRNA	30951980
C088060	bisindolylmaleimide	bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	25866363
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [HGF protein results in increased expression of MMP9 mRNA]	12745093
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	12745093
C002791	bismuth tripotassium dicitrate	bismuth tripotassium dicitrate results in decreased expression of MMP9 mRNA	15912405
C002791	bismuth tripotassium dicitrate	bismuth tripotassium dicitrate results in increased expression of MMP9 mRNA	15912405
C006780	bisphenol A	bisphenol A results in increased expression of MMP9 mRNA	28806546
C006780	bisphenol A	[Pam(3)CSK(4) peptide co-treated with bisphenol A] results in increased expression of MMP9 mRNA	28806546
C006780	bisphenol A	[Poly I-C co-treated with bisphenol A] results in increased expression of MMP9 mRNA	28806546
C006780	bisphenol A	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	24997338; 25312822;
C006780	bisphenol A	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]	19956873
C006780	bisphenol A	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	19956873; 24997338;
C006780	bisphenol A	3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	28844962
C006780	bisphenol A	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	25312822
C006780	bisphenol A	[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein	30398665
C006780	bisphenol A	bisphenol A results in decreased expression of MMP9 mRNA	31230753
C006780	bisphenol A	bisphenol A results in increased expression of and results in increased activity of MMP9 protein	24997338
C006780	bisphenol A	bisphenol A results in increased expression of MMP9 mRNA	19956873; 24997338; 25312822; 25534675; 26604029; 27038254;
C006780	bisphenol A	bisphenol A results in increased expression of MMP9 protein	19956873; 25312822; 25534675; 25690688; 27038254; 28844962;
C006780	bisphenol A	bisphenol A results in increased secretion of MMP9 protein	18585891
C006780	bisphenol A	ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP9 mRNA]	27038254
C006780	bisphenol A	ESRRG protein affects the reaction [bisphenol A results in increased expression of MMP9 protein]	27038254
C006780	bisphenol A	Fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]	19956873; 25534675;
C006780	bisphenol A	Fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	19956873; 25534675; 25690688; 28844962;
C006780	bisphenol A	RTKI cpd inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	25312822
C006780	bisphenol A	[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA	29718165
C006780	bisphenol A	bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
C006780	bisphenol A	bisphenol A results in decreased expression of MMP9 mRNA	30303745; 30675821;
C006780	bisphenol A	bisphenol A results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein	28903498
C006780	bisphenol A	Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA]	29718165
C006780	bisphenol A	bisphenol A affects the expression of MMP9 mRNA	25181051
C006780	bisphenol A	bisphenol A results in increased expression of MMP9 mRNA	27925325; 29323181; 30816183;
C000611646	bisphenol F	bisphenol F results in decreased expression of MMP9 mRNA	30265984
C000611646	bisphenol F	bisphenol F results in increased expression of MMP9 mRNA	28806546
C000611646	bisphenol F	[Pam(3)CSK(4) peptide co-treated with bisphenol F] results in increased expression of MMP9 mRNA	28806546
C000611646	bisphenol F	bisphenol F results in increased expression of MMP9 mRNA	30951980
D001761	Bleomycin	12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]	28694203
D001761	Bleomycin	12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28694203
D001761	Bleomycin	Bleomycin results in increased expression of MMP9 mRNA	28694203
D001761	Bleomycin	Bleomycin results in increased expression of MMP9 protein	26526764; 28300665; 28694203;
D001761	Bleomycin	Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]	28694203
D001761	Bleomycin	Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28300665; 28694203;
D001761	Bleomycin	Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28300665
D001761	Bleomycin	NOS2 protein affects the reaction [Bleomycin results in increased expression of MMP9 protein]	26526764
D001761	Bleomycin	allyl sulfide inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	23656969
D001761	Bleomycin	Bleomycin results in increased expression of MMP9 protein	23656969; 26768587;
D001761	Bleomycin	tripterine inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	26768587
D001786	Blood Glucose	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein	16806698
D001786	Blood Glucose	Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein]	16806698
D001786	Blood Glucose	2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]]	27274199
D001786	Blood Glucose	Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	30229846
D001786	Blood Glucose	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein	27274199; 30229846;
D001786	Blood Glucose	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	27274199
D000069286	Bortezomib	Bortezomib promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C086539	BQ 788	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein]	12875994
C086539	BQ 788	BQ 788 inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein]	12875994
D019819	Budesonide	Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]	25313925
D019819	Budesonide	Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	15734790
D019819	Budesonide	Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
D019819	Budesonide	Formoterol Fumarate promotes the reaction [Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
C022777	bufalin	bufalin results in decreased activity of MMP9 protein	21922632
C022777	bufalin	bufalin results in decreased expression of and results in decreased activity of MMP9 protein	23949904
C022777	bufalin	bufalin results in decreased expression of MMP9 mRNA	23949904
C022777	bufalin	bufalin results in decreased secretion of MMP9 protein	23949904
D002070	Butadienes	Butadienes results in increased activity of MMP9 protein	15922868
D002070	Butadienes	Butadienes results in increased expression of MMP9 mRNA	15922868
C040918	butein	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C040918	butein	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C040918	butein	Bortezomib promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C040918	butein	butein inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	20696233
C040918	butein	butein results in decreased expression of MMP9 mRNA	20696233
C040918	butein	butein results in decreased expression of MMP9 protein	20696233
C040918	butein	prolinedithiocarbamate promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C027561	butylbenzyl phthalate	butylbenzyl phthalate results in increased expression of MMP9 protein	31212022
C018475	butyraldehyde	butyraldehyde results in increased expression of MMP9 mRNA	26079696
C584509	C646 compound	C646 compound inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131
D002101	Cacodylic Acid	Cacodylic Acid results in increased expression of MMP9 mRNA	17441966
D002104	Cadmium	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D002104	Cadmium	Cadmium affects the expression of MMP9 mRNA	31154059
D002104	Cadmium	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein	31468104
D002104	Cadmium	Cadmium results in increased expression of and results in increased activity of MMP9 protein	26514923
D002104	Cadmium	Cadmium results in increased expression of MMP9 mRNA	26514923
D002104	Cadmium	Cadmium results in increased expression of MMP9 protein	22884995
D002104	Cadmium	Cadmium results in increased secretion of MMP9 mRNA	20049202
D002104	Cadmium	Cadmium results in increased secretion of MMP9 protein	22626610
D002104	Cadmium	Curcumin inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	ESR1 protein alternative form affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D002104	Cadmium	GPER1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D002104	Cadmium	pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	RTKI cpd inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D002104	Cadmium	Cadmium results in decreased expression of MMP9 mRNA	15240111
D002104	Cadmium	Ipratropium promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium results in increased activity of MMP9 protein]]	20826145
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of MMP9 mRNA	17961207
D019256	Cadmium Chloride	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D019256	Cadmium Chloride	ATG4A protein affects the reaction [Cadmium Chloride results in increased expression of MMP9 protein]	29179951
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of MMP9 mRNA	26238599
D019256	Cadmium Chloride	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein	31468104
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of MMP9 protein	28830677; 29179951;
D019256	Cadmium Chloride	Cadmium Chloride results in increased secretion of MMP9 protein	27510461; 28527916;
D019256	Cadmium Chloride	ESR1 protein alternative form affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D019256	Cadmium Chloride	GPER1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased activity of MMP9 protein]	31468104
D019256	Cadmium Chloride	HMGA2 protein affects the reaction [Cadmium Chloride results in increased expression of MMP9 protein]	28830677
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of MMP9 protein	25502771; 28830677;
D019256	Cadmium Chloride	tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in increased expression of MMP9 protein]	25502771
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of MMP9 mRNA	18804290
D019256	Cadmium Chloride	Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]	25313925
D019256	Cadmium Chloride	Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
D019256	Cadmium Chloride	Cadmium Chloride results in increased activity of MMP9 protein	20826145; 25313925;
D019256	Cadmium Chloride	Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]	20826145; 25313925;
D019256	Cadmium Chloride	Formoterol Fumarate promotes the reaction [Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
C055494	caffeic acid phenethyl ester	caffeic acid phenethyl ester results in decreased expression of MMP9 protein	20433813
C055494	caffeic acid phenethyl ester	caffeic acid phenethyl ester results in decreased activity of MMP9 protein	20836997
C055494	caffeic acid phenethyl ester	NGFR protein affects the susceptibility to [caffeic acid phenethyl ester results in decreased activity of MMP9 protein]	20836997
D002117	Calcitriol	Calcitriol results in decreased expression of MMP9 mRNA	26485663
D002122	Calcium Chloride	Calcium Chloride results in increased activity of MMP9 protein	21530968; 24337353;
D002122	Calcium Chloride	Calcium Chloride results in increased expression of MMP9 mRNA	22728078
D002122	Calcium Chloride	Calcium Chloride results in increased expression of MMP9 protein	22728078
D002122	Calcium Chloride	Quercetin inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein]	24337353
D002122	Calcium Chloride	Quercetin inhibits the reaction [Calcium Chloride results in increased expression of MMP9 mRNA]	22728078
D002122	Calcium Chloride	Quercetin inhibits the reaction [Calcium Chloride results in increased expression of MMP9 protein]	22728078
D002122	Calcium Chloride	Resveratrol inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein]	21530968
D002122	Calcium Chloride	Calcium Chloride results in increased expression of MMP9 mRNA	20621845
D002122	Calcium Chloride	Calcium Chloride results in increased expression of MMP9 protein	20621845
D002166	Camptothecin	Camptothecin results in decreased methylation of MMP9 gene	30720231
D002166	Camptothecin	MMP9 mRNA results in decreased susceptibility to Camptothecin	25269479
C081643	candesartan	candesartan results in decreased expression of MMP9 mRNA	19047581
C081643	candesartan	candesartan results in decreased expression of MMP9 protein	19047581
D002211	Capsaicin	4-aminobenzamide inhibits the reaction [Capsaicin results in increased activity of MMP9 protein]	21310942
D002211	Capsaicin	Capsaicin inhibits the reaction [EGF results in increased activity of MMP9 protein]	21462327
D002211	Capsaicin	Capsaicin inhibits the reaction [EGF results in increased expression of MMP9]	21462327
D002211	Capsaicin	Capsaicin results in increased expression of and results in increased activity of MMP9 protein	21310942
D002211	Capsaicin	Capsaicin results in increased expression of MMP9 mRNA	21310942; 22230393;
D002211	Capsaicin	TRPV1 inhibits the reaction [Capsaicin results in increased expression of and results in increased activity of MMP9 protein]	21310942
C005563	captax	captax results in increased expression of MMP9 mRNA	22952646
C005563	captax	captax results in increased expression of MMP9 protein	22952646
D002220	Carbamazepine	Carbamazepine affects the expression of MMP9 mRNA	25979313
C006698	carbendazim	carbendazim results in decreased expression of MMP9 mRNA	25530041
D002244	Carbon	Carbon promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MMP9 mRNA]	26880698
D002244	Carbon	Carbon results in increased expression of MMP9 mRNA	26880698
D002244	Carbon	lipopolysaccharide, E coli O55-B5 promotes the reaction [Carbon results in increased expression of MMP9 mRNA]	26880698
D002248	Carbon Monoxide	Carbon Monoxide results in increased expression of MMP9 mRNA	20197249
D002251	Carbon Tetrachloride	Anthocyanins inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein]	30056145
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea] results in decreased expression of MMP9 mRNA	25827057
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of MMP9 protein	19747501; 30056145;
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased activity of MMP9 protein	14999682
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of MMP9 mRNA	15056808; 20438794; 27042213; 30538632;
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of MMP9 protein	17944888; 20371262;
D002251	Carbon Tetrachloride	delphinidin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein]	20371262
D002251	Carbon Tetrachloride	Luteolin inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein]	19747501
D002251	Carbon Tetrachloride	MMP9 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]	16507762
D002251	Carbon Tetrachloride	MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]	16507762
D002251	Carbon Tetrachloride	MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of MMP2 mRNA]	16507762
D002251	Carbon Tetrachloride	MMP9 protein mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]	16507762
D002251	Carbon Tetrachloride	OSMR protein affects the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]	14999682
D002251	Carbon Tetrachloride	PLAT protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein]	17944888
D002251	Carbon Tetrachloride	PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	18038451
D002251	Carbon Tetrachloride	STF 083010 inhibits the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	30538632
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of MMP9 mRNA	15963578
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA	16762003
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased activity of MMP9 protein	17156884
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of MMP9 mRNA	17056239; 19784758;
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of MMP9 protein	17156884
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased activity of MMP9 protein	16097048; 22989100;
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of MMP9 mRNA	16420518; 17631135; 18481824; 22989100;
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of MMP9 protein	17631135
D002251	Carbon Tetrachloride	Celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	16420518
D002251	Carbon Tetrachloride	[Ibuprofen co-treated with Carbon Tetrachloride] results in increased expression of MMP9 protein	21360558
D002251	Carbon Tetrachloride	Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]	16097048
D002251	Carbon Tetrachloride	PLAU protein promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	18481824
D002251	Carbon Tetrachloride	Quercetin promotes the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]	22989100
D002251	Carbon Tetrachloride	Quercetin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	22989100
D002331	Carnitine	Carnitine inhibits the reaction [Sunitinib results in decreased expression of MMP9 mRNA]	26581635
D000077261	Carvedilol	Carvedilol affects the activity of MMP9 protein	16574429
D000077261	Carvedilol	Carvedilol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	17964422
D000077261	Carvedilol	Carvedilol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	17964422
D000077261	Carvedilol	Carvedilol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	17964422
D000077261	Carvedilol	Carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D000077261	Carvedilol	Carvedilol results in decreased activity of MMP9 protein	16310260
D000077261	Carvedilol	Carvedilol results in decreased expression of MMP9 mRNA	18971572
C054133	casticin	casticin results in decreased expression of MMP9 protein	28444820
C561931	CAY 10580	CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C561931	CAY 10580	CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
D000068579	Celecoxib	Celecoxib inhibits the reaction [Dihematoporphyrin Ether results in increased expression of MMP9 protein]	16230411
D000068579	Celecoxib	Celecoxib promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	16420518
C030583	ceric oxide	ceric oxide results in increased activity of MMP9 protein	23726862
C030583	ceric oxide	ceric oxide results in increased secretion of MMP9 protein	23726862
C097658	CGS 27023A	CGS 27023A affects the activity of MMP9 protein	22017477
D047188	Chalcones	Chalcones results in decreased expression of and results in decreased activity of MMP9 protein	23562496
D047188	Chalcones	Chalcones results in decreased expression of MMP9 mRNA	23562496
C016299	chelerythrine	[AG 1879 co-treated with chelerythrine] inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
D002686	Chitin	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D002686	Chitin	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Protein Synthesis Inhibitors binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D002686	Chitin	[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA	30041514
D002686	Chitin	[Protein Synthesis Inhibitors binds to Chitin] which results in decreased expression of MMP9 mRNA	30041514
D002734	Chlorophyll	Chlorophyll inhibits the reaction [dibenzo(a,l)pyrene results in increased expression of MMP9 mRNA]	22079312
C007020	chlorophyllin	chlorophyllin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	22485181
C007020	chlorophyllin	chlorophyllin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	22485181
D002737	Chloroprene	Chloroprene results in decreased expression of MMP9 mRNA	23125180
D002738	Chloroquine	Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D002746	Chlorpromazine	Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
D002746	Chlorpromazine	Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C011724	cholest-5-en-3 beta,7 alpha-diol	cholest-5-en-3 beta,7 alpha-diol results in increased expression of MMP9 mRNA	24802026
C011724	cholest-5-en-3 beta,7 alpha-diol	Quercetin analog inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased expression of MMP9 mRNA]	24802026
C002415	cholesterol alpha-oxide	cholesterol alpha-oxide results in increased expression of MMP9 mRNA	20466046
D002791	Cholesterol, Dietary	[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA	20835264
D002791	Cholesterol, Dietary	[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein	20835264
D002791	Cholesterol, Dietary	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA]	20835264
D002791	Cholesterol, Dietary	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein]	20835264
D002791	Cholesterol, Dietary	Carvedilol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	17964422
D002791	Cholesterol, Dietary	Carvedilol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	17964422
D002791	Cholesterol, Dietary	Cholesterol, Dietary results in increased expression of MMP9 mRNA	17964422
D002791	Cholesterol, Dietary	Cholesterol, Dietary results in increased expression of MMP9 protein	17964422
D002791	Cholesterol, Dietary	Probucol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	17964422
D002791	Cholesterol, Dietary	Probucol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	17964422
D002791	Cholesterol, Dietary	Cholesterol, Dietary results in increased expression of MMP9 mRNA	19505368
D002791	Cholesterol, Dietary	Cholesterol, Dietary results in increased expression of MMP9 protein	19505368
D002791	Cholesterol, Dietary	CPU0213 inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	19505368
D002791	Cholesterol, Dietary	CPU0213 inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	19505368
D002791	Cholesterol, Dietary	Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	19505368
D002791	Cholesterol, Dietary	Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	19505368
D008076	Cholesterol, HDL	[Arsenic results in increased expression of and results in increased secretion of MMP9 protein] which results in decreased abundance of Cholesterol, HDL	26637202
D002793	Cholic Acids	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of MMP9 mRNA	27344345
D002794	Choline	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 protein]	28973532
D002794	Choline	[Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MMP9 mRNA	23439872
D002794	Choline	[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 mRNA	22915297
D002794	Choline	[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 protein	28973532
D002794	Choline	Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 mRNA]	22915297
C074702	chromium hexavalent ion	chromium hexavalent ion results in increased expression of MMP9 protein	23518002; 25448439;
C074702	chromium hexavalent ion	Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of MMP9 protein]	25448439
C074702	chromium hexavalent ion	chromium hexavalent ion affects the expression of MMP9 mRNA	28472532
C043561	chrysin	chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C029010	cinnamic acid	cinnamic acid analog binds to and results in decreased activity of MMP9 protein	30048736
C007068	cinnamyl anthranilate	cinnamyl anthranilate results in increased expression of MMP9 mRNA	22952646
C007068	cinnamyl anthranilate	cinnamyl anthranilate results in increased expression of MMP9 protein	22952646
D002945	Cisplatin	[[BSG binds to PPIA] which results in decreased susceptibility to Cisplatin] which results in increased expression of MMP9	21956400
D002945	Cisplatin	[Cisplatin co-treated with Paclitaxel] results in increased expression of MMP9 mRNA	20705681
D002945	Cisplatin	Cisplatin results in decreased expression of MMP9	21789004
D002945	Cisplatin	Cisplatin results in decreased expression of MMP9 protein	30396169
D002945	Cisplatin	Cisplatin results in increased activity of MMP9 protein	21618587
D002945	Cisplatin	[NEAT1 protein affects the susceptibility to Cisplatin] which affects the expression of MMP9 protein	30291867
D002945	Cisplatin	Cisplatin results in decreased expression of MMP9 mRNA	29148169
D002945	Cisplatin	Cisplatin results in decreased expression of MMP9 mRNA	22023808
D017291	Clarithromycin	Clarithromycin results in decreased expression of MMP9 mRNA	9869567
D007464	Clioquinol	Clioquinol inhibits the reaction [MOG protein results in increased activity of MMP9 protein]	23360710
D002994	Clofibrate	Clofibrate results in decreased secretion of MMP9 protein	16860414
D000077144	Clopidogrel	Clopidogrel results in decreased activity of MMP9 protein	20195827
D003035	Cobalt	[tungsten carbide co-treated with Cobalt] results in decreased expression of MMP9 mRNA	18078969
D003035	Cobalt	TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA]	23503329
D003035	Cobalt	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA	23503329
C018021	cobaltous chloride	cobaltous chloride results in increased expression of MMP9 mRNA	24612858
D003042	Cocaine	Cocaine results in decreased expression of and results in decreased activity of MMP9 protein	18000554
D003042	Cocaine	Cocaine results in increased expression of MMP9 mRNA	27899881
C024989	coenzyme Q10	coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein]	27087047
D005576	Colforsin	Colforsin results in increased expression of MMP9 mRNA	24784705
D005576	Colforsin	plerixafor octahydrochloride inhibits the reaction [Colforsin results in increased expression of MMP9 mRNA]	24784705
D056831	Coordination Complexes	Coordination Complexes results in decreased activity of MMP9 protein	22583413
C558416	corvitin	corvitin inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	25816614
C495612	CP-471,358	CP-471,358 results in decreased activity of MMP9 protein	23611293
C513821	CPU0213	CPU0213 inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	19505368
C513821	CPU0213	CPU0213 inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	19505368
C513821	CPU0213	CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	18594475
C010561	crocetin	crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	16864425
D003436	Croton Oil	Croton Oil results in increased expression of MMP9 protein	14515793
D003436	Croton Oil	Dexamethasone inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D003436	Croton Oil	Indomethacin inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D003436	Croton Oil	Resveratrol inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D003471	Cuprizone	Cuprizone results in decreased expression of MMP9 mRNA	26577399
D003474	Curcumin	3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
D003474	Curcumin	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
D003474	Curcumin	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
D003474	Curcumin	Curcumin inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
D003474	Curcumin	Curcumin inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	17291458
D003474	Curcumin	Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein]	16243823
D003474	Curcumin	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248
D003474	Curcumin	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819; 20599481; 21354279;
D003474	Curcumin	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20152819; 21354279; 24211270; 25656647;
D003474	Curcumin	Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	16219905
D003474	Curcumin	Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	17291458; 17640567;
D003474	Curcumin	Curcumin inhibits the reaction [VIP protein results in increased activity of MMP9 protein]	19189304
D003474	Curcumin	Curcumin promotes the reaction [3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
D003474	Curcumin	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
D003474	Curcumin	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
D003474	Curcumin	Curcumin results in decreased activity of MMP9 protein	17996675; 22771723;
D003474	Curcumin	Curcumin results in decreased expression of MMP9 protein	17996675; 18226269;
D003474	Curcumin	Curcumin results in decreased secretion of and results in decreased activity of MMP9 protein	18495463
D003474	Curcumin	Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	17640567
D003474	Curcumin	TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of MMP9 protein]	18226269
D003474	Curcumin	[Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein	17440100
D003474	Curcumin	Curcumin results in decreased expression of MMP9 protein	17440100; 18829502;
D003474	Curcumin	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased activity of MMP9 protein]	17531121
D003474	Curcumin	Curcumin affects the expression of MMP9 mRNA	18379247
D003474	Curcumin	Curcumin affects the expression of MMP9 protein	18379247
D003474	Curcumin	Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
D003474	Curcumin	Curcumin results in increased activity of MMP9 protein	17531121
D003474	Curcumin	[Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA]	23933360
D003474	Curcumin	[Resveratrol co-treated with Curcumin] inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	19889203
C057862	cyanoginosin LR	cyanoginosin LR results in decreased expression of MMP9 protein	28189720
C057862	cyanoginosin LR	cyanoginosin LR results in increased expression of MMP9 mRNA	20934494
C057862	cyanoginosin LR	cyanoginosin LR results in increased expression of MMP9 protein	20934494
D016572	Cyclosporine	Cyclosporine results in decreased expression of MMP9 mRNA	27989131
C072247	cyclo(Trp-Asp-Pro-Val-Leu)	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein]	12875994
C072247	cyclo(Trp-Asp-Pro-Val-Leu)	cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [EDN1 protein results in increased secretion of and results in increased activity of MMP9 protein]	12875994
C072247	cyclo(Trp-Asp-Pro-Val-Leu)	cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 mRNA]	19150882
C072247	cyclo(Trp-Asp-Pro-Val-Leu)	cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 protein]	19150882
C017160	cypermethrin	cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	29471534
D003543	Cysteamine	Cysteamine results in decreased activity of MMP9 protein	22532830
D003543	Cysteamine	Cysteamine results in increased expression of and results in decreased activity of MMP9 protein	22532830
D003543	Cysteamine	Cysteamine results in increased expression of MMP9 mRNA	22532830
D015638	Cytochalasin D	Cytochalasin D promotes the reaction [TNF results in increased expression of MMP9 mRNA]	17560598
D003609	Dactinomycin	Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	24956101
D003609	Dactinomycin	Dactinomycin results in decreased expression of MMP9 mRNA	24956101
C004742	daidzein	daidzein inhibits the reaction [Flutamide results in increased expression of MMP9 mRNA]	23135684
D003622	Dapsone	Dapsone inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	21765237
D000077209	Decitabine	Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA]	21167264
D000077209	Decitabine	Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein]	21167264
D000077209	Decitabine	Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA]	29718165
D000077209	Decitabine	Decitabine results in increased expression of MMP9 mRNA	27915011
D003676	Deferoxamine	Deferoxamine inhibits the reaction [TF protein results in increased expression of MMP9 mRNA]	31238089
D003676	Deferoxamine	Deferoxamine results in decreased expression of MMP9 mRNA	31238089
D003676	Deferoxamine	TF protein affects the reaction [Deferoxamine results in increased expression of MMP9 mRNA]	31238089
C107676	deguelin	deguelin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	17015749
C107676	deguelin	deguelin results in decreased activity of MMP9 protein	25322282
C107676	deguelin	deguelin results in decreased expression of MMP9 mRNA	26884827
C107676	deguelin	deguelin results in decreased expression of MMP9 protein	26884827
C017185	delphinidin	delphinidin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 protein]	20371262
C050229	demethoxycurcumin	demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein	18495463
D003847	Deoxyglucose	Deoxyglucose analog results in decreased expression of MMP9 protein	27931795
C040424	destruxin B	destruxin B results in decreased expression of MMP9 mRNA	22465936
D003907	Dexamethasone	Dexamethasone results in increased activity of MMP9 protein	18281261
D003907	Dexamethasone	Dexamethasone results in increased expression of MMP9 mRNA	18281261
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone results in increased activity of MMP9 protein]	18281261
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MMP9 mRNA]	18281261
D003907	Dexamethasone	Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]	24722316
D003907	Dexamethasone	Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]	24722316
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	10455257
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30696844
D003907	Dexamethasone	Dexamethasone results in decreased expression of MMP9 mRNA	25047013
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]]	24722316
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]]	24722316
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 mRNA]	28694203
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28300665; 28694203;
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D003907	Dexamethasone	Dexamethasone results in decreased expression of MMP9 mRNA	23210436
D003907	Dexamethasone	Dexamethasone results in decreased expression of MMP9 protein	23210436
D003907	Dexamethasone	Dexamethasone results in increased expression of MMP9 mRNA	21041162
D003907	Dexamethasone	TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA]	23503329
D003907	Dexamethasone	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA	23503329
D003907	Dexamethasone	Dexamethasone affects the expression of MMP9 mRNA	18379247
D003907	Dexamethasone	Dexamethasone affects the expression of MMP9 protein	18379247
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]	24722316
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]	24722316
D003907	Dexamethasone	Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]	15963473
D003907	Dexamethasone	Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	15963473
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 mRNA]	21941784
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 protein]	21941784
D003907	Dexamethasone	Dexamethasone inhibits the reaction [sephadex results in increased expression of MMP9 mRNA]	25878373
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]]	24722316
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]]	24722316
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]	15963473
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]]	15963473
D003907	Dexamethasone	RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]	15963473
D003907	Dexamethasone	RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]]	15963473
D016264	Dextran Sulfate	Dextran Sulfate results in increased expression of MMP9 mRNA	19285099
D016264	Dextran Sulfate	Dextran Sulfate results in increased expression of MMP9 protein	19285099; 27125760;
D016264	Dextran Sulfate	mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]	27125760
D016264	Dextran Sulfate	Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]	19285099
D016264	Dextran Sulfate	Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]	19285099
D016264	Dextran Sulfate	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA	29950665
D003931	Diacetyl	Diacetyl results in increased expression of MMP9 mRNA	31381966
D003931	Diacetyl	Diacetyl results in increased secretion of MMP9 protein	31381966
C028009	diallyl disulfide	diallyl disulfide affects the expression of MMP9 protein	21695758
C028009	diallyl disulfide	diallyl disulfide results in decreased expression of and results in decreased activity of MMP9 protein	20600798
C028009	diallyl disulfide	diallyl disulfide results in decreased expression of MMP9 mRNA	20600798
C042577	diallyl trisulfide	diallyl trisulfide affects the expression of MMP9 protein	21695758
C042577	diallyl trisulfide	diallyl trisulfide results in decreased activity of MMP9 protein	24084732
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of and results in decreased activity of MMP9 protein	23430952; 27566995;
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of MMP9 mRNA	23430952; 24084732; 25927362;
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of MMP9 protein	25927362; 28741790; 30396169;
C042577	diallyl trisulfide	LDHA protein inhibits the reaction [diallyl trisulfide results in decreased expression of MMP9 protein]	27566995
C042577	diallyl trisulfide	NOTCH1 mutant form promotes the reaction [diallyl trisulfide results in decreased activity of MMP9 protein]	23430952
C041517	dibenzo(a,l)pyrene	Chlorophyll inhibits the reaction [dibenzo(a,l)pyrene results in increased expression of MMP9 mRNA]	22079312
C041517	dibenzo(a,l)pyrene	dibenzo(a,l)pyrene results in increased expression of MMP9 mRNA	22079312
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of MMP9 protein	19549552
D003633	Dichlorodiphenyl Dichloroethylene	Dichlorodiphenyl Dichloroethylene results in decreased expression of MMP9 mRNA	28651089
D001728	Dicumarol	Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	17669387
D001728	Dicumarol	Dicumarol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	17669387
D001728	Dicumarol	hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]]	17669387
C036042	dicyclohexyl phthalate	dicyclohexyl phthalate results in increased expression of MMP9 mRNA	26924002
D004026	Dieldrin	Dieldrin results in increased expression of MMP9 mRNA	23153324
C007366	diepoxybutane	diepoxybutane results in decreased activity of MMP9 protein	12242682
D004041	Dietary Fats	[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA	20835264
D004041	Dietary Fats	[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein	20835264
D004041	Dietary Fats	[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA	29988851
D004041	Dietary Fats	Dietary Fats promotes the reaction [arsenite results in increased expression of MMP9 mRNA]	18296743
D004041	Dietary Fats	Dietary Fats results in increased expression of MMP9 mRNA	21611899
D004041	Dietary Fats	Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA]	29988851
D004041	Dietary Fats	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA]	20835264
D004041	Dietary Fats	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein]	20835264
D004041	Dietary Fats	[Vehicle Emissions affects the reaction [APOE gene mutant form affects the susceptibility to Dietary Fats]] which results in increased expression of MMP9 mRNA	19891982
D004041	Dietary Fats	xiongshao inhibits the reaction [Dietary Fats results in increased expression of MMP9 mRNA]	21611899
D004041	Dietary Fats	[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA	21051528
D004041	Dietary Fats	[Ethanol co-treated with Dietary Fats] results in increased expression of MMP9 mRNA	21051528
D004051	Diethylhexyl Phthalate	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 mRNA]	19956873
D004051	Diethylhexyl Phthalate	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 protein]	19956873
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of MMP9 mRNA	19956873; 30944277;
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of MMP9 protein	19956873; 30944277;
D004051	Diethylhexyl Phthalate	Fulvestrant inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 mRNA]	19956873
D004051	Diethylhexyl Phthalate	Fulvestrant inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 protein]	19956873
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of MMP9 mRNA	20920545
D004052	Diethylnitrosamine	CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA]	16284949
D004052	Diethylnitrosamine	CCL3 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 protein]	16284949
D004052	Diethylnitrosamine	CCR1 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 mRNA]	16284949
D004052	Diethylnitrosamine	CCR1 protein affects the reaction [Diethylnitrosamine results in increased expression of MMP9 protein]	16284949
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of MMP9 mRNA	16284949
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of MMP9 protein	16284949
D004052	Diethylnitrosamine	2-aminofluorene promotes the reaction [Diethylnitrosamine results in increased activity of MMP9 protein]	19052882
D004052	Diethylnitrosamine	bacoside A inhibits the reaction [Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein]	20084675
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of MMP9 protein	19052882
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased activity of MMP9 protein	19052882
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of and results in increased activity of MMP9 protein	20084675
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of MMP9 protein	19539802
D004052	Diethylnitrosamine	morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein]	19539802
D017323	Dihematoporphyrin Ether	Celecoxib inhibits the reaction [Dihematoporphyrin Ether results in increased expression of MMP9 protein]	16230411
D017323	Dihematoporphyrin Ether	Dihematoporphyrin Ether inhibits the reaction [Dihematoporphyrin Ether results in increased expression of MMP9 protein]	16230411
D017323	Dihematoporphyrin Ether	Dihematoporphyrin Ether results in increased expression of MMP9 protein	16230411
C039060	dihydroartemisinin	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20152819
C039060	dihydroartemisinin	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819
C039060	dihydroartemisinin	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20152819
C025605	diisobutyl phthalate	diisobutyl phthalate results in increased expression of MMP9 mRNA	29458080
C012125	diisononyl phthalate	diisononyl phthalate affects the expression of MMP9 mRNA	31154059
C472511	dimethylarsinous acid	dimethylarsinous acid results in increased expression of MMP9 mRNA	23876855
D004128	Dimethylnitrosamine	Dimethylnitrosamine results in increased activity of MMP9 protein	15161499
C024629	dimethyl phthalate	dimethyl phthalate results in increased expression of MMP9 mRNA	26924002
D004121	Dimethyl Sulfoxide	[Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	26497626
D004121	Dimethyl Sulfoxide	Dimethyl Sulfoxide inhibits the reaction [Ethanol results in increased activity of MMP9 protein]	17603938
D004121	Dimethyl Sulfoxide	Dimethyl Sulfoxide results in increased expression of MMP9 protein	26497626
D015237	Dinoprost	Dinoprost results in increased expression of and results in increased activity of MMP9 protein	11719597
D015232	Dinoprostone	15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]	19880272
D015232	Dinoprostone	15-deoxyprostaglandin J2 inhibits the reaction [Dinoprostone results in increased secretion of MMP9 protein]	19880272
D015232	Dinoprostone	Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
D015232	Dinoprostone	Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
D015232	Dinoprostone	Dinoprostone results in increased expression of MMP9 mRNA	16330497; 19880272;
D015232	Dinoprostone	Dinoprostone results in increased expression of MMP9 protein	16330497
D015232	Dinoprostone	Dinoprostone results in increased secretion of MMP9 protein	19880272
D015232	Dinoprostone	Fenofibrate inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]	19880272
D015232	Dinoprostone	Fenofibrate inhibits the reaction [Dinoprostone results in increased secretion of MMP9 protein]	19880272
D004144	Diosgenin	Diosgenin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	16331273
D004144	Diosgenin	Diosgenin results in decreased activity of MMP9 protein	21814480
D004144	Diosgenin	Diosgenin results in decreased expression of MMP9 mRNA	21814480
D004147	Dioxins	Dioxins affects the expression of MMP9 mRNA	20463971
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C007517	diphenyleneiodonium	diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C007517	diphenyleneiodonium	diphenyleneiodonium promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004221	Disulfiram	Disulfiram results in decreased expression of MMP9	18047805
D016291	Dizocilpine Maleate	Dizocilpine Maleate inhibits the reaction [Folic Acid deficiency results in decreased expression of MMP9 mRNA]	20406136
D016291	Dizocilpine Maleate	Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of MMP9 protein]	20406136
D000077143	Docetaxel	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D000077143	Docetaxel	[Docetaxel binds to Chitin] which results in decreased expression of MMP9 mRNA	30041514
D000077143	Docetaxel	[O-(Chloroacetylcarbamoyl)fumagillol co-treated with Docetaxel] results in decreased expression of MMP9 protein	12576464
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in decreased expression of and results in decreased activity of MMP9 protein	23288142
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in decreased expression of MMP9 mRNA	23288142
D004281	Docosahexaenoic Acids	HMOX1 protein affects the reaction [Docosahexaenoic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]]	23288142
C063533	dofetilide	dofetilide binds to MMP9 protein	21634430
D000077265	Donepezil	Donepezil results in decreased expression of and results in decreased activity of MMP9 protein	21750701
D000077265	Donepezil	Donepezil results in decreased expression of MMP9 protein	21750701
D004317	Doxorubicin	Doxorubicin affects the expression of MMP9 mRNA	15205334
D004317	Doxorubicin	Doxorubicin results in decreased expression of MMP9 mRNA	29803840
D004317	Doxorubicin	Doxorubicin inhibits the reaction [Quercetin results in decreased activity of MMP9 protein]	14593496
D004317	Doxorubicin	Doxorubicin results in decreased expression of MMP9 mRNA	15033991
D004317	Doxorubicin	Doxorubicin results in increased expression of MMP9 mRNA	16455267; 19286953;
D004317	Doxorubicin	MMP9 gene mutant form results in decreased susceptibility to Doxorubicin	20407279
D004317	Doxorubicin	tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	19286953
D004317	Doxorubicin	Doxorubicin inhibits the reaction [Mechlorethamine results in increased expression of MMP9 protein]	29174984
D004317	Doxorubicin	Doxorubicin results in increased expression of MMP9 protein	17609194
D004317	Doxorubicin	Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]	19357873
D004317	Doxorubicin	benazepril inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]	19357873
D004317	Doxorubicin	Carvedilol inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein]	27087047
D004317	Doxorubicin	corvitin inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	25816614
D004317	Doxorubicin	diphenyleneiodonium promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	Doxorubicin results in decreased expression of MMP9 mRNA	19357873; 19801496;
D004317	Doxorubicin	Doxorubicin results in decreased expression of MMP9 protein	19357873; 19801496;
D004317	Doxorubicin	Doxorubicin results in increased activity of MMP9 protein	16213474; 25816614;
D004317	Doxorubicin	Doxorubicin results in increased expression of MMP9 mRNA	16213474; 30588110;
D004317	Doxorubicin	Doxorubicin results in increased expression of MMP9 protein	27087047; 30588110;
D004317	Doxorubicin	Ketoglutaric Acids inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	25816614
D004317	Doxorubicin	pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	30588110
D004317	Doxorubicin	pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein]	30588110
D004317	Doxorubicin	pyrazolanthrone promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	SB 203580 inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	16213474
D004317	Doxorubicin	SB 203580 inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D004317	Doxorubicin	Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]	19357873
D004317	Doxorubicin	Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]	19357873
D004317	Doxorubicin	Doxorubicin results in increased activity of MMP9 protein	19782292
D004317	Doxorubicin	Doxorubicin results in increased expression of MMP9 mRNA	19782292
D004318	Doxycycline	Doxycycline inhibits the reaction [Mustard Gas results in increased activity of MMP9 protein]	15778244
D004318	Doxycycline	Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19375915
D004318	Doxycycline	Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	17498959
D004318	Doxycycline	Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9]	18089841
D004318	Doxycycline	Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	15131573
D004318	Doxycycline	Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein]	15131573
D004318	Doxycycline	Doxycycline results in decreased expression of MMP9 protein	18178469
D004318	Doxycycline	Doxycycline inhibits the reaction [AGT protein modified form results in increased activity of MMP9 protein]	20837116
D004318	Doxycycline	Doxycycline results in decreased activity of MMP9 protein	20837116
D013759	Dronabinol	Dronabinol results in increased expression of MMP9 mRNA	16330497
D013759	Dronabinol	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Dronabinol results in increased expression of MMP9 mRNA]	16330497
D004365	Drugs, Chinese Herbal	Drugs, Chinese Herbal results in decreased expression of MMP9 mRNA	29148169
D004391	Dust	Dust results in increased expression of MMP9 mRNA	17805423
D004391	Dust	Dust results in increased secretion of MMP9 protein	29319804
D004391	Dust	Dust results in increased expression of MMP9 protein	30641074
C515537	E-2-(4'-methoxybenzylidene)-benzusuberone	E-2-(4'-methoxybenzylidene)-benzusuberone results in decreased secretion of MMP9 protein	20450969
D000077553	Edaravone	Edaravone inhibits the reaction [PLAT protein results in increased expression of and results in increased activity of MMP9 protein]	19095969
D000077553	Edaravone	Edaravone inhibits the reaction [PLAT protein results in increased expression of MMP9 mRNA]	19095969
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid results in decreased expression of MMP9 protein	21193197
D004610	Ellagic Acid	Ellagic Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	22485181
D004610	Ellagic Acid	Ellagic Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	22485181
C010945	embelin	embelin results in decreased expression of MMP9 protein	24694877
C529593	EMD 527040	EMD 527040 results in increased expression of and results in increased activity of MMP9 protein	18221819
C529593	EMD 527040	EMD 527040 results in increased expression of MMP9 mRNA	18221819
C070609	EMD 53998	EMD 53998 analog results in decreased expression of MMP9 mRNA	24977338
D004640	Emetine	Emetine results in decreased activity of MMP9 protein	26332055
D004640	Emetine	Emetine results in decreased expression of MMP9 mRNA	26332055
D004640	Emetine	MAPK14 mutant form inhibits the reaction [Emetine results in decreased activity of MMP9 protein]	26332055
C007590	emulphogene BC 720	emulphogene BC 720 results in increased expression of MMP9 mRNA	25398874
D004726	Endosulfan	Endosulfan results in increased expression of MMP9 mRNA	29391264
C118739	entinostat	entinostat results in decreased secretion of MMP9 protein	20421217
C118739	entinostat	entinostat results in increased expression of MMP9 mRNA	27188386
C118739	entinostat	entinostat results in decreased expression of MMP9 protein	21041383
C045651	epigallocatechin gallate	epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein]	16516891
C045651	epigallocatechin gallate	epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	16516891
C045651	epigallocatechin gallate	epigallocatechin gallate results in decreased activity of MMP9 protein	11746506
D000069347	Erlotinib Hydrochloride	[Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA	29274334
C472787	erucylphospho-N,N,N-trimethylpropylammonium	erucylphospho-N,N,N-trimethylpropylammonium results in increased expression of MMP9 mRNA	29464035
D004958	Estradiol	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	24997338
D004958	Estradiol	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in decreased expression of MMP9 mRNA]	19956873
D004958	Estradiol	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in decreased expression of MMP9 protein]	19956873
D004958	Estradiol	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	24997338
D004958	Estradiol	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	28844962
D004958	Estradiol	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [Estradiol results in increased activity of MMP9 protein]	31468104
D004958	Estradiol	[Estradiol co-treated with TGFB1 protein] results in increased expression of MMP9 mRNA	30165855
D004958	Estradiol	Estradiol inhibits the reaction [IL1B protein results in increased expression of MMP9 protein modified form]	22219637
D004958	Estradiol	Estradiol results in decreased activity of MMP9 protein	21760532
D004958	Estradiol	Estradiol results in decreased expression of MMP9 mRNA	19956873
D004958	Estradiol	Estradiol results in decreased expression of MMP9 protein	19956873; 21760532;
D004958	Estradiol	Estradiol results in increased activity of MMP9 protein	31468104
D004958	Estradiol	Estradiol results in increased expression of and results in increased activity of MMP9 protein	24997338
D004958	Estradiol	Estradiol results in increased expression of MMP9 mRNA	24997338
D004958	Estradiol	Estradiol results in increased expression of MMP9 protein	12948864; 25690688; 28844962;
D004958	Estradiol	Estradiol results in increased secretion of MMP9 protein	20951759
D004958	Estradiol	Fulvestrant inhibits the reaction [Estradiol results in decreased expression of MMP9 mRNA]	19956873
D004958	Estradiol	Fulvestrant inhibits the reaction [Estradiol results in decreased expression of MMP9 protein]	19956873
D004958	Estradiol	Fulvestrant inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	25690688; 28844962;
D004958	Estradiol	GPER1 protein affects the reaction [Estradiol results in increased activity of MMP9 protein]	31468104
D004958	Estradiol	[Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA	17404688
D004958	Estradiol	[Progesterone co-treated with Estradiol] results in increased expression of MMP9 mRNA	20226447
D004958	Estradiol	Estradiol results in increased activity of MMP9 protein	19279558
D004958	Estradiol	Estradiol results in increased expression of MMP9 mRNA	19416213
D004958	Estradiol	Progesterone inhibits the reaction [Estradiol results in increased expression of MMP9 mRNA]	19416213
D000431	Ethanol	Ethanol results in decreased expression of MMP9 mRNA	27112526
D000431	Ethanol	Ethanol results in increased expression of MMP9 mRNA	31059573
D000431	Ethanol	Ethanol results in increased expression of MMP9 mRNA	30319688
D000431	Ethanol	Acetylcysteine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D000431	Ethanol	Curcumin inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
D000431	Ethanol	Dimethyl Sulfoxide inhibits the reaction [Ethanol results in increased activity of MMP9 protein]	17603938
D000431	Ethanol	Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein]	16622519
D000431	Ethanol	[Ethanol co-treated with Dietary Fats co-treated with Acetylcysteine] results in increased expression of MMP9 mRNA	21051528
D000431	Ethanol	[Ethanol co-treated with Dietary Fats] results in increased expression of MMP9 mRNA	21051528
D000431	Ethanol	Ethanol results in increased expression of and results in increased activity of MMP9 protein	22257724
D000431	Ethanol	Ethanol results in increased expression of MMP9 mRNA	17603938; 17887948; 23155471; 29769550;
D000431	Ethanol	Ethanol results in increased expression of MMP9 protein	21360558; 23155471; 29769550;
D000431	Ethanol	Ethanol results in increased secretion of and results in increased activity of MMP9 protein	17603938
D000431	Ethanol	Ethanol results in increased secretion of MMP9 protein	22257724
D000431	Ethanol	Famotidine inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D000431	Ethanol	Famotidine inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17603938
D000431	Ethanol	Famotidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D000431	Ethanol	Famotidine inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
D000431	Ethanol	Lipopolysaccharides promotes the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
D000431	Ethanol	lipostabil inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
D000431	Ethanol	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D000431	Ethanol	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
D000431	Ethanol	Quercetin inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D000431	Ethanol	Quercetin inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
D000431	Ethanol	Ranitidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of MMP9 mRNA	29458080
D004997	Ethinyl Estradiol	Ethinyl Estradiol affects the expression of MMP9 mRNA	17555576
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of MMP9 mRNA	30675821
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of MMP9 protein	12538720
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of MMP9 mRNA	17942748
D004997	Ethinyl Estradiol	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA	17942748
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of MMP9 mRNA	23129252
C507035	ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate	ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C024565	ethylene dichloride	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 mRNA]	30081051
C024565	ethylene dichloride	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in increased expression of MMP9 protein]	30081051
C024565	ethylene dichloride	ethylene dichloride results in increased expression of MMP9 mRNA	24964198; 30081051;
C024565	ethylene dichloride	ethylene dichloride results in increased expression of MMP9 protein	24964198; 30081051;
C046522	ethyl pyruvate	ethyl pyruvate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of MMP9 protein]	21316417
C046522	ethyl pyruvate	ethyl pyruvate inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	21316417
C098546	ethyl tert-butyl ether	ethyl tert-butyl ether results in decreased expression of MMP9 mRNA	22609741
D017308	Etodolac	Etodolac results in decreased expression of MMP9 mRNA	16391837
D005054	Eugenol	Eugenol results in decreased expression of MMP9 mRNA	30518369
D005054	Eugenol	Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]	20434464
D005054	Eugenol	Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA]	20434464
C049639	evodiamine	evodiamine inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	15710601
C562064	EVP 4593	EVP 4593 results in decreased expression of MMP9 protein	30801954
D018690	Excitatory Amino Acid Agonists	Excitatory Amino Acid Agonists results in increased expression of MMP9 protein	26655082
D015738	Famotidine	Famotidine inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D015738	Famotidine	Famotidine inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17603938
D015738	Famotidine	Famotidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D015738	Famotidine	Famotidine inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
C004808	farnesyl pyrophosphate	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
C004808	farnesyl pyrophosphate	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
C093323	farnesylthiosalicylic acid	farnesylthiosalicylic acid results in increased activity of MMP9 protein	15288472
C069346	fascaplysine	fascaplysine analog results in decreased expression of MMP9 protein	28756150
C049347	fasudil	fasudil affects the expression of MMP9 mRNA	26120273
C545733	fatostatin	fatostatin results in decreased expression of MMP9 protein	30394316
C545733	fatostatin	SREBF2 protein inhibits the reaction [fatostatin results in decreased expression of MMP9 protein]	30394316
D005228	Fatty Acids, Essential	Fatty Acids, Essential deficiency results in increased expression of MMP9 mRNA	23333450
D011345	Fenofibrate	Fenofibrate inhibits the reaction [Dinoprostone results in increased expression of MMP9 mRNA]	19880272
D011345	Fenofibrate	Fenofibrate inhibits the reaction [Dinoprostone results in increased secretion of MMP9 protein]	19880272
D011345	Fenofibrate	Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	21075133
D011345	Fenofibrate	Fenofibrate results in decreased expression of MMP9 protein	25545733
D017313	Fenretinide	Fenretinide inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	16230421
D017313	Fenretinide	Fenretinide results in increased expression of MMP9 mRNA	28973697
C093230	fexofenadine	fexofenadine inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	15663564
C093230	fexofenadine	fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	15663564
C093230	fexofenadine	fexofenadine inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	15663564
D000068876	Fingolimod Hydrochloride	Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	25980589
D000068876	Fingolimod Hydrochloride	Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	25980589
C017875	fisetin	fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA]	22931364
C017875	fisetin	fisetin results in decreased expression of MMP9 mRNA	30076913
C017875	fisetin	fisetin results in decreased expression of MMP9 protein	30076913
C017875	fisetin	HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
C017875	fisetin	NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
C017875	fisetin	tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]	30076913
C017875	fisetin	tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
C017875	fisetin	zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]	30076913
C017875	fisetin	zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
D005419	Flavonoids	Flavonoids results in decreased expression of MMP9 mRNA	24036141
D005419	Flavonoids	Flavonoids results in decreased expression of MMP9 protein	24036141
D005419	Flavonoids	Flavonoids results in decreased expression of MMP9 mRNA	18035473
C024352	fludarabine	fludarabine results in increased expression of and affects the localization of MMP9 protein	24956101
C024352	fludarabine	fludarabine results in increased expression of MMP9 mRNA	24956101
C024352	fludarabine	MMP9 protein inhibits the reaction [fludarabine results in decreased expression of BCL2L1 protein]	24956101
C024352	fludarabine	MMP9 protein inhibits the reaction [fludarabine results in decreased expression of MCL1 protein]	24956101
C024352	fludarabine	MMP9 protein results in decreased susceptibility to fludarabine	24956101
D005459	Fluorides	Fluorides results in decreased expression of MMP9 mRNA	22610969
D005459	Fluorides	Fluorides results in increased expression of MMP9 protein	29800585
D005472	Fluorouracil	Fluorouracil affects the expression of MMP9 mRNA	15205334
D005472	Fluorouracil	Fluorouracil results in increased expression of MMP9 protein	26310874
D005473	Fluoxetine	Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]	15312242
D005473	Fluoxetine	Fluoxetine results in decreased activity of MMP9 protein	21966942
D005480	Flurbiprofen	Flurbiprofen results in decreased expression of MMP9 mRNA	19501039
D005480	Flurbiprofen	[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA	19501039
D005480	Flurbiprofen	[[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein	19501039
D005485	Flutamide	daidzein inhibits the reaction [Flutamide results in increased expression of MMP9 mRNA]	23135684
D005485	Flutamide	Flutamide results in increased expression of MMP9 mRNA	23135684
D000077340	Fluvastatin	Amitrole inhibits the reaction [Fluvastatin results in decreased expression of MMP9 mRNA]	24964743
D000077340	Fluvastatin	Fluvastatin results in decreased expression of MMP9 mRNA	24964743
D005492	Folic Acid	[Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MMP9 mRNA	23439872
D005492	Folic Acid	Dizocilpine Maleate inhibits the reaction [Folic Acid deficiency results in decreased expression of MMP9 mRNA]	20406136
D005492	Folic Acid	Folic Acid deficiency results in decreased activity of MMP9 protein	20406136
D005492	Folic Acid	Folic Acid deficiency results in decreased expression of MMP9 mRNA	20406136
C067584	formosanin C	formosanin C results in decreased expression of MMP9 protein	21304274
D000068759	Formoterol Fumarate	Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
D000068759	Formoterol Fumarate	Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]	20826145; 25313925;
D000068759	Formoterol Fumarate	Formoterol Fumarate promotes the reaction [Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]	25313925
D000068759	Formoterol Fumarate	Ipratropium promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium results in increased activity of MMP9 protein]]	20826145
D017328	Fosinopril	Fosinopril results in decreased expression of MMP9 mRNA	21051829
D017328	Fosinopril	Fosinopril results in decreased expression of MMP9 protein	21051829
D017328	Fosinopril	[Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA	21051829
D017328	Fosinopril	[Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein	21051829
D005620	Freund's Adjuvant	[Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA	12400877
C442779	fruit extract, Alpinia oxyphylla	fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein]	30367734
C460864	FSL-1 lipoprotein, synthetic	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	BAY 11-7085 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	BAY 11-7085 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	Chlorpromazine inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA	25200491
C460864	FSL-1 lipoprotein, synthetic	FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein	25200491
C460864	FSL-1 lipoprotein, synthetic	MYD88 protein affects the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	MYD88 protein affects the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	pyrazolanthrone inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	pyrazolanthrone inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	Resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	Resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	SB 203580 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	SB 203580 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	TLR2 protein affects the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	TLR2 protein affects the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	U 0126 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	U 0126 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C460864	FSL-1 lipoprotein, synthetic	XMD 8-92 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C460864	FSL-1 lipoprotein, synthetic	XMD 8-92 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C096856	FTI 277	FTI 277 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
C096856	FTI 277	FTI 277 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
C007789	fucoidan	fucoidan results in decreased expression of MMP9	24333868
C007789	fucoidan	Wortmannin inhibits the reaction [fucoidan results in decreased expression of MMP9]	24333868
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 mRNA]	19956873; 25534675;
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	19956873; 25534675; 25690688; 28844962;
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 mRNA]	19956873
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MMP9 protein]	19956873
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Estradiol results in decreased expression of MMP9 mRNA]	19956873
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Estradiol results in decreased expression of MMP9 protein]	19956873
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Estradiol results in increased expression of MMP9 protein]	25690688; 28844962;
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]	28390675
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [nonylphenol results in increased expression of MMP9 protein]	25690688
D000077267	Fulvestrant	Fulvestrant inhibits the reaction [Triclosan results in increased expression of MMP9 protein]	28844962
C492995	fumigaclavine C	fumigaclavine C results in decreased activity of MMP9 protein	16023606
C492995	fumigaclavine C	fumigaclavine C results in decreased expression of MMP9 mRNA	16023606
C038958	gadolinium chloride	gadolinium chloride results in increased expression of MMP9 mRNA	12493575
C038958	gadolinium chloride	SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP9 mRNA]	12493575
D005690	Galactose	fruit extract, Alpinia oxyphylla inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein]	30367734
D005690	Galactose	Galactose results in increased expression of and results in increased activity of MMP9 protein	30367734
D005707	Gallic Acid	EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27634460
D005707	Gallic Acid	[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	27634460
D005707	Gallic Acid	[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27634460
D005707	Gallic Acid	Gallic Acid inhibits the reaction [EGF protein results in increased expression of and results in increased secretion of MMP9 protein]	27087131
D005707	Gallic Acid	Gallic Acid inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	27087131; 27634460;
D005707	Gallic Acid	Gallic Acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27634460
D005707	Gallic Acid	Gallic Acid results in decreased activity of MMP9 protein	22387266
D005707	Gallic Acid	Gallic Acid results in decreased expression of MMP9 mRNA	22387266
D005707	Gallic Acid	Gallic Acid results in decreased expression of MMP9 protein	22387266
D005707	Gallic Acid	MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27634460
D005707	Gallic Acid	[MAP2K1 protein modified form co-treated with AKT1 protein modified form] inhibits the reaction [Gallic Acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27087131
D005707	Gallic Acid	SRC protein modified form inhibits the reaction [Gallic Acid inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27087131
D005707	Gallic Acid	Gallic Acid results in decreased expression of MMP9 mRNA	16304905
D005707	Gallic Acid	Gallic Acid inhibits the reaction [ALB modified form results in increased expression of MMP9 mRNA]	24309158
D005707	Gallic Acid	Gallic Acid inhibits the reaction [ALB modified form results in increased expression of MMP9 protein]	24309158
D000077156	Gefitinib	Gefitinib inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131
D000077156	Gefitinib	Gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]	23127547
D000077156	Gefitinib	Gefitinib promotes the reaction [Resveratrol inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]	23127547
D000077156	Gefitinib	Gefitinib promotes the reaction [Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
D000077156	Gefitinib	Resveratrol promotes the reaction [Gefitinib inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]	23127547
D000077156	Gefitinib	Resveratrol promotes the reaction [Gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
D000077156	Gefitinib	Gefitinib inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	15841081
D000077156	Gefitinib	Gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein]]	29228391
C056507	gemcitabine	[gemcitabine co-treated with IFNA2 protein] results in increased expression of MMP9 protein	12738744
C056507	gemcitabine	[Curcumin co-treated with gemcitabine] results in decreased expression of MMP9 protein	17440100
C007834	genipin	genipin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	29630948
D019833	Genistein	Genistein results in decreased activity of MMP9 protein	16598420
D019833	Genistein	Genistein results in decreased expression of MMP9 mRNA	15256057; 15754008;
D019833	Genistein	Genistein results in decreased expression of MMP9 protein	15256057
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]	15728660
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]	15728660
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	15728660
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9]]	19299917
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
C547856	GGTI-2133	GGTI-2133 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
C547856	GGTI-2133	GGTI-2133 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
C007845	gingerol	gingerol results in decreased activity of MMP9 protein	17683926
C007845	gingerol	gingerol results in decreased expression of MMP9 mRNA	17683926
C112772	ginsenoside M1	ginsenoside M1 results in decreased secretion of MMP9 protein	21875580
D005934	Glucagon	Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA]	29988851
D005934	Glucagon	Glucagon analog inhibits the reaction [LEPR gene mutant form results in increased expression of MMP9 mRNA]	29988851
D005944	Glucosamine	Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19375915
D005944	Glucosamine	Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19375915
D005944	Glucosamine	Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	17498959
D005944	Glucosamine	Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	17498959
D005944	Glucosamine	Glucosamine inhibits the reaction [IL1B results in increased expression of MMP9 mRNA]	17109745
D005944	Glucosamine	Glucosamine results in increased expression of MMP9 mRNA	17109745
D005944	Glucosamine	IL1B affects the reaction [Glucosamine results in increased expression of MMP9 mRNA]	17109745
D005947	Glucose	[Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA	24064760
D005947	Glucose	Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]	26179980
D005947	Glucose	Glucose promotes the reaction [Air Pollutants results in increased expression of MMP9 mRNA]	26179980
D005947	Glucose	Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]	26179980
D005947	Glucose	Glucose promotes the reaction [Particulate Matter results in increased expression of MMP9 mRNA]	26179980
D005947	Glucose	SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]]	26179980
D005947	Glucose	SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]]	26179980
D005947	Glucose	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA	24682241
D005947	Glucose	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein	24682241
D005947	Glucose	[Resveratrol co-treated with Glucose] results in decreased activity of MMP9 protein	24659233
D005947	Glucose	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
D005947	Glucose	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
D005947	Glucose	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
D005947	Glucose	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
D005947	Glucose	Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]	19505525
D005947	Glucose	Glucose affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D005947	Glucose	[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D005978	Glutathione	Glutathione binds to MMP9 protein	17015178
D005978	Glutathione	Glutathione inhibits the reaction [4-aminophenylmercuriacetate results in increased activity of MMP9 protein]	17015178
D005978	Glutathione	Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	17640567
D005978	Glutathione	Glutathione results in decreased secretion of MMP9 protein	15147517
D005978	Glutathione	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glutathione binds to MMP9 protein]	17015178
D005978	Glutathione	Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	21722719
C086566	glycitein	glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20188714
C086566	glycitein	glycitein results in decreased expression of MMP9 mRNA	20188714
C086566	glycitein	glycitein results in decreased expression of MMP9 protein	20188714
C010974	glyphosate	glyphosate results in increased expression of MMP9 mRNA	25636363
C081021	Go 6976	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
C081021	Go 6976	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21354279
C081021	Go 6976	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	21354279
C081021	Go 6976	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
C081021	Go 6976	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
D006046	Gold	EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27634460
D006046	Gold	[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	27634460
D006046	Gold	[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27634460
D006046	Gold	MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	27634460
D017612	Gold Compounds	[Gold Compounds co-treated with TNF protein] results in increased expression of MMP9 mRNA	30096344
D056604	Grape Seed Extract	Grape Seed Extract inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	28300665
D006108	Graphite	Graphite results in increased expression of MMP9 mRNA	29933104
C425931	GW 501516	BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]]	23737761
C425931	GW 501516	BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	23737761
C425931	GW 501516	GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23737761
C425931	GW 501516	GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	23737761
C425931	GW 501516	PPARD mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	23737761
D006493	Heparin	Heparin results in decreased activity of MMP9 protein	10958381
D006493	Heparin	Heparin results in increased expression of MMP9 mRNA	14630814; 16190367;
D006493	Heparin	Heparin results in increased expression of MMP9 protein	16190367
D006493	Heparin	Heparin results in increased metabolism of and results in increased activity of MMP9 protein	14630814
D006533	Heptachlor	Heptachlor results in increased expression of MMP9 mRNA	23153324
D006569	Hesperidin	Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of and results in increased activity of MMP9 protein]	19110045
D006569	Hesperidin	Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of MMP9 mRNA]	19110045
D006569	Hesperidin	Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20138977
D006569	Hesperidin	Hesperidin results in decreased secretion of MMP9 protein	19110045
D006581	Hexachlorobenzene	alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein]	23462309
D006581	Hexachlorobenzene	Hexachlorobenzene results in increased expression of MMP9 mRNA	23462309
D006581	Hexachlorobenzene	Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein	23462309
D006581	Hexachlorobenzene	RTKI cpd inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein]	23462309
D006581	Hexachlorobenzene	Hexachlorobenzene results in increased expression of MMP9 mRNA	15159207
D015699	HIV Envelope Protein gp120	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
D015699	HIV Envelope Protein gp120	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of and results in increased activity of MMP9 protein]	21425912
D015699	HIV Envelope Protein gp120	HIV Envelope Protein gp120 promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
D015699	HIV Envelope Protein gp120	HIV Envelope Protein gp120 promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of MMP9 protein]	21425912
D006710	Homocysteine	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
D006710	Homocysteine	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
D006710	Homocysteine	Acetylcysteine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
D006710	Homocysteine	Acetylcysteine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
D006710	Homocysteine	Homocysteine results in increased activity of MMP9 protein	16251475
D006710	Homocysteine	Homocysteine results in increased expression of MMP9 protein	16251475
D006710	Homocysteine	Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
D006710	Homocysteine	Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
D006710	Homocysteine	Homocysteine results in increased activity of and results in increased expression of MMP9 protein	22326992
D006710	Homocysteine	Dizocilpine Maleate inhibits the reaction [Homocysteine analog results in decreased expression of MMP9 protein]	20406136
D006710	Homocysteine	Homocysteine analog results in decreased expression of MMP9 protein	20406136
C494417	huanglian	[xiongshao co-treated with huanglian] affects the expression of and affects the secretion of MMP9 protein	20694780
D006812	Humic Substances	Humic Substances results in increased activity of MMP9 protein	19686714
D006812	Humic Substances	Humic Substances results in increased expression of MMP9 protein	25728215
D006820	Hyaluronic Acid	Hyaluronic Acid affects the activity of MMP9 protein	15597151
D006851	Hydrochloric Acid	Hydrochloric Acid results in increased expression of MMP9 protein	18339021
D006851	Hydrochloric Acid	Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein]	18339021
D006854	Hydrocortisone	Hydrocortisone results in increased activity of MMP9 protein	18281261
D006854	Hydrocortisone	Hydrocortisone results in increased expression of MMP9 mRNA	18281261
D006854	Hydrocortisone	Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of MMP9 protein]	18281261
D006854	Hydrocortisone	Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of MMP9 mRNA]	18281261
D006854	Hydrocortisone	Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]	18722610
D006854	Hydrocortisone	Hydrocortisone inhibits the reaction [IL1A protein results in increased expression of MMP9 mRNA]	18722610
D006854	Hydrocortisone	Mifepristone inhibits the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]	18722610
D006854	Hydrocortisone	NR3C1 protein promotes the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]	18722610
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of MMP9 mRNA	26846883
D006861	Hydrogen Peroxide	acetovanillone inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	AKT1 mutant form inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	anagliptin inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	31586451
D006861	Hydrogen Peroxide	diphenyleneiodonium inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	EGFR mutant form inhibits the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of MMP9 mRNA	26339600
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased activity of MMP9 protein	15531749
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of MMP9 mRNA	26514923; 31586451;
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of MMP9 protein	15531749
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased secretion of MMP9 protein	15531749
D006861	Hydrogen Peroxide	IKBKB protein affects the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	MAP2K1 protein affects the reaction [Hydrogen Peroxide results in increased expression of MMP9 mRNA]	26514923
D006861	Hydrogen Peroxide	CAT protein inhibits the reaction [[SOD2 protein results in increased chemical synthesis of Hydrogen Peroxide] which results in increased expression of MMP9 mRNA]	12538496
D006861	Hydrogen Peroxide	[CAT protein results in decreased abundance of Hydrogen Peroxide] which results in decreased expression of MMP9	18930813
D006861	Hydrogen Peroxide	Hydrogen Peroxide affects the expression of MMP9	18930813
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of MMP9	24894401
D006861	Hydrogen Peroxide	[SOD2 protein results in increased chemical synthesis of Hydrogen Peroxide] which results in increased expression of MMP9 mRNA	12538496
D006862	Hydrogen Sulfide	Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]	24722316
D006862	Hydrogen Sulfide	Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]	24722316
D006862	Hydrogen Sulfide	Hydrogen Sulfide results in increased expression of MMP9 mRNA	24722316
D006862	Hydrogen Sulfide	Hydrogen Sulfide results in increased expression of MMP9 protein	24722316
D006862	Hydrogen Sulfide	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]]	24722316
D006862	Hydrogen Sulfide	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]]	24722316
C031927	hydroquinone	hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]]	17669387
C031927	hydroquinone	hydroquinone promotes the reaction [TNF protein results in increased secretion of MMP9 protein]	17669387
C031927	hydroquinone	hydroquinone results in increased expression of MMP9 mRNA	26807887
C031927	hydroquinone	hydroquinone results in increased secretion of MMP9 protein	26807887
C031927	hydroquinone	pyrazolanthrone inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein]	26807887
C031927	hydroquinone	SB 203580 inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein]	26807887
D006877	Hydroxamic Acids	Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	27163855
D006877	Hydroxamic Acids	Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	27163855
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in increased expression of MMP9 protein]]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [Particulate Matter results in increased expression of MMP9 protein]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [Vehicle Emissions results in increased expression of MMP9 protein]	24192212
D007052	Ibuprofen	Ibuprofen inhibits the reaction [EGF protein results in increased activity of MMP9 protein]	16340751
D007052	Ibuprofen	Ibuprofen inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	16340751
D007052	Ibuprofen	[Ibuprofen co-treated with Carbon Tetrachloride] results in increased expression of MMP9 protein	21360558
C026777	ICI 118551	ICI 118551 results in decreased expression of MMP9 mRNA	20424515
C026777	ICI 118551	ICI 118551 results in decreased expression of MMP9 protein	20424515
C026777	ICI 118551	ICI 118551 results in decreased secretion of MMP9 protein	20424515
C036619	idebenone	idebenone inhibits the reaction [Streptozocin results in increased expression of MMP9 protein]	28648635
C036619	idebenone	idebenone results in decreased expression of MMP9 protein	28648635
D007069	Ifosfamide	IFNA2 promotes the reaction [Ifosfamide results in decreased activity of MMP9 protein]	15659795
D007069	Ifosfamide	IFNB1 promotes the reaction [Ifosfamide results in decreased activity of MMP9 protein]	15659795
D007069	Ifosfamide	Ifosfamide affects the expression of MMP9 mRNA	15659795
D007069	Ifosfamide	[Ifosfamide co-treated with IFNA2] affects the expression of MMP9 mRNA	15659795
D007069	Ifosfamide	[Ifosfamide co-treated with IFNA2] affects the expression of MMP9 protein	15659795
D007069	Ifosfamide	[Ifosfamide co-treated with IFNB1] affects the expression of MMP9 mRNA	15659795
D007069	Ifosfamide	[Ifosfamide co-treated with IFNB1] affects the expression of MMP9 protein	15659795
D007069	Ifosfamide	Ifosfamide results in decreased activity of MMP9 protein	15659795
D000077271	Imiquimod	Imiquimod results in decreased activity of MMP9 protein	14708627
D000077271	Imiquimod	Imiquimod results in decreased expression of MMP9	16302556
D007166	Immunosuppressive Agents	Immunosuppressive Agents results in decreased expression of MMP9 protein	19652986
D019469	Indinavir	Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	14662518
D019469	Indinavir	Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	14662518
D019469	Indinavir	Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	14662518
C016517	indole-3-carbinol	indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	15811958
C016517	indole-3-carbinol	indole-3-carbinol results in decreased expression of MMP9 protein	29775573
D007213	Indomethacin	Indomethacin results in decreased expression of and results in decreased activity of MMP9 protein	11719597
D007213	Indomethacin	[Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein	16537180
D007213	Indomethacin	Indomethacin inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D007213	Indomethacin	Indomethacin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D007213	Indomethacin	Indomethacin results in decreased activity of MMP9 protein	16537180
D007213	Indomethacin	Indomethacin results in increased activity of MMP9 protein	17000239
D007213	Indomethacin	Indomethacin results in decreased activity of MMP9 protein	10231640
D007213	Indomethacin	Indomethacin results in increased activity of MMP9 protein	10878458
D007213	Indomethacin	Indomethacin results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein	16934674
D007213	Indomethacin	Indomethacin results in increased expression of and results in increased secretion of MMP9 protein	16150113
D007213	Indomethacin	Indomethacin results in increased expression of MMP9 protein	29523851
D007213	Indomethacin	Irbesartan inhibits the reaction [Indomethacin results in increased expression of MMP9 protein]	29523851
D007213	Indomethacin	Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein]	16150113
D007213	Indomethacin	Ranitidine inhibits the reaction [Indomethacin results in increased expression of MMP9 protein]	29523851
D007220	Industrial Waste	Industrial Waste results in increased expression of MMP9 protein	30641074
D053590	Interleukin 1 Receptor Antagonist Protein	[Carbon Tetrachloride co-treated with Interleukin 1 Receptor Antagonist Protein] results in increased expression of MMP9 mRNA	16762003
D009241	Ipratropium	Ipratropium promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium results in increased activity of MMP9 protein]]	20826145
D000077405	Irbesartan	Irbesartan inhibits the reaction [Indomethacin results in increased expression of MMP9 protein]	29523851
D000077146	Irinotecan	Irinotecan metabolite results in increased expression of MMP9 mRNA	15956246
D000077146	Irinotecan	Irinotecan results in increased expression of MMP9 mRNA	15956246
C448299	iron protoporphyrin IX	iron protoporphyrin IX inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	24211270
C040920	isoliquiritigenin	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C040920	isoliquiritigenin	20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
C040920	isoliquiritigenin	AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C040920	isoliquiritigenin	AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
C040920	isoliquiritigenin	CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C040920	isoliquiritigenin	CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
C040920	isoliquiritigenin	Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]	25094029
C040920	isoliquiritigenin	Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]	25094029
C040920	isoliquiritigenin	isoliquiritigenin results in decreased expression of MMP9 mRNA	25094029
C040920	isoliquiritigenin	isoliquiritigenin results in decreased expression of MMP9 protein	25094029
D007545	Isoproterenol	Isoproterenol results in increased expression of MMP9 mRNA	16574429; 24929186;
D007545	Isoproterenol	Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	16574429
D007545	Isoproterenol	Doxycycline inhibits the reaction [Isoproterenol results in increased activity of MMP9]	18089841
D007545	Isoproterenol	Isoproterenol results in increased activity of MMP9	18089841
D007545	Isoproterenol	CPU0213 inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	18594475
D007545	Isoproterenol	Isoproterenol results in increased expression of MMP9 mRNA	18594475
D007545	Isoproterenol	pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	18594475
C016527	isoquercitrin	isoquercitrin results in decreased expression of and results in decreased activity of MMP9 protein	18715546
C432511	isorhamnetin 3-O-glucoside	isorhamnetin 3-O-glucoside results in decreased expression of and results in decreased activity of MMP9 protein	18715546
D015474	Isotretinoin	Isotretinoin inhibits the reaction [Arachidonic Acid results in increased expression of MMP9 mRNA]	16185265
D015474	Isotretinoin	Isotretinoin inhibits the reaction [Arachidonic Acid results in increased secretion of MMP9 protein]	16185265
D015474	Isotretinoin	Isotretinoin results in decreased expression of MMP9 protein	16185265
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [TNFSF11 protein promotes the reaction [BRD4 protein binds to MMP9 promoter]]	24646477
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]	24646477
C561695	(+)-JQ1 compound	(+)-JQ1 compound results in decreased expression of MMP9 mRNA	25961927
C471998	JTE 013	JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	26518876
C471998	JTE 013	JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	26518876
C471998	JTE 013	JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 mRNA]	26518876
C471998	JTE 013	JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 protein]	26518876
C005134	juglone	[juglone co-treated with Ascorbic Acid] results in decreased expression of MMP9 mRNA	29992683
D007656	Ketoglutaric Acids	Ketoglutaric Acids inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	25816614
C572783	kuguacin J	kuguacin J results in decreased expression of MMP9 mRNA	22266361
C572783	kuguacin J	kuguacin J results in decreased secretion of MMP9 protein alternative form	22266361
C008261	lead acetate	lead acetate results in increased expression of MMP9 mRNA	20542052
C410793	leptin (116-130)	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [leptin (116-130) results in decreased expression of MMP9 mRNA]	31499123
C410793	leptin (116-130)	leptin (116-130) results in decreased expression of MMP9 mRNA	31499123
D000077289	Letrozole	Letrozole inhibits the reaction [sodium arsenite results in increased activity of and results in increased secretion of MMP9 protein]	24068038
D007975	Leukotriene B4	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein]	19837106
D007975	Leukotriene B4	Leukotriene B4 results in increased expression of MMP9 protein	19837106
D007975	Leukotriene B4	SB 203580 inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein]	19837106
D017997	Leukotriene C4	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]	19837106
D017997	Leukotriene C4	Leukotriene C4 results in increased expression of MMP9 protein	19837106
D017997	Leukotriene C4	SB 203580 inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]	19837106
D017998	Leukotriene D4	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]	19837106
D017998	Leukotriene D4	Leukotriene D4 results in increased expression of MMP9 protein	19837106
D017998	Leukotriene D4	SB 203580 inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]	19837106
D016729	Leuprolide	Leuprolide inhibits the reaction [Resveratrol results in decreased expression of MMP9 protein]	25462211
D016729	Leuprolide	Leuprolide results in decreased expression of MMP9 protein	25462211
D016729	Leuprolide	Resveratrol inhibits the reaction [Leuprolide results in decreased expression of MMP9 protein]	25462211
C035965	lewisite	lewisite results in increased expression of MMP9 protein	28973427
C018584	linalool	linalool results in increased expression of MMP9 mRNA	26703569
D019787	Linoleic Acid	Linoleic Acid results in decreased expression of and results in decreased activity of MMP9 protein	23288142
D019787	Linoleic Acid	Linoleic Acid results in decreased expression of MMP9 mRNA	23288142
D019787	Linoleic Acid	Linoleic Acid affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D019787	Linoleic Acid	[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of MMP9 protein]	22467055
D008055	Lipids	[Methotrexate analog binds to Lipids] which results in decreased expression of MMP9 mRNA	24065615
C050016	lipoarabinomannan	lipoarabinomannan results in increased activity of MMP9 protein	11839551
C433788	lipopolysaccharide, E. coli O26-B6	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
C433788	lipopolysaccharide, E. coli O26-B6	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of and results in increased activity of MMP9 protein]	21425912
C433788	lipopolysaccharide, E. coli O26-B6	HIV Envelope Protein gp120 promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
C433788	lipopolysaccharide, E. coli O26-B6	HIV Envelope Protein gp120 promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of MMP9 protein]	21425912
C433788	lipopolysaccharide, E. coli O26-B6	lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA	21425912
C433788	lipopolysaccharide, E. coli O26-B6	lipopolysaccharide, E. coli O26-B6 results in increased secretion of and results in increased activity of MMP9 protein	21425912
C433788	lipopolysaccharide, E. coli O26-B6	Methamphetamine promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
C433788	lipopolysaccharide, E. coli O26-B6	Methamphetamine promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of MMP9 protein]	21425912
C482199	lipopolysaccharide, E coli O55-B5	lipopolysaccharide, E coli O55-B5 results in decreased expression of MMP9 mRNA	24972896
C482199	lipopolysaccharide, E coli O55-B5	Carbon promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of MMP9 mRNA]	26880698
C482199	lipopolysaccharide, E coli O55-B5	lipopolysaccharide, E coli O55-B5 promotes the reaction [Carbon results in increased expression of MMP9 mRNA]	26880698
C482199	lipopolysaccharide, E coli O55-B5	lipopolysaccharide, E coli O55-B5 results in increased expression of MMP9 mRNA	26880698
C440499	lipopolysaccharide, Escherichia coli O111 B4	lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased secretion of MMP9 protein	23625030
C440499	lipopolysaccharide, Escherichia coli O111 B4	lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA	23625030
C440499	lipopolysaccharide, Escherichia coli O111 B4	Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased secretion of MMP9 protein]	23625030
C440499	lipopolysaccharide, Escherichia coli O111 B4	Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	23625030
C440499	lipopolysaccharide, Escherichia coli O111 B4	SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 protein]]	23625030
C440499	lipopolysaccharide, Escherichia coli O111 B4	Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	15734790
C440499	lipopolysaccharide, Escherichia coli O111 B4	lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA	15734790
C440499	lipopolysaccharide, Escherichia coli O111 B4	Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	15734790
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 mRNA	18557954
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 protein	18557954
D008070	Lipopolysaccharides	Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	21075133
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased activity of MMP9 protein	22102721
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 mRNA	18625914; 23724058;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 protein	17038636; 20093109; 20421217; 26497626;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased secretion of MMP9 protein	21075133
D008070	Lipopolysaccharides	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	20093109
D008070	Lipopolysaccharides	perfluorooctanoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	21075133
D008070	Lipopolysaccharides	phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	23724058
D008070	Lipopolysaccharides	PPARA protein affects the reaction [perfluorooctanoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]]	21075133
D008070	Lipopolysaccharides	Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	26497626
D008070	Lipopolysaccharides	Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	18625914
D008070	Lipopolysaccharides	Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	17038636
D008070	Lipopolysaccharides	Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D008070	Lipopolysaccharides	[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA	29718165
D008070	Lipopolysaccharides	bisphenol A inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
D008070	Lipopolysaccharides	cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	29471534
D008070	Lipopolysaccharides	Decitabine inhibits the reaction [[bisphenol A affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA]	29718165
D008070	Lipopolysaccharides	Diethylhexyl Phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
D008070	Lipopolysaccharides	diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D008070	Lipopolysaccharides	ethyl pyruvate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of MMP9 protein]	21316417
D008070	Lipopolysaccharides	ethyl pyruvate inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	21316417
D008070	Lipopolysaccharides	Lipopolysaccharides affects the expression of MMP9 mRNA	30942577
D008070	Lipopolysaccharides	[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA	29718165
D008070	Lipopolysaccharides	[Lipopolysaccharides co-treated with Zymosan] results in increased activity of MMP9 protein	15259001
D008070	Lipopolysaccharides	[Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 mRNA	15259001
D008070	Lipopolysaccharides	[Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 protein	15259001
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein	21200322
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of and results in increased secretion of MMP9 protein	21316417
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 mRNA	15557194; 21200322; 21316417; 21554007; 22102721; 23585870; 29471534; 29743444; 30048646;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 protein	22102721; 30048646;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased secretion of MMP9 protein	21200322; 29743444;
D008070	Lipopolysaccharides	[LLY-507 affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA	29718165
D008070	Lipopolysaccharides	Losartan inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	23585870
D008070	Lipopolysaccharides	mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
D008070	Lipopolysaccharides	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	21554007
D008070	Lipopolysaccharides	PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	21200322
D008070	Lipopolysaccharides	PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	21200322
D008070	Lipopolysaccharides	PRDX6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	21200322
D008070	Lipopolysaccharides	Reactive Oxygen Species affects the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D008070	Lipopolysaccharides	Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D008070	Lipopolysaccharides	rottlerin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D008070	Lipopolysaccharides	Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	29743444
D008070	Lipopolysaccharides	Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	29743444
D008070	Lipopolysaccharides	[SMYD2 mRNA affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in increased expression of MMP9 mRNA	29718165
D008070	Lipopolysaccharides	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	30048646
D008070	Lipopolysaccharides	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	30048646
D008070	Lipopolysaccharides	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234
D008070	Lipopolysaccharides	2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	16683234
D008070	Lipopolysaccharides	[Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	26497626
D008070	Lipopolysaccharides	HNRNPD mutant form inhibits the reaction [2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]]	16683234
D008070	Lipopolysaccharides	Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	14662518
D008070	Lipopolysaccharides	Indinavir inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	14662518
D008070	Lipopolysaccharides	Indinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	14662518
D008070	Lipopolysaccharides	[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein	14700523; 16647178;
D008070	Lipopolysaccharides	Lipopolysaccharides promotes the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein	16683234; 27098997; 30980805;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 mRNA	14662518; 16683234; 23378038;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of MMP9 protein	14662518; 21362633; 26497626;
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased secretion of MMP9 protein	14662518; 21362633;
D008070	Lipopolysaccharides	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	27098997
D008070	Lipopolysaccharides	Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523; 16647178;
D008070	Lipopolysaccharides	SB 203580 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]	16683234
D008070	Lipopolysaccharides	SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234
D008070	Lipopolysaccharides	SB 203580 promotes the reaction [U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
D008070	Lipopolysaccharides	U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]	16683234
D008070	Lipopolysaccharides	U 0126 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234; 30980805;
D008070	Lipopolysaccharides	U 0126 promotes the reaction [SB 203580 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
D008070	Lipopolysaccharides	wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523
D008070	Lipopolysaccharides	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	14662518
D008070	Lipopolysaccharides	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	14662518
D008070	Lipopolysaccharides	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	14662518
C005152	lipostabil	lipostabil inhibits the reaction [Ethanol results in increased expression of MMP9 mRNA]	17887948
C083152	liquiritigenin	liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein]	29908794
C512196	liquiritin	liquiritin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein]	29908794
D008095	Lithocholic Acid	Lithocholic Acid results in decreased expression of MMP9 protein	21224350
C000600304	LLY-507	[LLY-507 affects the susceptibility to [Lipopolysaccharides co-treated with IFNG protein]] which results in decreased expression of MMP9 mRNA	29718165
C115354	lonafarnib	lonafarnib inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	15090542
D019808	Losartan	Losartan inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	23585870
D019808	Losartan	Losartan inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA]	25233898
D019808	Losartan	Losartan results in decreased expression of MMP9 mRNA	18971572
D008148	Lovastatin	Lovastatin results in decreased expression of MMP9 protein	19360310
D047311	Luteolin	Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30133131
D047311	Luteolin	Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30133131
D047311	Luteolin	Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of MMP9 protein]	25448439
D047311	Luteolin	Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein]	15135307
D047311	Luteolin	Luteolin results in decreased secretion of MMP9 protein	15135307
D047311	Luteolin	Luteolin results in increased expression of MMP9 protein	10556937
D047311	Luteolin	Luteolin inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP9 protein]	19747501
D047311	Luteolin	Luteolin inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	21679050
C530478	LYR 71	LYR 71 inhibits the reaction [CCL5 protein promotes the reaction [EP300 protein binds to MMP9 promoter]]	18985009
C530478	LYR 71	LYR 71 inhibits the reaction [CCL5 protein promotes the reaction [STAT3 protein binds to MMP9 promoter]]	18985009
C530478	LYR 71	LYR 71 inhibits the reaction [CCL5 protein results in increased expression of and results in increased activity of MMP9 protein]	18985009
C530478	LYR 71	LYR 71 inhibits the reaction [CCL5 protein results in increased expression of MMP9 mRNA]	18985009
C530478	LYR 71	LYR 71 results in decreased expression of MMP9 protein	18985009
C032881	lysophosphatidic acid	Gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]	23127547
C032881	lysophosphatidic acid	Gefitinib promotes the reaction [Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
C032881	lysophosphatidic acid	lysophosphatidic acid results in increased expression of MMP9 mRNA	23127547
C032881	lysophosphatidic acid	Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]	23127547
C032881	lysophosphatidic acid	Resveratrol promotes the reaction [Gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
D058185	Magnetite Nanoparticles	[Magnetite Nanoparticles co-treated with TNF protein] results in increased expression of MMP9 mRNA	30096344
D058185	Magnetite Nanoparticles	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA	26378955
D058185	Magnetite Nanoparticles	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA	21641980
C025340	manganese chloride	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased expression of and results in increased secretion of MMP9 protein]	23811825
C025340	manganese chloride	manganese chloride results in increased expression of and results in increased secretion of MMP9 protein	23811825
C025340	manganese chloride	manganese chloride results in increased expression of MMP9 mRNA	23811825
C025340	manganese chloride	Resveratrol inhibits the reaction [manganese chloride results in increased expression of and results in increased secretion of MMP9 protein]	23811825
C025340	manganese chloride	Resveratrol inhibits the reaction [manganese chloride results in increased expression of MMP9 mRNA]	23811825
C013592	mangiferin	mangiferin results in decreased activity of MMP9 protein	22465218
C013592	mangiferin	mangiferin results in decreased expression of and results in decreased secretion of MMP9 protein	22465218
C013592	mangiferin	mangiferin results in decreased expression of MMP9 mRNA	22465218
C013592	mangiferin	mangiferin results in decreased expression of MMP9 protein	23707762
C013592	mangiferin	mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]	27125760
C021053	mangostin	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]	28722351
C021053	mangostin	mangostin analog results in decreased expression of MMP9 mRNA	28722351
C021053	mangostin	mangostin analog results in decreased expression of MMP9 protein	28722351
C021053	mangostin	pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]	28722351
D008351	Mannans	Mannans results in increased activity of MMP9 protein	11839551
D061965	Matrix Metalloproteinase Inhibitors	Matrix Metalloproteinase Inhibitors inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	19765281
D061965	Matrix Metalloproteinase Inhibitors	Matrix Metalloproteinase Inhibitors inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein]	19765281
C577554	MC1568	MC1568 inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	24429678
C577554	MC1568	MC1568 inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	24429678
D008466	Mechlorethamine	Mechlorethamine results in increased expression of MMP9	24631667
D008466	Mechlorethamine	Mechlorethamine results in increased expression of MMP9 protein	25891025; 30060251;
D008466	Mechlorethamine	MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of MMP9]	24631667
D008466	Mechlorethamine	SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MMP9 protein]	30060251
D008466	Mechlorethamine	Doxorubicin inhibits the reaction [Mechlorethamine results in increased expression of MMP9 protein]	29174984
D008466	Mechlorethamine	Mechlorethamine results in increased expression of MMP9 protein	29174984
D008466	Mechlorethamine	Silybin inhibits the reaction [Mechlorethamine results in increased expression of MMP9 protein]	29174984
D008466	Mechlorethamine	Mechlorethamine results in increased expression of MMP9 mRNA	26273949; 28184907;
D008466	Mechlorethamine	Mechlorethamine results in increased expression of MMP9 protein	20883710
D008466	Mechlorethamine	Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of MMP9 mRNA]	28184907
D017258	Medroxyprogesterone Acetate	Medroxyprogesterone Acetate results in decreased expression of MMP9 mRNA	20843944
D017258	Medroxyprogesterone Acetate	[Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP9 protein	16537180
D017258	Medroxyprogesterone Acetate	Medroxyprogesterone Acetate results in decreased activity of MMP9 protein	16537180
D008550	Melatonin	Melatonin inhibits the reaction [Indomethacin results in increased expression of and results in increased secretion of MMP9 protein]	16150113
D008555	Melitten	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19969058
D008555	Melitten	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	20082219
D008555	Melitten	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20082219
D008555	Melitten	Melitten inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	22926441
D008555	Melitten	Melitten inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	22926441
D008555	Melitten	Melitten inhibits the reaction [TNF protein results in increased secretion of MMP9 protein]	22926441
D008628	Mercury	MMP9 promoter polymorphism affects the susceptibility to Mercury	20554312
C527236	metacept-1	metacept-1 inhibits the reaction [Azacitidine results in increased expression of MMP9]	19148494
D008687	Metformin	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
D008687	Metformin	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20590612
D008687	Metformin	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20590612
D008687	Metformin	Metformin results in decreased activity of MMP9 protein	20590612
D008687	Metformin	Metformin results in decreased expression of MMP9 mRNA	22246099
D008687	Metformin	Metformin inhibits the reaction [IL13 protein results in increased expression of MMP9 mRNA]	26497364
D008694	Methamphetamine	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
D008694	Methamphetamine	[HIV Envelope Protein gp120 co-treated with Methamphetamine] promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of and results in increased activity of MMP9 protein]	21425912
D008694	Methamphetamine	Methamphetamine promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of MMP9 mRNA]	21425912
D008694	Methamphetamine	Methamphetamine promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of MMP9 protein]	21425912
D008694	Methamphetamine	Methamphetamine results in increased activity of MMP9 protein	18198472
D008694	Methamphetamine	Methamphetamine results in increased expression of MMP9	18766021
D008694	Methamphetamine	MMP9 protein results in increased susceptibility to Methamphetamine	18198472
C088155	methanandamide	methanandamide results in increased expression of MMP9 mRNA	16330497
C088155	methanandamide	methanandamide results in increased expression of MMP9 protein	16330497
C088155	methanandamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [methanandamide results in increased expression of MMP9 mRNA]	16330497
C088155	methanandamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [methanandamide results in increased expression of MMP9 protein]	16330497
D008715	Methionine	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 protein]	28973532
D008715	Methionine	[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 mRNA	22915297
D008715	Methionine	[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 protein	28973532
D008715	Methionine	Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 mRNA]	22915297
D008727	Methotrexate	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 mRNA	23146660
D008727	Methotrexate	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of MMP9 protein	23146660
D008727	Methotrexate	Methotrexate results in increased expression of MMP9 mRNA	17696278
D008727	Methotrexate	[Methotrexate analog binds to Lipids] which results in decreased expression of MMP9 mRNA	24065615
D008727	Methotrexate	Methotrexate results in increased expression of MMP9 mRNA	29935243
C042405	methyl caffeate	methyl caffeate analog results in decreased expression of and results in decreased activity of MMP9 protein	25481497
D008748	Methylcholanthrene	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MMP9 mRNA	23519560
D008748	Methylcholanthrene	Methylcholanthrene results in decreased expression of MMP9 mRNA	29554273
D008748	Methylcholanthrene	Methylcholanthrene results in increased expression of MMP9 mRNA	18804290
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of MMP9 mRNA	17961207; 20181659; 23458150;
C004925	methylmercuric chloride	methylmercuric chloride inhibits the reaction [ETV4 protein binds to MMP9 promoter]	28526320
C004925	methylmercuric chloride	methylmercuric chloride inhibits the reaction [MECP2 protein binds to MMP9 promoter]	28526320
C004925	methylmercuric chloride	methylmercuric chloride results in decreased methylation of MMP9 promoter	28526320
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of MMP9 mRNA	28526320
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of MMP9 protein	28526320
C004925	methylmercuric chloride	SB 3CT compound inhibits the reaction [methylmercuric chloride results in increased expression of MMP9 protein]	28526320
D008767	Methylmercury Compounds	Methylmercury Compounds results in increased expression of MMP9 mRNA	16966085
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in decreased expression of MMP9 mRNA	26011545
D008769	Methylnitronitrosoguanidine	Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]	20434464
D008769	Methylnitronitrosoguanidine	Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA]	20434464
D008769	Methylnitronitrosoguanidine	Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein	20434464
D008769	Methylnitronitrosoguanidine	Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA	20434464
D008777	Methyltestosterone	Methyltestosterone results in increased expression of MMP9 mRNA	29458080
D008790	Metoprolol	Metoprolol results in decreased expression of MMP9 mRNA	20424515
D008790	Metoprolol	Metoprolol results in decreased expression of MMP9 protein	20424515
D008790	Metoprolol	Metoprolol results in decreased secretion of MMP9 protein	20424515
D008798	Mevalonic Acid	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]	15728660
D008798	Mevalonic Acid	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone results in increased activity of MMP9 protein]	18281261
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MMP9 mRNA]	18281261
D015735	Mifepristone	Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of MMP9 protein]	18281261
D015735	Mifepristone	Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of MMP9 mRNA]	18281261
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]]	24722316
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]]	24722316
D015735	Mifepristone	Mifepristone inhibits the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]	18722610
D015735	Mifepristone	Mifepristone results in increased expression of MMP9 mRNA	19439560
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 mRNA]]	24722316
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Hydrogen Sulfide results in increased expression of MMP9 protein]]	24722316
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]	15963473
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]]	15963473
D015735	Mifepristone	Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	30229846
C051602	mifobate	mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
D008911	Minocycline	Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]	19285099
D008911	Minocycline	Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]	19285099
D008911	Minocycline	Minocycline inhibits the reaction [FMR1 gene mutant form results in increased expression of and results in increased activity of MMP9 protein]	18835858
D008911	Minocycline	Minocycline results in decreased secretion of MMP9 protein	20298932
D008911	Minocycline	Minocycline results in decreased activity of MMP9 protein	16846501
D008911	Minocycline	Minocycline results in decreased expression of MMP9 protein	16846501
C575097	MK-8825	MK-8825 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of MMP9 protein]	29535050
C060893	MK-886	MK-886 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA]	20061081
C060893	MK-886	MK-886 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C000621807	MM-589	[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of MMP9 mRNA	31023824
C408362	momordin I (Oleanolic Acid)	momordin I (Oleanolic Acid) results in decreased expression of MMP9 protein	30654085
C016599	mono-(2-ethylhexyl)phthalate	2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
C016599	mono-(2-ethylhexyl)phthalate	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]	28390675
C016599	mono-(2-ethylhexyl)phthalate	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein]	28390675
C016599	mono-(2-ethylhexyl)phthalate	[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein	30398665
C016599	mono-(2-ethylhexyl)phthalate	Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]	28390675
C016599	mono-(2-ethylhexyl)phthalate	mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein	28416457
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA	28390675
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein	28390675
C016599	mono-(2-ethylhexyl)phthalate	PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]	29718165
C103325	mono-benzyl phthalate	[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein	30398665
C028577	monobutyl phthalate	[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein	30398665
D016686	Monocrotaline	[TBXA2R protein affects the susceptibility to Monocrotaline] which affects the expression of MMP9 mRNA	31470032
D016686	Monocrotaline	liquiritigenin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein]	29908794
D016686	Monocrotaline	liquiritin inhibits the reaction [Monocrotaline results in increased expression of MMP9 protein]	29908794
D016686	Monocrotaline	[Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein]	27870162
D016686	Monocrotaline	[Monocrotaline co-treated with LGALS3 protein] results in decreased expression of MMP9 protein	27870162
D016686	Monocrotaline	[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein	27870162
D016686	Monocrotaline	Monocrotaline results in increased expression of MMP9 protein	29908794
C406082	monomethylarsonous acid	CXCL8 protein affects the reaction [monomethylarsonous acid results in increased expression of MMP9 mRNA]	22015448
C406082	monomethylarsonous acid	monomethylarsonous acid results in increased expression of MMP9 mRNA	22015448
C517284	monomethyl phthalate	monomethyl phthalate results in increased expression of MMP9 mRNA	26924002
C008548	morin	morin results in decreased expression of MMP9 mRNA	16304905
C008548	morin	morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein]	19539802
D009020	Morphine	[7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein]	20519536
D009020	Morphine	MMP9 protein affects the reaction [Morphine results in increased phosphorylation of GRIN1 protein]	20519536
D009020	Morphine	MMP9 protein affects the reaction [Morphine results in increased phosphorylation of GRIN2B protein]	20519536
D009020	Morphine	MMP9 protein affects the reaction [Morphine results in increased phosphorylation of MAPK1 protein]	20519536
D009020	Morphine	MMP9 protein affects the reaction [Morphine results in increased phosphorylation of MAPK3 protein]	20519536
D009020	Morphine	[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein	20519536
D009020	Morphine	Morphine results in increased activity of MMP9 protein	20519536
C057451	morusin	morusin results in decreased expression of and results in decreased activity of MMP9 protein	25476160
D009151	Mustard Gas	Doxycycline inhibits the reaction [Mustard Gas results in increased activity of MMP9 protein]	15778244
D009151	Mustard Gas	Mustard Gas results in increased activity of MMP9 protein	15778244
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 protein	10330031
D009151	Mustard Gas	Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26082309
D009151	Mustard Gas	Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26082309
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 mRNA	18809459
D009151	Mustard Gas	Mustard Gas results in increased secretion of MMP9 protein	18809459
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 mRNA	16489579; 18955075; 21939433; 25275893;
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 protein	16489579
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 protein	20659490
D009151	Mustard Gas	Mustard Gas results in increased expression of MMP9 mRNA	12481301
C040015	myricetin	myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
C549043	N-2-(4-bromophenyl) ethyl caffeamide	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	20093109
C549043	N-2-(4-bromophenyl) ethyl caffeamide	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [RELA protein binds to MMP9 promoter]	20093109
C549043	N-2-(4-bromophenyl) ethyl caffeamide	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20093109
C549043	N-2-(4-bromophenyl) ethyl caffeamide	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	20093109
C549043	N-2-(4-bromophenyl) ethyl caffeamide	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	20093109
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [anandamide results in increased expression of MMP9 mRNA]	16330497
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Dronabinol results in increased expression of MMP9 mRNA]	16330497
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [HGF results in increased expression of MMP9]	11981761
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [methanandamide results in increased expression of MMP9 mRNA]	16330497
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [methanandamide results in increased expression of MMP9 protein]	16330497
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19804834
C078131	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Zymosan results in increased expression of MMP9 protein]	18557954
C078131	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
C078131	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
C078131	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [4-aminophenylmercuriacetate results in increased secretion of MMP9 protein]	23525277
C492919	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [TNF results in increased expression of MMP9 mRNA]	17560598
C580583	N6L peptide	N6L peptide results in decreased activity of MMP9 protein	23109338
C487056	N-Acetylcysteinamide	N-Acetylcysteinamide results in decreased secretion of MMP9 protein	15147517
D009270	Naloxone	[7-nitroindazole results in decreased activity of NOS1 protein] inhibits the reaction [[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein]	20519536
D009270	Naloxone	[Morphine co-treated with Naloxone] results in increased activity of MMP9 protein	20519536
D000077603	Nandrolone Decanoate	Nandrolone Decanoate results in increased expression of MMP9 mRNA	25542992
D000077603	Nandrolone Decanoate	Taurine inhibits the reaction [Nandrolone Decanoate results in increased expression of MMP9 mRNA]	25542992
D037742	Nanotubes, Carbon	Nanotubes, Carbon results in increased expression of MMP9 mRNA	15585362; 25511174;
D037742	Nanotubes, Carbon	Nanotubes, Carbon affects the expression of MMP9 mRNA	23845593
D037742	Nanotubes, Carbon	Nanotubes, Carbon analog affects the expression of MMP9 mRNA	25554681
D037742	Nanotubes, Carbon	Nanotubes, Carbon analog results in increased expression of MMP9 mRNA	25554681
D037742	Nanotubes, Carbon	Nanotubes, Carbon results in increased expression of MMP9 mRNA	25554681; 30081225;
C031721	naphthalene	naphthalene results in increased expression of MMP9 mRNA	18978301
C073873	naphtho(1,2-b)furan-4,5-dione	[naphtho(1,2-b)furan-4,5-dione inhibits the reaction [EGF protein binds to and results in increased activity of EGFR protein]] which results in decreased expression of MMP9	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [EGF protein results in increased activity of MMP9 protein]	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [RTKI cpd inhibits the reaction [EGF protein results in increased activity of MMP9 protein]]	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [RTKI cpd inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [Wortmannin inhibits the reaction [EGF protein results in increased activity of MMP9 protein]]	23064031
C073873	naphtho(1,2-b)furan-4,5-dione	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [Wortmannin inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	23064031
C495860	naphthol AS-E phosphate	naphthol AS-E phosphate results in decreased expression of MMP9 protein	30394316
C495860	naphthol AS-E phosphate	SREBF2 protein inhibits the reaction [naphthol AS-E phosphate results in decreased expression of MMP9 protein]	30394316
C005273	naringenin	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	25866363
C005273	naringenin	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	25866363
C005273	naringenin	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25866363
C005273	naringenin	naringenin results in decreased expression of and results in decreased activity of MMP9 protein	30431227
C005273	naringenin	naringenin results in decreased expression of MMP9 mRNA	30153467
C005274	naringin	naringin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25866363
C005274	naringin	naringin results in decreased expression of and results in decreased activity of MMP9 protein	26721195
C005274	naringin	naringin inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA]	23603004
C005274	naringin	naringin inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	23603004
C005274	naringin	naringin inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	19810018
C005274	naringin	naringin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	19810018
C005274	naringin	naringin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MMP9 protein]	22985397
C568509	ND 322	ND 322 results in decreased activity of MMP9 protein	21866961
C057222	neferine	FGFR2 protein inhibits the reaction [neferine results in decreased expression of MMP9 protein]	31207222
C057222	neferine	MIR374A mRNA inhibits the reaction [neferine results in decreased expression of MMP9 protein]	31207222
C057222	neferine	neferine results in decreased expression of MMP9 protein	31207222
C010463	n-hexanal	n-hexanal results in increased secretion of MMP9 protein	28947239
D009536	Niacinamide	Niacinamide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D009536	Niacinamide	Niacinamide results in increased expression of MMP9 protein	24962570
D009536	Niacinamide	Resveratrol inhibits the reaction [Niacinamide results in increased expression of MMP9 protein]	24962570
D009532	Nickel	Nickel results in increased activity of MMP9 protein	21401309
D009532	Nickel	Nickel results in increased expression of MMP9 mRNA	21401309; 25583101;
D009532	Nickel	Nickel results in increased expression of MMP9 protein	24840272
D009532	Nickel	tanespimycin affects the reaction [Nickel results in increased activity of MMP9 protein]	21401309
D009532	Nickel	tanespimycin inhibits the reaction [Nickel results in increased expression of MMP9 mRNA]	21401309
D009532	Nickel	TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA]	23503329
D009532	Nickel	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA	23503329
C022838	nickel chloride	nickel chloride results in increased expression of MMP9 mRNA	24612858
C022838	nickel chloride	chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C022838	nickel chloride	ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C022838	nickel chloride	nickel chloride results in increased activity of MMP9 protein	26962057
C022838	nickel chloride	nickel chloride results in increased expression of and results in increased activity of MMP9 protein	30016632
C022838	nickel chloride	nickel chloride results in increased expression of MMP9 protein	21473897
C022838	nickel chloride	Quercetin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C022838	nickel chloride	SC 514 inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
C029938	nickel sulfate	nickel sulfate results in increased expression of and results in increased secretion of MMP9 protein	15020194
C029938	nickel sulfate	nickel sulfate results in increased expression of MMP9 mRNA	18651567
D009534	Niclosamide	Niclosamide results in decreased expression of MMP9 protein	29480568
D009534	Niclosamide	Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MMP9 mRNA]	28824321
D009538	Nicotine	MK-886 inhibits the reaction [Nicotine results in increased expression of MMP9 mRNA]	20061081
D009538	Nicotine	Nicotine results in increased expression of MMP9 mRNA	20061081
D009538	Nicotine	Nicotine results in increased expression of MMP9 protein	14569062
D009538	Nicotine	Nicotine results in decreased expression of MMP9 protein	20448088
D009543	Nifedipine	Nifedipine results in decreased expression of and results in decreased activity of MMP9 protein	18204791
C012655	nimesulide	nimesulide results in decreased expression of MMP9 mRNA	21176579
C012655	nimesulide	nimesulide results in decreased expression of MMP9 protein	21176579
D009569	Nitric Oxide	Nitric Oxide results in increased expression of MMP9 mRNA	20197249
D009578	Nitrobenzenes	Nitrobenzenes analog results in decreased expression of MMP9 mRNA	19784758
D005996	Nitroglycerin	Nitroglycerin results in increased activity of MMP9 protein	12084592
D005996	Nitroglycerin	Nitroglycerin results in increased expression of MMP9 mRNA	12084592
C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Glutathione binds to MMP9 protein]	17015178
C010615	Nonidet P-40	Nonidet P-40 results in decreased expression of MMP9 mRNA	26552463
C025256	nonylphenol	Fulvestrant inhibits the reaction [nonylphenol results in increased expression of MMP9 protein]	25690688
C025256	nonylphenol	nonylphenol results in increased expression of MMP9 protein	25690688
C069741	norcantharidin	norcantharidin results in decreased activity of MMP9 protein	15711181
C069741	norcantharidin	norcantharidin results in decreased expression of and results in decreased activity of MMP9 protein	19616522
C069741	norcantharidin	norcantharidin results in decreased expression of MMP9 mRNA	19616522
C069741	norcantharidin	SP1 protein affects the reaction [norcantharidin results in decreased expression of MMP9 mRNA]	19616522
D009638	Norepinephrine	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D009638	Norepinephrine	Norepinephrine results in increased activity of MMP9 protein	24929186
D009638	Norepinephrine	Norepinephrine results in increased expression of MMP9 mRNA	24929186
D009638	Norepinephrine	Propranolol inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]	24929186
D009638	Norepinephrine	Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D009638	Norepinephrine	quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]	24929186
D009638	Norepinephrine	quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D009638	Norepinephrine	SR 11302 inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D009638	Norepinephrine	tanshinone inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D009638	Norepinephrine	crocetin inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	16864425
D009638	Norepinephrine	Norepinephrine results in increased activity of MMP9 protein	16864425
D009638	Norepinephrine	Norepinephrine results in increased expression of MMP9 mRNA	16864425
C434926	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [AGT protein modified form results in increased expression of MMP9 protein]	30354818
C520337	NSC 74859	NSC 74859 affects the expression of MMP9 protein	25476160
D000077609	O-(Chloroacetylcarbamoyl)fumagillol	[O-(Chloroacetylcarbamoyl)fumagillol co-treated with Docetaxel] results in decreased expression of MMP9 protein	12576464
C025589	ochratoxin A	NFE2L2 protein affects the reaction [ochratoxin A results in increased expression of MMP9 protein]	28710020
C025589	ochratoxin A	ochratoxin A results in increased expression of MMP9 mRNA	28710020
C025589	ochratoxin A	ochratoxin A results in increased expression of MMP9 protein	28710020
C025589	ochratoxin A	Ethanol affects the reaction [ochratoxin A results in increased expression of MMP9 protein]	16622519
C025589	ochratoxin A	ochratoxin A results in increased expression of MMP9 protein	16622519
C002769	oleuropein	oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22595400
C002769	oleuropein	oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
D000069463	Olive Oil	Olive Oil inhibits the reaction [Streptozocin results in increased activity of MMP9 protein]	25246140
D000069463	Olive Oil	Olive Oil results in decreased activity of MMP9 protein	25246140
C507134	ON 01910	ON 01910 affects the expression of MMP9 mRNA	22351695
C046627	osthol	osthol inhibits the reaction [RELA protein binds to MMP9 promoter]	22503731
C046627	osthol	osthol results in decreased activity of and results in decreased expression of MMP9 protein	22503731
C046627	osthol	osthol results in decreased expression of MMP9 mRNA	22503731
D010042	Ouabain	Ouabain results in decreased expression of MMP9 protein	28795476
C432447	ovatodiolide	ovatodiolide results in decreased activity of MMP9 protein	22033475
C432447	ovatodiolide	ovatodiolide results in decreased expression of MMP9 mRNA	22033475
C432447	ovatodiolide	ovatodiolide results in decreased expression of MMP9 protein	22033475
C432447	ovatodiolide	pyrazolanthrone promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
C432447	ovatodiolide	SB 203580 promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
C432447	ovatodiolide	Wortmannin promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
D000077150	Oxaliplatin	[Oxaliplatin co-treated with Topotecan] results in increased expression of MMP9 mRNA	25729387
D000077150	Oxaliplatin	Oxaliplatin results in increased expression of MMP9 mRNA	25729387
D016627	Oxidopamine	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
D016627	Oxidopamine	Acetylcysteine inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
D016627	Oxidopamine	Oxidopamine results in increased expression of MMP9 mRNA	19962414
D016627	Oxidopamine	SB 203580 inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
C029341	oxophenylarsine	oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	10569804
D010100	Oxygen	Oxygen inhibits the reaction [Hydrochloric Acid results in increased expression of MMP9 protein]	18339021
D010100	Oxygen	AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]]	26509796
D010100	Oxygen	genipin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	29630948
D010100	Oxygen	Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26082309
D010100	Oxygen	Mustard Gas inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26082309
D010100	Oxygen	Oxygen deficiency results in increased activity of MMP9 protein	18674879
D010100	Oxygen	Oxygen deficiency results in increased expression of MMP9 mRNA	18674879; 26082309; 26509796;
D010100	Oxygen	Oxygen deficiency results in increased expression of MMP9 protein	26082309; 26509796; 29630948;
D010100	Oxygen	Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	18674879
D010100	Oxygen	trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26509796
D010100	Oxygen	trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26509796
D010100	Oxygen	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein	16806698
D010100	Oxygen	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA	24682241
D010100	Oxygen	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein	24682241
D010100	Oxygen	Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein]	16806698
D010100	Oxygen	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
D010100	Oxygen	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
D010100	Oxygen	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
D010100	Oxygen	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
D010100	Oxygen	2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]]	27274199
D010100	Oxygen	4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	23270704
D010100	Oxygen	4-chlorobenzyltetrahydroberberine inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	23270704
D010100	Oxygen	acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	23270704
D010100	Oxygen	acetovanillone inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	23270704
D010100	Oxygen	Mifepristone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	30229846
D010100	Oxygen	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein	27274199; 30229846;
D010100	Oxygen	Oxygen deficiency results in increased expression of MMP9 mRNA	23270704; 26476374;
D010100	Oxygen	Oxygen deficiency results in increased expression of MMP9 protein	23270704; 26476374;
D010100	Oxygen	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26476374
D010100	Oxygen	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26476374
D010100	Oxygen	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	27274199
D010117	Oxypurinol	Oxypurinol inhibits the reaction [Acrolein results in increased expression of MMP9 protein]	19371603
D010121	Oxytocin	MMP9 protein results in decreased susceptibility to Oxytocin	22496348
D010126	Ozone	Ozone results in increased expression of MMP9 mRNA	27206323
D010126	Ozone	MMP9 gene mutant form promotes the reaction [Ozone results in increased activity of MMP2 protein]	18007984
D010126	Ozone	MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 mRNA]	18007984
D010126	Ozone	MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 protein]	18007984
D010126	Ozone	MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 mRNA]	18007984
D010126	Ozone	MMP9 gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein]	18007984
D010126	Ozone	MMP9 protein results in decreased susceptibility to Ozone	18007984
D010126	Ozone	Ozone results in increased activity of MMP9 protein	12763055; 18007984;
D010126	Ozone	Ozone results in increased expression of MMP9 mRNA	12763055; 18007984;
D010126	Ozone	Ozone results in increased expression of MMP9 protein	18007984
D017239	Paclitaxel	[Cisplatin co-treated with Paclitaxel] results in increased expression of MMP9 mRNA	20705681
D017239	Paclitaxel	Curcumin inhibits the reaction [Paclitaxel results in increased expression of MMP9 protein]	16243823
C508075	Pam(3)CSK(4) peptide	[Pam(3)CSK(4) peptide co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MMP9 mRNA	28806546
C508075	Pam(3)CSK(4) peptide	[Pam(3)CSK(4) peptide co-treated with bisphenol A] results in increased expression of MMP9 mRNA	28806546
C508075	Pam(3)CSK(4) peptide	[Pam(3)CSK(4) peptide co-treated with bisphenol F] results in increased expression of MMP9 mRNA	28806546
C508075	Pam(3)CSK(4) peptide	Pam(3)CSK(4) peptide results in increased expression of MMP9 mRNA	28806546
C519374	Panax notoginseng extract	Panax notoginseng extract analog results in decreased expression of MMP9 protein	18637019
D010269	Paraquat	[CCN2 protein co-treated with Paraquat] affects the expression of MMP9 mRNA	26129822
D010269	Paraquat	Paraquat results in increased expression of MMP9 mRNA	22230393
D010269	Paraquat	ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	25945502
D010269	Paraquat	Dapsone inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	21765237
D010269	Paraquat	naringin inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA]	23603004
D010269	Paraquat	naringin inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	23603004
D010269	Paraquat	Paraquat results in increased expression of MMP9 mRNA	17215068; 23603004;
D010269	Paraquat	Paraquat results in increased expression of MMP9 protein	21765237; 23603004; 25945502; 26758514; 26988026;
D010269	Paraquat	plant extract, Puerariae Radix inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	26758514
D010269	Paraquat	Losartan inhibits the reaction [Paraquat results in increased expression of MMP9 mRNA]	25233898
D010269	Paraquat	Paraquat results in increased expression of MMP9 mRNA	18630695; 21468558; 25233898; 25873302;
D010269	Paraquat	Paraquat results in increased expression of MMP9 protein	18630695; 21468558;
C002669	parthenolide	parthenolide inhibits the reaction [RELA protein binds to MMP9 promoter]	20093109
D052638	Particulate Matter	Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]	26179980
D052638	Particulate Matter	Glucose promotes the reaction [Particulate Matter results in increased expression of MMP9 mRNA]	26179980
D052638	Particulate Matter	Particulate Matter results in increased activity of MMP9 protein	26179980
D052638	Particulate Matter	Particulate Matter results in increased expression of MMP9 mRNA	26179980; 28341207; 28846189;
D052638	Particulate Matter	SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]]	26179980
D052638	Particulate Matter	Particulate Matter promotes the reaction [FOSL1 protein binds to MMP9 promoter]	14565943
D052638	Particulate Matter	Particulate Matter results in decreased expression of MMP9 protein	30698894
D052638	Particulate Matter	Particulate Matter results in increased expression of MMP9 mRNA	14565943
D052638	Particulate Matter	Vitamin D inhibits the reaction [Particulate Matter results in decreased expression of MMP9 protein]	30698894
D052638	Particulate Matter	Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]	19505525
D052638	Particulate Matter	Particulate Matter results in increased activity of MMP9 protein	19505525
D052638	Particulate Matter	2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]	24192212
D052638	Particulate Matter	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in increased expression of MMP9 protein]]	24192212
D052638	Particulate Matter	hydroxysafflor yellow A inhibits the reaction [Particulate Matter results in increased expression of MMP9 protein]	24192212
D052638	Particulate Matter	Particulate Matter results in increased expression of MMP9 protein	24192212
C410127	PCB 180	PCB 180 affects the expression of MMP9 mRNA	21703328
C410127	PCB 180	PCB 180 results in decreased expression of MMP9 mRNA	26238599
C086401	pentabromodiphenyl ether	pentabromodiphenyl ether results in increased expression of MMP9 mRNA	23948077
D010426	Pentosan Sulfuric Polyester	Pentosan Sulfuric Polyester results in increased expression of MMP9	10968687
C539348	perfluorobutanesulfonic acid	perfluorobutanesulfonic acid results in increased expression of MMP9 mRNA	30239974
C076994	perfluorooctane sulfonic acid	ATF2 protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of MMP9 protein]	27818224
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of MMP9 protein	27818224
C076994	perfluorooctane sulfonic acid	SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of MMP9 protein]	27818224
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased activity of MMP9 protein	28973641
C023036	perfluorooctanoic acid	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of and results in increased activity of MMP9 protein]	24960061
C023036	perfluorooctanoic acid	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 mRNA]	24960061; 29753068;
C023036	perfluorooctanoic acid	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 protein]	29753068
C023036	perfluorooctanoic acid	perfluorooctanoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	21075133
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of and results in increased activity of MMP9 protein	24960061
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of MMP9 mRNA	24960061; 29753068;
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of MMP9 protein	29753068
C023036	perfluorooctanoic acid	PPARA protein affects the reaction [perfluorooctanoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]]	21075133
C023036	perfluorooctanoic acid	U 0126 inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 mRNA]	29753068
C023036	perfluorooctanoic acid	U 0126 inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 protein]	29753068
D020913	Perindopril	Perindopril inhibits the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]	16097048
D010618	Phenanthrolines	Phenanthrolines results in decreased activity of MMP9 protein	14662518
C058305	phenethyl isothiocyanate	phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	23724058
D010656	Phenylephrine	1-Butanol inhibits the reaction [Phenylephrine results in increased activity of MMP9 protein]	18539131
D010656	Phenylephrine	Phenylephrine results in increased activity of MMP9 protein	18539131
D010656	Phenylephrine	SLC9A1 protein affects the reaction [Phenylephrine results in increased activity of MMP9 protein]	18539131
D010656	Phenylephrine	Phenylephrine results in increased expression of MMP9 mRNA	16574429
D015240	Phorbol 12,13-Dibutyrate	Phorbol 12,13-Dibutyrate results in increased activity of MMP9 protein	14593496
D015240	Phorbol 12,13-Dibutyrate	Quercetin inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased activity of MMP9 protein]	14593496
D010705	Phosgene	Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 mRNA]	21941784
D010705	Phosgene	Dexamethasone inhibits the reaction [Phosgene results in increased expression of MMP9 protein]	21941784
D010705	Phosgene	Phosgene results in increased expression of MMP9 mRNA	21941784
D010705	Phosgene	Phosgene results in increased expression of MMP9 protein	21941784
D064801	Phospholipase A2 Inhibitors	Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	19765281
D064801	Phospholipase A2 Inhibitors	Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein]	19765281
D064801	Phospholipase A2 Inhibitors	Phospholipase A2 Inhibitors results in decreased expression of MMP9 mRNA	19765281
D064209	Phytochemicals	Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	25980589
D064209	Phytochemicals	Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	25980589
D010862	Pilocarpine	Pilocarpine results in increased activity of MMP9 protein	19631748
D010862	Pilocarpine	Pilocarpine results in increased expression of MMP9 protein	19631748
C004479	pimagedine	pimagedine inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	18594475
C008911	pimaric acid	pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]	22705379
C008911	pimaric acid	pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	22705379
D000077205	Pioglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
D000077205	Pioglitazone	Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	17055343
D000077205	Pioglitazone	Pioglitazone results in decreased expression of MMP9 mRNA	30031879
D000077205	Pioglitazone	Pioglitazone results in decreased secretion of MMP9 protein	16860414
C008922	piperine	piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21354279
C008922	piperine	piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	21354279
C008922	piperine	piperine results in decreased expression of MMP9 protein	15531295
C000121	pipoxolan	pipoxolan results in decreased expression of and results in decreased activity of MMP9 protein	25899827
C442842	plant extract, Puerariae Radix	plant extract, Puerariae Radix inhibits the reaction [Paraquat results in increased expression of MMP9 protein]	26758514
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	22634262
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22634262; 30259628;
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30259628
D010936	Plant Extracts	Plant Extracts inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	18841906; 25019995;
D010936	Plant Extracts	Plant Extracts results in decreased activity of MMP9 protein	22144737
D010936	Plant Extracts	Plant Extracts results in decreased expression of and results in decreased activity of MMP9 protein	23955962
D010936	Plant Extracts	Plant Extracts results in decreased secretion of and results in decreased expression of MMP9 protein	20670616
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	21554007
D010936	Plant Extracts	Plant Extracts inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	19401153
D010936	Plant Extracts	Plant Extracts results in decreased activity of MMP9 protein	22144737; 25882088;
D010936	Plant Extracts	Plant Extracts results in decreased expression of MMP9 mRNA	23232078
D010936	Plant Extracts	Plant Extracts affects the expression of and affects the activity of MMP9 protein	18097624
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	27098997
C108953	platycodin D	platycodin D results in decreased activity of MMP9 protein	23867902
C108953	platycodin D	platycodin D results in decreased expression of MMP9 mRNA	23867902
C108953	platycodin D	platycodin D results in decreased expression of MMP9 protein	29595072
C088327	plerixafor octahydrochloride	plerixafor octahydrochloride inhibits the reaction [Colforsin results in increased expression of MMP9 mRNA]	24784705
C060540	polyhexamethyleneguanidine	polyhexamethyleneguanidine results in increased expression of MMP9 mRNA	25716161
D011070	Poly I-C	[Poly I-C co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MMP9 mRNA	28806546
D011070	Poly I-C	[Poly I-C co-treated with bisphenol A] results in increased expression of MMP9 mRNA	28806546
D000077182	Polylactic Acid-Polyglycolic Acid Copolymer	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D000077182	Polylactic Acid-Polyglycolic Acid Copolymer	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
C113831	poly-N-acetyl glucosamine	poly-N-acetyl glucosamine results in increased expression of MMP9 mRNA	19638916
D011134	Polysaccharides	Polysaccharides results in decreased activity of MMP9 protein	25882088
D017035	Pravastatin	Pravastatin results in decreased activity of MMP9 protein	16935385
D017035	Pravastatin	Pravastatin results in decreased expression of MMP9 mRNA	16935385
D011239	Prednisolone	Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
C023617	pregna-4,17-diene-3,16-dione	pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	15322087
D011285	Pregnenolone Carbonitrile	Pregnenolone Carbonitrile results in decreased expression of MMP9 mRNA	22698814
C009043	pristimerin	pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	30588110
C009043	pristimerin	pristimerin inhibits the reaction [Doxorubicin results in increased expression of MMP9 protein]	30588110
D011341	Probucol	Probucol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	17964422
D011341	Probucol	Probucol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	17964422
D011341	Probucol	Probucol inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	17964422
D011374	Progesterone	[Progesterone co-treated with Estradiol] results in decreased expression of MMP9 mRNA	17404688
D011374	Progesterone	[Progesterone co-treated with Estradiol] results in increased expression of MMP9 mRNA	20226447
D011374	Progesterone	[Progesterone co-treated with Triclosan] results in increased expression of MMP9 mRNA	26604029
D011374	Progesterone	Progesterone inhibits the reaction [IL1B protein results in increased expression of MMP9 protein modified form]	22219637
D011374	Progesterone	Progesterone results in increased expression of MMP9 mRNA	20226447; 26604029;
D011374	Progesterone	Progesterone affects the expression of MMP9 mRNA	21291521
D011374	Progesterone	Progesterone inhibits the reaction [Estradiol results in increased expression of MMP9 mRNA]	19416213
D011374	Progesterone	Progesterone results in increased expression of MMP9 mRNA	21770760
C066229	prolinedithiocarbamate	prolinedithiocarbamate affects the expression of MMP9 protein	25476160
C066229	prolinedithiocarbamate	prolinedithiocarbamate inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	24613819
C066229	prolinedithiocarbamate	prolinedithiocarbamate inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	24613819
C066229	prolinedithiocarbamate	prolinedithiocarbamate promotes the reaction [butein results in decreased expression of MMP9 protein]	20696233
C066229	prolinedithiocarbamate	prolinedithiocarbamate results in decreased expression of MMP9 protein	27279714
C066229	prolinedithiocarbamate	Quercetin promotes the reaction [prolinedithiocarbamate results in decreased expression of MMP9 protein]	27279714
D011433	Propranolol	DLL4 protein inhibits the reaction [Propranolol results in decreased expression of MMP9 protein]	30130526
D011433	Propranolol	Propranolol inhibits the reaction [Isoproterenol results in increased expression of MMP9 mRNA]	16574429
D011433	Propranolol	Propranolol inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]	24929186
D011433	Propranolol	Propranolol inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D011433	Propranolol	Propranolol results in decreased expression of MMP9	21042766
D011433	Propranolol	Propranolol results in decreased expression of MMP9 mRNA	20424515
D011433	Propranolol	Propranolol results in decreased expression of MMP9 protein	20424515; 30130526;
D011433	Propranolol	Propranolol results in decreased secretion of MMP9 protein	20424515
D011441	Propylthiouracil	Propylthiouracil results in decreased expression of MMP9 mRNA	24780913
D011480	Protease Inhibitors	Protease Inhibitors inhibits the reaction [MMP9 protein results in increased degradation of ITGB1 protein]	19631748
D047428	Protein Kinase Inhibitors	[Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
D047428	Protein Kinase Inhibitors	[Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
D011500	Protein Synthesis Inhibitors	[[Aptamers, Nucleotide binds to Chitin] which binds to MUC1 protein] promotes the reaction [[Protein Synthesis Inhibitors binds to Chitin] which results in decreased expression of MMP9 mRNA]	30041514
D011500	Protein Synthesis Inhibitors	[Protein Synthesis Inhibitors binds to Chitin] which results in decreased expression of MMP9 mRNA	30041514
D011509	Proteoglycans	Proteoglycans affects the secretion of MMP9 protein	14511379
C456319	PS1145	PS1145 inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	24613819
C456319	PS1145	PS1145 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	24613819
C043680	ptaquiloside	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA	23274088
C043680	ptaquiloside	ptaquiloside results in decreased expression of MMP9 mRNA	23274088
C586999	PTC-209	[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of MMP9 mRNA	31023824
C107773	pterostilbene	pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19447859
C107773	pterostilbene	pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19447859
C107773	pterostilbene	pterostilbene results in decreased activity of MMP9 protein	19617202
C107773	pterostilbene	pterostilbene results in decreased expression of MMP9 mRNA	20152895
C107773	pterostilbene	pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein]	20681671
C107773	pterostilbene	pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 mRNA]	19617202
C107773	pterostilbene	pterostilbene inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein]	19617202
C526689	punarnavine	punarnavine results in decreased activity of MMP9 protein	24060680
C526689	punarnavine	punarnavine results in decreased expression of MMP9 mRNA	19171408
C526689	punarnavine	punarnavine results in decreased expression of MMP9 protein	19171408
C432165	pyrazolanthrone	pyrazolanthrone affects the reaction [TNF protein results in increased expression of MMP9 protein]	22926441
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein]	26807887
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]	28722351
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Resveratrol results in decreased expression of MMP9]	24841706
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30133131
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30133131
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]	27060453
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]	22705379
C432165	pyrazolanthrone	pyrazolanthrone promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
C432165	pyrazolanthrone	pyrazolanthrone results in decreased activity of MMP9 protein	22033475
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C432165	pyrazolanthrone	pyrazolanthrone promotes the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
C432165	pyrazolanthrone	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
C030984	pyrene	pyrene results in decreased expression of MMP9 mRNA	15963578
C020972	pyrrolidine dithiocarbamic acid	pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased activity of MMP9 protein]	16340751
C020972	pyrrolidine dithiocarbamic acid	pyrrolidine dithiocarbamic acid inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	16340751
C020972	pyrrolidine dithiocarbamic acid	pyrrolidine dithiocarbamic acid results in decreased activity of MMP9 protein	22033475
C020972	pyrrolidine dithiocarbamic acid	pyrrolidine dithiocarbamic acid results in decreased expression of MMP9 mRNA	23566884
D011765	Pyruvaldehyde	Pyruvaldehyde results in increased expression of MMP9 protein	28760545
D011765	Pyruvaldehyde	[TNFSF11 protein co-treated with Pyruvaldehyde co-treated with bergenin] results in decreased expression of MMP9 mRNA	31369791
D011794	Quercetin	Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of MMP9 mRNA]	24802026
D011794	Quercetin	Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of MMP9 mRNA]	24802026
D011794	Quercetin	Quercetin analog inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased expression of MMP9 mRNA]	24802026
D011794	Quercetin	Quercetin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein]	15135307
D011794	Quercetin	Quercetin inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	22871832
D011794	Quercetin	Quercetin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
D011794	Quercetin	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D011794	Quercetin	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248
D011794	Quercetin	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	18628248; 22595400;
D011794	Quercetin	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
D011794	Quercetin	Quercetin inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	12589822
D011794	Quercetin	Quercetin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	12589822
D011794	Quercetin	Quercetin promotes the reaction [prolinedithiocarbamate results in decreased expression of MMP9 protein]	27279714
D011794	Quercetin	Quercetin promotes the reaction [TLR4 protein affects the expression of MMP9 protein]	27279714
D011794	Quercetin	Quercetin results in decreased activity of MMP9 protein	22871832
D011794	Quercetin	Quercetin results in decreased expression of and results in decreased activity of MMP9 protein	23645742
D011794	Quercetin	Quercetin results in decreased expression of and results in decreased secretion of MMP9 protein	22871832
D011794	Quercetin	Quercetin results in decreased expression of MMP9 mRNA	22871832
D011794	Quercetin	Quercetin results in decreased expression of MMP9 protein	25481090; 27279714;
D011794	Quercetin	Quercetin results in decreased secretion of MMP9 protein	15135307
D011794	Quercetin	Quercetin results in increased expression of MMP9 protein	10556937
D011794	Quercetin	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 mRNA]	21294050
D011794	Quercetin	Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	21294050
D011794	Quercetin	Doxorubicin inhibits the reaction [Quercetin results in decreased activity of MMP9 protein]	14593496
D011794	Quercetin	Quercetin inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein]	24337353
D011794	Quercetin	Quercetin inhibits the reaction [Calcium Chloride results in increased expression of MMP9 mRNA]	22728078
D011794	Quercetin	Quercetin inhibits the reaction [Calcium Chloride results in increased expression of MMP9 protein]	22728078
D011794	Quercetin	Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of MMP9 mRNA]	22915297
D011794	Quercetin	Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased activity of MMP9 protein]	16806698
D011794	Quercetin	Quercetin inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased activity of MMP9 protein]	14593496
D011794	Quercetin	Quercetin inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	19401153
D011794	Quercetin	Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]	19495926
D011794	Quercetin	Quercetin results in decreased activity of MMP9 protein	14593496; 24275163;
D011794	Quercetin	Quercetin results in decreased expression of MMP9 mRNA	16304905; 24275163;
D011794	Quercetin	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D011794	Quercetin	[Quercetin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer] inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
D011794	Quercetin	Quercetin inhibits the reaction [Ethanol results in increased expression of and results in increased activity of MMP9 protein]	22257724
D011794	Quercetin	Quercetin inhibits the reaction [Ethanol results in increased secretion of MMP9 protein]	22257724
D011794	Quercetin	Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523; 16647178;
D011794	Quercetin	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26476374
D011794	Quercetin	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26476374
D011794	Quercetin	Quercetin promotes the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]	22989100
D011794	Quercetin	Quercetin promotes the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	22989100
C443401	quercetin 3-O-glucuronide	quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased activity of MMP9 protein]	24929186
C443401	quercetin 3-O-glucuronide	quercetin 3-O-glucuronide inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D019257	Quinpirole	Quinpirole results in decreased secretion of MMP9 protein	27920206
D020849	Raloxifene Hydrochloride	Raloxifene Hydrochloride results in decreased activity of MMP9 protein	17582780
D020849	Raloxifene Hydrochloride	Raloxifene Hydrochloride results in decreased expression of MMP9 mRNA	17582780
D020849	Raloxifene Hydrochloride	Raloxifene Hydrochloride results in increased expression of MMP9 mRNA	22841776
D011899	Ranitidine	Ranitidine inhibits the reaction [Ethanol results in increased secretion of and results in increased activity of MMP9 protein]	17603938
D011899	Ranitidine	Ranitidine inhibits the reaction [Indomethacin results in increased expression of MMP9 protein]	29523851
D011929	Razoxane	Razoxane inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
D017382	Reactive Oxygen Species	Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D017382	Reactive Oxygen Species	Reactive Oxygen Species affects the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
C559147	regorafenib	regorafenib results in decreased expression of MMP9 protein	30801954
D000077185	Resveratrol	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in increased expression of and results in increased activity of MMP9 protein]	23229870
D000077185	Resveratrol	2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol affects the expression of MMP9 protein]	17007354
D000077185	Resveratrol	2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
D000077185	Resveratrol	3-methyladenine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	ATG5 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	BECN1 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	Gefitinib promotes the reaction [Resveratrol inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]	23127547
D000077185	Resveratrol	Gefitinib promotes the reaction [Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
D000077185	Resveratrol	[Glucose co-treated with Resveratrol] results in decreased expression of MMP9 mRNA	24064760
D000077185	Resveratrol	Niacinamide inhibits the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	pyrazolanthrone inhibits the reaction [Resveratrol results in decreased expression of MMP9]	24841706
D000077185	Resveratrol	Resveratrol affects the expression of MMP9 protein	17007354
D000077185	Resveratrol	Resveratrol inhibits the reaction [2,2'-Dipyridyl results in increased activity of MMP9 protein]	18674879
D000077185	Resveratrol	Resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of MMP9 protein]	24895526
D000077185	Resveratrol	Resveratrol inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]	23127547
D000077185	Resveratrol	Resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
D000077185	Resveratrol	Resveratrol inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
D000077185	Resveratrol	Resveratrol inhibits the reaction [HMOX1 protein results in increased expression of MMP9 protein]	20461740
D000077185	Resveratrol	Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	26497626
D000077185	Resveratrol	Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]	23127547
D000077185	Resveratrol	Resveratrol inhibits the reaction [Niacinamide results in increased expression of MMP9 protein]	24962570
D000077185	Resveratrol	Resveratrol inhibits the reaction [NRG1 protein alternative form results in increased expression of MMP9 protein]	17651959
D000077185	Resveratrol	Resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	18674879
D000077185	Resveratrol	Resveratrol inhibits the reaction [Temozolomide results in decreased expression of MMP9 protein]	22530672
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]	19371443
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA]	19371443
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	17055343
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22523472; 22595400; 22696189;
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	22696189
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22523472; 22595400;
D000077185	Resveratrol	Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA]	23992306
D000077185	Resveratrol	Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of MMP9 protein]	23992306; 25884904;
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	23257246
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]	16317118
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	16317118
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	24145604
D000077185	Resveratrol	Resveratrol promotes the reaction [Gefitinib inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]]	23127547
D000077185	Resveratrol	Resveratrol promotes the reaction [Gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of MMP9 mRNA]]	23127547
D000077185	Resveratrol	Resveratrol results in decreased activity of MMP9 protein	15688415; 17935668;
D000077185	Resveratrol	Resveratrol results in decreased expression of and results in decreased activity of MMP9 protein	14627504; 17049120; 18674879;
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9	21238464; 24841706;
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9 mRNA	14627504; 17935668; 18334147; 18674879; 23992306; 27064016;
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9 protein	16490592; 18334147; 21209944; 23992306; 25936406; 26310874; 26911335; 26959057; 27064016;
D000077185	Resveratrol	[Resveratrol results in decreased expression of [RELA co-treated with FOS]] which results in decreased expression of MMP9	21238464
D000077185	Resveratrol	Resveratrol results in decreased secretion of MMP9 protein	18674879
D000077185	Resveratrol	Resveratrol results in increased expression of and results in increased activity of MMP9 protein	23229870
D000077185	Resveratrol	[Resveratrol results in increased expression of SIRT1] which results in decreased expression of MMP9	21238464
D000077185	Resveratrol	Resveratrol results in increased secretion of MMP9 protein	22314268
D000077185	Resveratrol	SB 203580 promotes the reaction [Resveratrol results in decreased expression of MMP9]	24841706
D000077185	Resveratrol	SB 203580 promotes the reaction [Resveratrol results in increased expression of and results in increased activity of MMP9 protein]	23229870
D000077185	Resveratrol	SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	24145604
D000077185	Resveratrol	SIRT1 protein affects the reaction [Resveratrol results in decreased expression of MMP9 protein]	26959057
D000077185	Resveratrol	[SU 1498 results in decreased activity of KDR protein] inhibits the reaction [Resveratrol results in increased secretion of MMP9 protein]	22314268
D000077185	Resveratrol	[Resveratrol co-treated with Glucose] results in decreased activity of MMP9 protein	24659233
D000077185	Resveratrol	Resveratrol inhibits the reaction [Calcium Chloride results in increased activity of MMP9 protein]	21530968
D000077185	Resveratrol	Resveratrol inhibits the reaction [Croton Oil results in increased expression of MMP9 protein]	14515793
D000077185	Resveratrol	Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased secretion of MMP9 protein]	23625030
D000077185	Resveratrol	Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	23625030
D000077185	Resveratrol	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
D000077185	Resveratrol	Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	22069489
D000077185	Resveratrol	Resveratrol results in decreased expression of and results in decreased activity of MMP9 protein	16321402
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9 mRNA	16304905; 16321402;
D000077185	Resveratrol	SIRT1 mutant form inhibits the reaction [Resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 protein]]	23625030
D000077185	Resveratrol	SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]	22069489
D000077185	Resveratrol	[Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	26497626
D000077185	Resveratrol	Leuprolide inhibits the reaction [Resveratrol results in decreased expression of MMP9 protein]	25462211
D000077185	Resveratrol	Resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]	15734790
D000077185	Resveratrol	Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]	12208745
D000077185	Resveratrol	Resveratrol inhibits the reaction [Leuprolide results in decreased expression of MMP9 protein]	25462211
D000077185	Resveratrol	Resveratrol inhibits the reaction [manganese chloride results in increased expression of and results in increased secretion of MMP9 protein]	23811825
D000077185	Resveratrol	Resveratrol inhibits the reaction [manganese chloride results in increased expression of MMP9 mRNA]	23811825
D000077185	Resveratrol	Resveratrol inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]	22191573
D000077185	Resveratrol	Resveratrol results in decreased activity of MMP9 protein	21962734
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9 mRNA	19228061; 22552115; 23075401;
D000077185	Resveratrol	Resveratrol results in decreased expression of MMP9 protein	25462211
D000077185	Resveratrol	[FLT1 protein results in decreased activity of VEGFA protein] inhibits the reaction [Resveratrol results in increased secretion of MMP9 protein]	22314268
D000077185	Resveratrol	Resveratrol affects the expression of MMP9	24066520
D000077185	Resveratrol	[Resveratrol co-treated with Curcumin] inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	19889203
D000077185	Resveratrol	Resveratrol inhibits the reaction [EGF protein results in increased expression of and results in increased secretion of MMP9 protein]	21942447
D000077185	Resveratrol	Resveratrol inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	18606398; 22936809;
D000077185	Resveratrol	Resveratrol inhibits the reaction [RELA protein binds to MMP9 promoter]	24894401
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	14661062
D000077185	Resveratrol	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	14661062
D000077185	Resveratrol	Resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9]	17988825
D000077185	Resveratrol	Resveratrol results in decreased activity of MMP9 protein	24894401
D000077185	Resveratrol	[Resveratrol results in decreased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP9]	24429678
D000077185	Resveratrol	TNFSF10 protein promotes the reaction [Resveratrol results in decreased expression of MMP9 protein]	21209944
C014794	retinol palmitate	retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein]	17164434
C014794	retinol palmitate	retinol palmitate promotes the reaction [RARA protein binds to MMP9 protein]	17164434
C014794	retinol palmitate	retinol palmitate results in increased expression of MMP9 mRNA	17164434
D012256	Riboflavin	Riboflavin analog results in increased activity of MMP9 protein	20688149
D012256	Riboflavin	Riboflavin results in increased activity of MMP9 protein	20688149
C453902	Ro 28-2653	Ro 28-2653 results in decreased activity of MMP9 protein	16178123
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21454668
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21454668
D000077154	Rosiglitazone	Rosiglitazone results in decreased expression of MMP9 mRNA	20021931
D000077154	Rosiglitazone	Rosiglitazone results in decreased secretion of MMP9 protein	20021931
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [sephadex results in increased expression of MMP9 mRNA]	25878373
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [Streptozocin deficiency results in increased expression of MMP9 mRNA]	19236438
D000077154	Rosiglitazone	Rosiglitazone results in decreased activity of MMP9 protein	19201691
D000077154	Rosiglitazone	GSK3B affects the reaction [Rosiglitazone inhibits the reaction [TNF protein results in increased activity of MMP9 protein]]	19201691
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [AGT protein results in increased expression of MMP9 mRNA]	19451898
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [AGT protein results in increased expression of MMP9 protein]	19451898
D000077154	Rosiglitazone	Rosiglitazone inhibits the reaction [TNF protein results in increased activity of MMP9 protein]	19201691
D000077154	Rosiglitazone	TLR4 mRNA affects the reaction [Rosiglitazone inhibits the reaction [AGT protein results in increased expression of MMP9 protein]]	19451898
C041376	rosmarinic acid	rosmarinic acid results in decreased expression of MMP9 mRNA	28789951
C041376	rosmarinic acid	rosmarinic acid results in decreased expression of MMP9 protein	28789951
D012402	Rotenone	Rotenone inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D012402	Rotenone	Rotenone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of MMP9 protein]	30857887
C085746	rottlerin	rottlerin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	15557194
D012406	Roxarsone	Roxarsone results in increased expression of MMP9 mRNA	22952646
D012406	Roxarsone	Roxarsone results in increased expression of MMP9 protein	22952646
C101044	RTKI cpd	RTKI cpd inhibits the reaction [Acrolein results in increased expression of MMP9 mRNA]	18006877
C101044	RTKI cpd	RTKI cpd inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]	25312822
C101044	RTKI cpd	RTKI cpd inhibits the reaction [Cadmium results in increased expression of MMP9 mRNA]	26514923
C101044	RTKI cpd	RTKI cpd inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein]	23462309
C101044	RTKI cpd	RTKI cpd inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C101044	RTKI cpd	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [RTKI cpd inhibits the reaction [EGF protein results in increased activity of MMP9 protein]]	23064031
C101044	RTKI cpd	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [RTKI cpd inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	23064031
C101044	RTKI cpd	RTKI cpd inhibits the reaction [EGF protein results in increased activity of MMP9 protein]	23064031
C101044	RTKI cpd	RTKI cpd inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	23064031
C000589029	RU24858	RU24858 inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]	15963473
C000589029	RU24858	RU24858 inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	15963473
C085917	RU 43044	RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]]	15963473
C085917	RU 43044	RU 43044 inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]]	15963473
D012431	Rutin	Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	29743444
D012431	Rutin	Rutin inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	29743444
D012431	Rutin	Rutin results in decreased expression of MMP9 mRNA	16304905
C503948	S 3304	S 3304 results in decreased activity of MMP9 protein	15968885
C010327	salinomycin	salinomycin results in decreased secretion of MMP9 protein	28395993
C005705	sanguinarine	sanguinarine results in decreased expression of MMP9 mRNA	19063874
C005705	sanguinarine	sanguinarine results in decreased expression of MMP9 protein	19063874
D012503	Saponins	Saponins results in decreased expression of MMP9 mRNA	29148169
D012503	Saponins	Saponins analog results in decreased expression of MMP9 protein	18637019
C528847	sargahydroquinoic acid	sargahydroquinoic acid inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	25019995
C093642	SB 203580	SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
C093642	SB 203580	SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
C093642	SB 203580	SB 203580 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C093642	SB 203580	SB 203580 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C093642	SB 203580	SB 203580 inhibits the reaction [Glucose promotes the reaction [Air Pollutants results in increased activity of MMP9 protein]]	26179980
C093642	SB 203580	SB 203580 inhibits the reaction [Glucose promotes the reaction [Particulate Matter results in increased activity of MMP9 protein]]	26179980
C093642	SB 203580	SB 203580 inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein]	26807887
C093642	SB 203580	SB 203580 inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]	15728660
C093642	SB 203580	SB 203580 inhibits the reaction [Oxidopamine results in increased expression of MMP9 mRNA]	19962414
C093642	SB 203580	SB 203580 inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C093642	SB 203580	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
C093642	SB 203580	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
C093642	SB 203580	SB 203580 inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]	27060453
C093642	SB 203580	SB 203580 inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]	22705379
C093642	SB 203580	SB 203580 promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
C093642	SB 203580	SB 203580 promotes the reaction [Resveratrol results in decreased expression of MMP9]	24841706
C093642	SB 203580	SB 203580 promotes the reaction [Resveratrol results in increased expression of and results in increased activity of MMP9 protein]	23229870
C093642	SB 203580	SB 203580 results in decreased activity of MMP9 protein	22033475
C093642	SB 203580	SB 203580 results in decreased expression of MMP9 mRNA	27829220
C093642	SB 203580	SB 203580 results in decreased expression of MMP9 protein	30801954
C093642	SB 203580	SB 203580 inhibits the reaction [Leukotriene B4 results in increased expression of MMP9 protein]	19837106
C093642	SB 203580	SB 203580 inhibits the reaction [Leukotriene C4 results in increased expression of MMP9 protein]	19837106
C093642	SB 203580	SB 203580 inhibits the reaction [Leukotriene D4 results in increased expression of MMP9 protein]	19837106
C093642	SB 203580	SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of MMP9 protein]	27818224
C093642	SB 203580	SB 203580 results in decreased activity of MMP9 protein	15657063
C093642	SB 203580	SB 203580 results in decreased expression of MMP9 mRNA	15657063
C093642	SB 203580	SB 203580 inhibits the reaction [Doxorubicin results in increased activity of MMP9 protein]	16213474
C093642	SB 203580	SB 203580 inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	16213474
C093642	SB 203580	SB 203580 inhibits the reaction [gadolinium chloride results in increased expression of MMP9 mRNA]	12493575
C093642	SB 203580	SB 203580 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]	16683234
C093642	SB 203580	SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234
C093642	SB 203580	SB 203580 inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
C093642	SB 203580	SB 203580 promotes the reaction [U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
C093642	SB 203580	U 0126 promotes the reaction [SB 203580 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
C093642	SB 203580	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
C112019	SB 225002	SB 225002 inhibits the reaction [CXCL1 protein results in increased secretion of MMP9 protein]	15831558
C112019	SB 225002	SB 225002 inhibits the reaction [CXCL8 protein results in increased secretion of MMP9 protein]	15831558
C429533	SB 3CT compound	SB 3CT compound inhibits the reaction [PLAU protein results in increased activity of MMP9 protein]	20177776
C429533	SB 3CT compound	SB 3CT compound inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
C429533	SB 3CT compound	SB 3CT compound inhibits the reaction [methylmercuric chloride results in increased expression of MMP9 protein]	28526320
C429533	SB 3CT compound	SB 3CT compound results in decreased activity of MMP9 protein	22496348; 29228391;
C477523	SC 514	SC 514 inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein]	30016632
D012643	Selenium	Selenium results in decreased expression of MMP9 mRNA	17390030
C025614	sephadex	Dexamethasone inhibits the reaction [sephadex results in increased expression of MMP9 mRNA]	25878373
C025614	sephadex	Rosiglitazone inhibits the reaction [sephadex results in increased expression of MMP9 mRNA]	25878373
C025614	sephadex	sephadex results in increased expression of MMP9 mRNA	25878373
C040115	shogaol	shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	23899529
C040115	shogaol	shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	23899529
D012825	Silicon	[Silicon co-treated with Silicon Dioxide] results in increased activity of MMP9 protein	26079203
D012825	Silicon	[Silicon co-treated with Silicon Dioxide] results in increased expression of MMP9 mRNA	26079203
D012822	Silicon Dioxide	[Silicon co-treated with Silicon Dioxide] results in increased activity of MMP9 protein	26079203
D012822	Silicon Dioxide	[Silicon co-treated with Silicon Dioxide] results in increased expression of MMP9 mRNA	26079203
D012822	Silicon Dioxide	fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA]	22931364
D012822	Silicon Dioxide	Silicon Dioxide results in increased expression of MMP9 mRNA	22931364
D012822	Silicon Dioxide	Silicon Dioxide results in decreased expression of MMP9 protein	30698894
D012822	Silicon Dioxide	Vitamin D inhibits the reaction [Silicon Dioxide results in decreased expression of MMP9 protein]	30698894
D012822	Silicon Dioxide	Silicon Dioxide results in increased expression of MMP9 mRNA	21602193
D018030	Silver Compounds	Silver Compounds results in increased expression of MMP9 mRNA	30096344
D000077385	Silybin	[Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP9 mRNA	21969006
D000077385	Silybin	[Silybin co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein	21969006
D000077385	Silybin	Silybin results in decreased activity of MMP9 protein	21969006
D000077385	Silybin	Silybin results in decreased expression of MMP9 mRNA	21969006
D000077385	Silybin	Silybin inhibits the reaction [Mechlorethamine results in increased expression of MMP9 protein]	29174984
D012839	Simazine	Simazine results in decreased expression of MMP9 mRNA	22984576; 27431321;
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]]	15728660
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]	15728660
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	15728660
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
D019821	Simvastatin	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]]	15728660
D019821	Simvastatin	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
D019821	Simvastatin	Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased expression of MMP9 mRNA]	15728660
D019821	Simvastatin	Simvastatin inhibits the reaction [[IL1A co-treated with PDGFB] results in increased secretion of MMP9 protein]	15728660
D019821	Simvastatin	Simvastatin inhibits the reaction [IL1B protein results in increased activity of MMP9 protein]	31260663
D019821	Simvastatin	Simvastatin inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	31260663
D019821	Simvastatin	Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	18625914
D019821	Simvastatin	Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	17038636
D019821	Simvastatin	Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	15728660
D019821	Simvastatin	Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
D019821	Simvastatin	Simvastatin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	17277159
D019821	Simvastatin	Simvastatin inhibits the reaction [TNF results in increased secretion of MMP9 protein]	15537504; 17560598;
D019821	Simvastatin	Simvastatin promotes the reaction [TNF results in increased expression of MMP9 mRNA]	17560598
D019821	Simvastatin	Simvastatin results in decreased activity of MMP9 protein	15107580
D019821	Simvastatin	Simvastatin results in decreased expression of MMP9 protein	17038636; 19360310; 19589242;
D019821	Simvastatin	Simvastatin results in increased activity of MMP9 protein	15210533
D019821	Simvastatin	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 mRNA]	20835264
D019821	Simvastatin	Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of MMP9 protein]	20835264
D019821	Simvastatin	Simvastatin results in decreased activity of MMP9 protein	17169357
D019821	Simvastatin	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
D019821	Simvastatin	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9]]	19299917
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
D019821	Simvastatin	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
D019821	Simvastatin	Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 mRNA]	19505368
D019821	Simvastatin	Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of MMP9 protein]	19505368
D019821	Simvastatin	Simvastatin inhibits the reaction [Smoke analog results in increased activity of MMP9 protein]	16002570
D019821	Simvastatin	Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D019821	Simvastatin	Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
D019821	Simvastatin	Simvastatin inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]	19820293
D019821	Simvastatin	Simvastatin results in decreased activity of MMP9 protein	18569431
D019821	Simvastatin	Simvastatin results in decreased expression of and results in decreased activity of MMP9 protein	18309148
D019821	Simvastatin	Simvastatin results in decreased expression of MMP9 mRNA	16414398; 18309148;
D019821	Simvastatin	Simvastatin results in decreased expression of MMP9 protein	16414398
D019821	Simvastatin	Simvastatin results in increased activity of MMP9 protein	23831763
D020123	Sirolimus	Sirolimus results in decreased expression of MMP9 mRNA	21865292
D012906	Smoke	Smoke results in decreased nitrosation of MMP9 protein	21652289
D012906	Smoke	Smoke results in increased expression of MMP9 mRNA	22516759
D012906	Smoke	AGT protein modified form promotes the reaction [Smoke results in increased activity of MMP9 protein]	20937366
D012906	Smoke	Smoke promotes the reaction [AGT protein modified form results in increased activity of MMP9 protein]	20937366
D012906	Smoke	Smoke results in increased activity of MMP9 protein	20937366
D012906	Smoke	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
D012906	Smoke	5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
D012906	Smoke	farnesyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
D012906	Smoke	FTI 277 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	FTI 277 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
D012906	Smoke	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9]]	19299917
D012906	Smoke	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]]	19299917
D012906	Smoke	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]]	19299917
D012906	Smoke	GGTI-2133 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	GGTI-2133 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
D012906	Smoke	Simvastatin inhibits the reaction [Smoke analog results in increased activity of MMP9 protein]	16002570
D012906	Smoke	Simvastatin inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	Simvastatin inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
D012906	Smoke	Smoke analog results in increased activity of MMP9 protein	16002570
D012906	Smoke	Smoke analog results in increased expression of MMP9 mRNA	19299917
D012906	Smoke	Smoke analog results in increased secretion of MMP9 protein	19299917
D012906	Smoke	U 0126 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
D012906	Smoke	U 0126 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
C118258	SN50 peptide	SN50 peptide results in decreased secretion of MMP9 protein	15962302
C118258	SN50 peptide	SN50 peptide inhibits the reaction [Sunitinib results in decreased expression of MMP9 mRNA]	26581635
C017947	sodium arsenite	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C017947	sodium arsenite	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C017947	sodium arsenite	Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA]	21167264
C017947	sodium arsenite	Decitabine inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein]	21167264
C017947	sodium arsenite	Letrozole inhibits the reaction [sodium arsenite results in increased activity of and results in increased secretion of MMP9 protein]	24068038
C017947	sodium arsenite	RTKI cpd inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C017947	sodium arsenite	sodium arsenite results in increased activity of and results in increased secretion of MMP9 protein	24068038
C017947	sodium arsenite	sodium arsenite results in increased activity of MMP9 protein	21167264
C017947	sodium arsenite	sodium arsenite results in increased expression of MMP9 mRNA	21167264
C017947	sodium arsenite	sodium arsenite results in increased expression of MMP9 protein	21167264
C017947	sodium arsenite	sodium arsenite results in increased secretion of and results in increased activity of MMP9 protein	18572023
C017947	sodium arsenite	sodium arsenite results in increased secretion of MMP9 protein	15504454; 19524636; 19933942; 20056578; 21820459; 23052196; 25201354; 30334557; 30428081;
C017947	sodium arsenite	U 0126 inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA]	21167264
C017947	sodium arsenite	U 0126 inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein]	21167264
C017947	sodium arsenite	U 0126 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C017947	sodium arsenite	sodium arsenite results in increased expression of MMP9 mRNA	16014739; 21134390;
C017947	sodium arsenite	Gefitinib inhibits the reaction [HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein]]	29228391
C017947	sodium arsenite	HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein]	29228391
C017947	sodium arsenite	HBEGF protein inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein]	29228391
C017947	sodium arsenite	sodium arsenite results in increased activity of MMP9 protein	21167264; 23137061;
C017947	sodium arsenite	sodium arsenite results in increased expression of and results in increased secretion of and results in increased activity of MMP9 protein	29228391
C017947	sodium arsenite	sodium arsenite results in increased expression of MMP9 protein	21167264; 29228391;
C017947	sodium arsenite	sodium arsenite results in increased secretion of MMP9 protein	19933942
C017947	sodium arsenite	Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	19933942
C016104	sodium bichromate	sodium bichromate results in increased expression of MMP9 mRNA	24612858
C016104	sodium bichromate	sodium bichromate results in decreased expression of MMP9 mRNA	17685462
C025451	sodium bisulfide	Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]	24722316
C025451	sodium bisulfide	Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]	24722316
C025451	sodium bisulfide	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 mRNA]]	24722316
C025451	sodium bisulfide	Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in increased expression of MMP9 protein]]	24722316
C025451	sodium bisulfide	sodium bisulfide results in increased expression of MMP9 mRNA	24722316
C025451	sodium bisulfide	sodium bisulfide results in increased expression of MMP9 protein	24722316
D017673	Sodium Chloride, Dietary	[IGF2R protein alternative form results in increased susceptibility to Sodium Chloride, Dietary] which results in increased expression of MMP9 protein	30450786
D018038	Sodium Selenite	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of MMP9 mRNA	23274088
D018038	Sodium Selenite	Sodium Selenite inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	19933942
C012037	solasodine	solasodine results in decreased expression of MMP9 mRNA	28283413
D012999	Soman	Soman results in increased expression of MMP9 mRNA	19281266
D053260	Soot	Soot results in increased expression of MMP9 mRNA	24982919
D053260	Soot	Soot results in increased expression of MMP9 mRNA	19165387
C060506	sphingosine 1-phosphate	Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	25980589
C060506	sphingosine 1-phosphate	Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	25980589
C060506	sphingosine 1-phosphate	JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	26518876
C060506	sphingosine 1-phosphate	JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	26518876
C060506	sphingosine 1-phosphate	Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]	25980589
C060506	sphingosine 1-phosphate	Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]	25980589
C060506	sphingosine 1-phosphate	sphingosine 1-phosphate results in increased expression of MMP9 mRNA	25980589; 26518876;
C060506	sphingosine 1-phosphate	sphingosine 1-phosphate results in increased expression of MMP9 protein	25980589; 26518876;
D013111	Spider Venoms	Spider Venoms results in increased expression of MMP9 protein	27060202
D013148	Spironolactone	Spironolactone results in decreased expression of MMP9 protein	20082611
C106195	SR 11302	SR 11302 inhibits the reaction [Tamoxifen results in increased expression of MMP9 mRNA]	26908177
C106195	SR 11302	SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]	27829220
C106195	SR 11302	SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
C106195	SR 11302	SR 11302 inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
C106195	SR 11302	SR 11302 results in decreased expression of MMP9 mRNA	27829220
C525422	SRT1720	[SRT1720 results in decreased activity of SIRT1 protein] inhibits the reaction [IL1B protein results in increased expression of MMP9]	24429678
D019311	Staurosporine	Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]	16251475
D019311	Staurosporine	Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein]	16251475
C556690	STF 083010	STF 083010 inhibits the reaction [Carbon Tetrachloride results in increased expression of MMP9 mRNA]	30538632
D013311	Streptozocin	PRDX4 protein inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]	20446767
D013311	Streptozocin	[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA	29988851
D013311	Streptozocin	Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of MMP9 mRNA]	29988851
D013311	Streptozocin	Streptozocin results in increased expression of MMP9 mRNA	20446767
D013311	Streptozocin	idebenone inhibits the reaction [Streptozocin results in increased expression of MMP9 protein]	28648635
D013311	Streptozocin	Olive Oil inhibits the reaction [Streptozocin results in increased activity of MMP9 protein]	25246140
D013311	Streptozocin	Resveratrol inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]	22191573
D013311	Streptozocin	Rosiglitazone inhibits the reaction [Streptozocin deficiency results in increased expression of MMP9 mRNA]	19236438
D013311	Streptozocin	Simvastatin inhibits the reaction [Streptozocin results in increased expression of MMP9 mRNA]	19820293
D013311	Streptozocin	[Streptozocin co-treated with Tobacco Smoke Pollution] results in increased expression of MMP9 protein	30421503
D013311	Streptozocin	Streptozocin results in increased activity of MMP9 protein	25246140
D013311	Streptozocin	Streptozocin results in increased expression of MMP9 mRNA	19236438; 19820293; 22191573;
D013311	Streptozocin	Streptozocin results in increased expression of MMP9 protein	28648635
C483044	SU 1498	[SU 1498 results in decreased activity of KDR protein] inhibits the reaction [Resveratrol results in increased secretion of MMP9 protein]	22314268
D004113	Succimer	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA	26378955
D004113	Succimer	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA	21641980
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [HGF protein results in increased expression of MMP9 mRNA]	12745093
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	12745093
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of MMP9 protein]	16684522
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	16684522
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	16684522
D012460	Sulfasalazine	Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
D000077210	Sunitinib	Carnitine inhibits the reaction [Sunitinib results in decreased expression of MMP9 mRNA]	26581635
D000077210	Sunitinib	SN50 peptide inhibits the reaction [Sunitinib results in decreased expression of MMP9 mRNA]	26581635
D000077210	Sunitinib	Sunitinib results in decreased expression of MMP9 mRNA	26581635
D013605	T-2 Toxin	T-2 Toxin affects the expression of MMP9 mRNA	22960706
D013605	T-2 Toxin	T-2 Toxin results in increased activity of MMP9 protein	21112371
D013605	T-2 Toxin	T-2 Toxin results in increased expression of and results in increased activity of MMP9 protein	22960706
D013605	T-2 Toxin	T-2 Toxin results in increased expression of MMP9 mRNA	21112371; 22800716;
D013605	T-2 Toxin	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
D013605	T-2 Toxin	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
D013605	T-2 Toxin	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
D013605	T-2 Toxin	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
D013605	T-2 Toxin	SB 203580 inhibits the reaction [T-2 Toxin results in increased expression of MMP9 mRNA]	29079362
D013605	T-2 Toxin	T-2 Toxin results in increased expression of MMP9 mRNA	29079362
C112689	TAC 101	TAC 101 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	9848099
C000602275	taiwanin E	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
C000602275	taiwanin E	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C000602275	taiwanin E	MAPK11 protein promotes the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
C000602275	taiwanin E	MAPK11 protein promotes the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C000602275	taiwanin E	MAPK14 protein promotes the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
C000602275	taiwanin E	MAPK14 protein promotes the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C000602275	taiwanin E	[Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 mRNA]	27807932
C000602275	taiwanin E	[Protein Kinase Inhibitors results in decreased activity of MAPK14 protein] inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C000602275	taiwanin E	SB 203580 inhibits the reaction [taiwanin E results in decreased expression of MMP9 protein]	27807932
C000602275	taiwanin E	taiwanin E results in decreased expression of MMP9 mRNA	27807932
C000602275	taiwanin E	taiwanin E results in decreased expression of MMP9 protein	27807932
C557331	TAK-875	TAK-875 results in increased expression of MMP9 mRNA	30243991
D013629	Tamoxifen	SR 11302 inhibits the reaction [Tamoxifen results in increased expression of MMP9 mRNA]	26908177
D013629	Tamoxifen	Tamoxifen results in increased expression of MMP9 mRNA	26908177
D013629	Tamoxifen	Tamoxifen affects the expression of MMP9 mRNA	14699072
D013629	Tamoxifen	Tamoxifen results in decreased expression of MMP9 mRNA	30153467
D013629	Tamoxifen	Tamoxifen affects the expression of MMP9 mRNA	17555576
D013629	Tamoxifen	Tamoxifen results in decreased activity of MMP9 protein	19393235
D013629	Tamoxifen	Tamoxifen results in decreased expression of MMP9 mRNA	19393235
D013629	Tamoxifen	Tamoxifen results in increased activity of MMP9 protein	19279558
D013629	Tamoxifen	Tamoxifen results in increased expression of MMP9 mRNA	22841776
D013629	Tamoxifen	Tamoxifen results in decreased activity of MMP9 protein	15696052
C112765	tanespimycin	tanespimycin affects the reaction [Nickel results in increased activity of MMP9 protein]	21401309
C112765	tanespimycin	tanespimycin inhibits the reaction [Nickel results in increased expression of MMP9 mRNA]	21401309
C021751	tanshinone	tanshinone inhibits the reaction [Norepinephrine results in increased expression of MMP9 mRNA]	24929186
D013654	Taurine	Taurine inhibits the reaction [Nandrolone Decanoate results in increased expression of MMP9 mRNA]	25542992
D013656	Taurocholic Acid	JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 mRNA]	26518876
D013656	Taurocholic Acid	JTE 013 inhibits the reaction [Taurocholic Acid results in increased expression of MMP9 protein]	26518876
D013656	Taurocholic Acid	Taurocholic Acid results in increased expression of MMP9 mRNA	26518876
D013656	Taurocholic Acid	Taurocholic Acid results in increased expression of MMP9 protein	26518876
C087114	tebuconazole	tebuconazole results in decreased expression of MMP9 mRNA	26852204
D000077204	Temozolomide	Resveratrol inhibits the reaction [Temozolomide results in decreased expression of MMP9 protein]	22530672
D000077204	Temozolomide	Temozolomide results in decreased expression of MMP9 protein	22530672
C001803	tempol	tempol results in increased activity of MMP9 protein	17196988
C480848	tephrosin	tephrosin inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	18841906
D000077291	Terbinafine	Terbinafine results in decreased expression of MMP9 mRNA	17172416
C096680	tertiary-amyl methyl ether	tertiary-amyl methyl ether results in decreased expression of MMP9 mRNA	22609741
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of MMP9 mRNA	20728951
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of MMP9 protein	27239688
C020806	tetrabromobisphenol A	tetrabromobisphenol A inhibits the reaction [Triiodothyronine results in increased expression of MMP9 mRNA]	16678281
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of MMP9 mRNA	16678281
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased activity of MMP9 protein	17003102
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA	17003102; 18495758; 30398377;
D013749	Tetrachlorodibenzodioxin	JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]	19371443
D013749	Tetrachlorodibenzodioxin	JUN protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA]	19371443
D013749	Tetrachlorodibenzodioxin	MMP1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]	24469321
D013749	Tetrachlorodibenzodioxin	Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of MMP9 protein]	19371443
D013749	Tetrachlorodibenzodioxin	Resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA]	19371443
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased activity of MMP9 protein	15922868; 19371443; 24469321;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of MMP9 protein	15982688
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of MMP9	17003102
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA	12377990; 15922868; 16704738; 19371443; 19755661;
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of MMP9 mRNA	21570461; 28922406;
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of MMP9 mRNA	21167638
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMP9 mRNA	17942748
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased activity of MMP9 protein	24154488
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA	17586704; 17975115; 19372248; 22749964; 24154488; 29673856; 31270306;
D013749	Tetrachlorodibenzodioxin	tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA]	22749964
C117155	tetracycline CMT-3	tetracycline CMT-3 results in decreased activity of MMP9 protein	16003065
C117153	tetracycline CMT-8	tetracycline CMT-8 results in decreased activity of MMP9 protein	11983005
D013754	Tetracyclines	Tetracyclines results in decreased activity of MMP9 protein	11172685
D013755	Tetradecanoylphorbol Acetate	10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21454668
D013755	Tetradecanoylphorbol Acetate	10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21454668
D013755	Tetradecanoylphorbol Acetate	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859; 19804834;
D013755	Tetradecanoylphorbol Acetate	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248; 23288142;
D013755	Tetradecanoylphorbol Acetate	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19804834; 25656647;
D013755	Tetradecanoylphorbol Acetate	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
D013755	Tetradecanoylphorbol Acetate	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093; 15728660; 21354279;
D013755	Tetradecanoylphorbol Acetate	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859; 25866363;
D013755	Tetradecanoylphorbol Acetate	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25656647
D013755	Tetradecanoylphorbol Acetate	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
D013755	Tetradecanoylphorbol Acetate	2-chloro-5-nitrobenzanilide inhibits the reaction [10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	21454668
D013755	Tetradecanoylphorbol Acetate	2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
D013755	Tetradecanoylphorbol Acetate	2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]]	17055343
D013755	Tetradecanoylphorbol Acetate	3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22595400
D013755	Tetradecanoylphorbol Acetate	3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
D013755	Tetradecanoylphorbol Acetate	3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
D013755	Tetradecanoylphorbol Acetate	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20599481
D013755	Tetradecanoylphorbol Acetate	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20599481
D013755	Tetradecanoylphorbol Acetate	3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20599481
D013755	Tetradecanoylphorbol Acetate	3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
D013755	Tetradecanoylphorbol Acetate	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
D013755	Tetradecanoylphorbol Acetate	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819; 21354279;
D013755	Tetradecanoylphorbol Acetate	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20152819; 21354279;
D013755	Tetradecanoylphorbol Acetate	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
D013755	Tetradecanoylphorbol Acetate	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
D013755	Tetradecanoylphorbol Acetate	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	22245252
D013755	Tetradecanoylphorbol Acetate	antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25656647
D013755	Tetradecanoylphorbol Acetate	antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	25656647
D013755	Tetradecanoylphorbol Acetate	Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	22634262
D013755	Tetradecanoylphorbol Acetate	Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22634262
D013755	Tetradecanoylphorbol Acetate	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	23253724
D013755	Tetradecanoylphorbol Acetate	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	23253724
D013755	Tetradecanoylphorbol Acetate	Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15962302
D013755	Tetradecanoylphorbol Acetate	Atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
D013755	Tetradecanoylphorbol Acetate	baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	10455257
D013755	Tetradecanoylphorbol Acetate	Bee Venoms inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19969058
D013755	Tetradecanoylphorbol Acetate	Benzofurans analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30696844
D013755	Tetradecanoylphorbol Acetate	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
D013755	Tetradecanoylphorbol Acetate	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
D013755	Tetradecanoylphorbol Acetate	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
D013755	Tetradecanoylphorbol Acetate	bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	25866363
D013755	Tetradecanoylphorbol Acetate	CAMK1 mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248
D013755	Tetradecanoylphorbol Acetate	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819; 20599481; 21354279;
D013755	Tetradecanoylphorbol Acetate	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20152819; 21354279; 24211270; 25656647;
D013755	Tetradecanoylphorbol Acetate	Curcumin promotes the reaction [3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20599481
D013755	Tetradecanoylphorbol Acetate	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	20152819
D013755	Tetradecanoylphorbol Acetate	Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]]	20152819
D013755	Tetradecanoylphorbol Acetate	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	10455257
D013755	Tetradecanoylphorbol Acetate	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30696844
D013755	Tetradecanoylphorbol Acetate	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20152819
D013755	Tetradecanoylphorbol Acetate	dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	Docosahexaenoic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
D013755	Tetradecanoylphorbol Acetate	Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19375915
D013755	Tetradecanoylphorbol Acetate	Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	17498959
D013755	Tetradecanoylphorbol Acetate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]]	15728660
D013755	Tetradecanoylphorbol Acetate	geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
D013755	Tetradecanoylphorbol Acetate	Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19375915
D013755	Tetradecanoylphorbol Acetate	Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19375915
D013755	Tetradecanoylphorbol Acetate	Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	17498959
D013755	Tetradecanoylphorbol Acetate	Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	17498959
D013755	Tetradecanoylphorbol Acetate	glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20188714
D013755	Tetradecanoylphorbol Acetate	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21354279
D013755	Tetradecanoylphorbol Acetate	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	21354279
D013755	Tetradecanoylphorbol Acetate	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
D013755	Tetradecanoylphorbol Acetate	Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20138977
D013755	Tetradecanoylphorbol Acetate	HMOX1 protein affects the reaction [Docosahexaenoic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]]	23288142
D013755	Tetradecanoylphorbol Acetate	Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	27163855
D013755	Tetradecanoylphorbol Acetate	Hydroxamic Acids inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	27163855
D013755	Tetradecanoylphorbol Acetate	iron protoporphyrin IX inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	24211270
D013755	Tetradecanoylphorbol Acetate	Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30133131
D013755	Tetradecanoylphorbol Acetate	Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30133131
D013755	Tetradecanoylphorbol Acetate	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19969058
D013755	Tetradecanoylphorbol Acetate	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	20082219
D013755	Tetradecanoylphorbol Acetate	Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20082219
D013755	Tetradecanoylphorbol Acetate	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	20590612
D013755	Tetradecanoylphorbol Acetate	Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]]	15728660
D013755	Tetradecanoylphorbol Acetate	myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	20093109
D013755	Tetradecanoylphorbol Acetate	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19804834
D013755	Tetradecanoylphorbol Acetate	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	25866363
D013755	Tetradecanoylphorbol Acetate	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	25866363
D013755	Tetradecanoylphorbol Acetate	naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25866363
D013755	Tetradecanoylphorbol Acetate	naringin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	25866363
D013755	Tetradecanoylphorbol Acetate	oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22595400
D013755	Tetradecanoylphorbol Acetate	oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
D013755	Tetradecanoylphorbol Acetate	oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	10569804
D013755	Tetradecanoylphorbol Acetate	Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	17055343
D013755	Tetradecanoylphorbol Acetate	piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21354279
D013755	Tetradecanoylphorbol Acetate	piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	21354279
D013755	Tetradecanoylphorbol Acetate	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	22634262
D013755	Tetradecanoylphorbol Acetate	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22634262; 30259628;
D013755	Tetradecanoylphorbol Acetate	Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30259628
D013755	Tetradecanoylphorbol Acetate	pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	19447859
D013755	Tetradecanoylphorbol Acetate	pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	19447859
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19447859
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	30133131
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	30133131
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
D013755	Tetradecanoylphorbol Acetate	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	18628248
D013755	Tetradecanoylphorbol Acetate	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	18628248; 22595400;
D013755	Tetradecanoylphorbol Acetate	Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22595400
D013755	Tetradecanoylphorbol Acetate	Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	19804834
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	17055343
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	22523472; 22595400; 22696189;
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	22696189
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	22523472; 22595400;
D013755	Tetradecanoylphorbol Acetate	Rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	21454668
D013755	Tetradecanoylphorbol Acetate	Rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21454668
D013755	Tetradecanoylphorbol Acetate	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	21354279
D013755	Tetradecanoylphorbol Acetate	shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	23899529
D013755	Tetradecanoylphorbol Acetate	shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	23899529
D013755	Tetradecanoylphorbol Acetate	Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	15728660
D013755	Tetradecanoylphorbol Acetate	Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
D013755	Tetradecanoylphorbol Acetate	Sulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of MMP9 protein	14627504
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein	10455257; 17055343; 19804834; 20590612; 20599481; 22634262; 25866363; 28731287;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein	18628248; 19375915; 19447859; 19969058; 21295103; 22245252; 23288142;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein	20082219; 23899529; 25866363; 27163855;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA	10569804; 12745093; 14627504; 15728660; 16574429; 17498959; 18155510; 18628248; 19205902; 19375915; 19447859; 19804834; 20082219; 20138977; 20152819; 20590612; 20599481; 21354279; 21454668; 22523472; 22595400; 22634262; 22696189; 23253724; 23899529; 25656647; 25866363; 28731287; 30133131; 30259628; 30696844;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein	10569804; 17498959; 20093109; 20152819; 20590612; 20599481; 21354279; 22696189; 24211270; 25656647; 30133131; 30259628; 31545954;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein	20152819; 23253724;
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein	12745093; 15728660; 15962302; 20188714; 20590612; 21354279; 21454668; 22523472; 22595400; 26807887;
D013755	Tetradecanoylphorbol Acetate	tomatidine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	31545954
D013755	Tetradecanoylphorbol Acetate	tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	28731287
D013755	Tetradecanoylphorbol Acetate	tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	28731287
D013755	Tetradecanoylphorbol Acetate	Troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	18155510
D013755	Tetradecanoylphorbol Acetate	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
D013755	Tetradecanoylphorbol Acetate	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
D013755	Tetradecanoylphorbol Acetate	Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	10569804
D013755	Tetradecanoylphorbol Acetate	Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	10569804
D013755	Tetradecanoylphorbol Acetate	Vorinostat inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	27163855
D013755	Tetradecanoylphorbol Acetate	W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20590612
D013755	Tetradecanoylphorbol Acetate	wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	21295103
D013755	Tetradecanoylphorbol Acetate	Wortmannin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
D013755	Tetradecanoylphorbol Acetate	Y 27632 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
D013755	Tetradecanoylphorbol Acetate	Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D013755	Tetradecanoylphorbol Acetate	Indomethacin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D013755	Tetradecanoylphorbol Acetate	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MMP9 mRNA	23519560
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	14515793
D013755	Tetradecanoylphorbol Acetate	TAC 101 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	9848099
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein	14515793
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein	9848099
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein	17332158
D013755	Tetradecanoylphorbol Acetate	[Thiram co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein	17332158
D013755	Tetradecanoylphorbol Acetate	[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein	14700523; 16647178;
D013755	Tetradecanoylphorbol Acetate	Quercetin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523; 16647178;
D013755	Tetradecanoylphorbol Acetate	wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523
D013755	Tetradecanoylphorbol Acetate	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	14661062
D013755	Tetradecanoylphorbol Acetate	Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	14661062
D013755	Tetradecanoylphorbol Acetate	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein	14661062
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of MMP9	26807887
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA	14661062
D013755	Tetradecanoylphorbol Acetate	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
C096277	tetrahydrocurcumin	tetrahydrocurcumin inhibits the reaction [Cadmium Chloride results in increased expression of MMP9 protein]	25502771
C050950	tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex	tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Doxorubicin results in increased expression of MMP9 mRNA]	19286953
C009438	tetrandrine	tetrandrine results in decreased expression of MMP9 protein	30549224
C009438	tetrandrine	tetrandrine inhibits the reaction [IL1B protein results in increased expression of and results in increased activity of MMP9 protein]	22001142
D013792	Thalidomide	Thalidomide results in decreased expression of MMP9 protein	15863203
D013853	Thioacetamide	Thioacetamide results in decreased expression of MMP9 mRNA	19784758
D013853	Thioacetamide	Thioacetamide results in increased expression of MMP9 protein	15095483
D013853	Thioacetamide	Thioacetamide results in increased secretion of MMP9 protein	22899499
D013893	Thiram	[Thiram co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein	17332158
D013893	Thiram	[Thiram co-treated with Tretinoin] results in increased activity of MMP9 protein	17332158
D013943	Thymol	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	30048646
D013943	Thymol	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	30048646
D013943	Thymol	Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]	30048646
D013943	Thymol	Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]	30048646
C003466	thymoquinone	pyrazolanthrone inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]	27060453
C003466	thymoquinone	SB 203580 inhibits the reaction [thymoquinone results in decreased expression of MMP9 protein]	27060453
C003466	thymoquinone	thymoquinone results in decreased expression of and results in decreased activity of MMP9 protein	27060453
D013974	Thyroxine	Thyroxine results in increased expression of MMP9 mRNA	23935926
C032628	tin protoporphyrin IX	tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]	30076913
C032628	tin protoporphyrin IX	tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
C016151	tinuvin	tinuvin analog results in decreased expression of MMP9 mRNA	30315675
D014025	Titanium	Titanium results in increased expression of MMP9 mRNA	14661256
C009495	titanium dioxide	titanium dioxide results in decreased expression of MMP9 mRNA	21513982
C009495	titanium dioxide	titanium dioxide results in increased activity of MMP9 protein	23726862
C009495	titanium dioxide	titanium dioxide results in increased expression of MMP9 mRNA	19695317
C009495	titanium dioxide	titanium dioxide results in increased secretion of MMP9 protein	23726862
C009495	titanium dioxide	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA	29950665
C009495	titanium dioxide	titanium dioxide results in increased expression of MMP9 mRNA	23557971
D014028	Tobacco Smoke Pollution	KLF5 protein inhibits the reaction [MIR145 mRNA inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MMP9 protein]]	30639269
D014028	Tobacco Smoke Pollution	MIR145 mRNA inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MMP9 protein]	30639269
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution affects the expression of and results in increased secretion of MMP9 protein	30291989
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution affects the expression of MMP9 mRNA	29505817
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of MMP9 protein	29505817
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of MMP9 mRNA	29673796; 30610935;
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of MMP9 protein	30639269
D014028	Tobacco Smoke Pollution	[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of MMP9 protein	24096154
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution deficiency inhibits the reaction [[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of MMP9 protein]	24096154
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of and results in increased secretion of MMP9 protein	26609137
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of MMP9 protein	26032511
D014028	Tobacco Smoke Pollution	naringin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of MMP9 protein]	22985397
D014028	Tobacco Smoke Pollution	[Streptozocin co-treated with Tobacco Smoke Pollution] results in increased expression of MMP9 protein	30421503
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of and results in increased secretion of MMP9 protein	27818348
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of MMP9 mRNA	23967268; 29545142;
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased expression of MMP9 protein	22985397
C479163	tofacitinib	tofacitinib promotes the reaction [IL6 protein results in increased expression of MMP9 mRNA]	24285838
D014051	Toluene 2,4-Diisocyanate	Toluene 2,4-Diisocyanate results in decreased expression of MMP9 protein	12534559
D014051	Toluene 2,4-Diisocyanate	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	15131573
D014051	Toluene 2,4-Diisocyanate	4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein]	15131573
D014051	Toluene 2,4-Diisocyanate	Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	15131573
D014051	Toluene 2,4-Diisocyanate	Doxycycline inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein]	15131573
D014051	Toluene 2,4-Diisocyanate	epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein]	16516891
D014051	Toluene 2,4-Diisocyanate	epigallocatechin gallate inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA]	16516891
D014051	Toluene 2,4-Diisocyanate	Toluene 2,4-Diisocyanate results in increased activity of MMP9 protein	11742282
D014051	Toluene 2,4-Diisocyanate	Toluene 2,4-Diisocyanate results in increased expression of and results in increased activity of MMP9 protein	16516891
D014051	Toluene 2,4-Diisocyanate	Toluene 2,4-Diisocyanate results in increased expression of MMP9 mRNA	12789230; 14987308; 15131573; 16516891;
D014051	Toluene 2,4-Diisocyanate	Toluene 2,4-Diisocyanate results in increased expression of MMP9 protein	12789230; 14987308; 15131573;
C003677	tomatidine	tomatidine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	31545954
C003677	tomatidine	tomatidine results in decreased expression of MMP9 mRNA	23566884
C003677	tomatidine	tomatidine results in decreased expression of MMP9 protein	23566884; 31545954;
D019772	Topotecan	[Oxaliplatin co-treated with Topotecan] results in increased expression of MMP9 mRNA	25729387
D014108	Tosylphenylalanyl Chloromethyl Ketone	Tosylphenylalanyl Chloromethyl Ketone results in decreased activity of MMP9 protein	22033475
D014118	Toxins, Biological	Toxins, Biological affects the expression of MMP9 mRNA	19682533
C000604982	TPD7 compound	TPD7 compound results in decreased expression of MMP9 protein	25753200
D014212	Tretinoin	Tretinoin results in decreased expression of MMP9 mRNA	20530235
D014212	Tretinoin	Tretinoin results in increased activity of MMP9 protein	17332158
D014212	Tretinoin	Tretinoin results in decreased expression of and results in decreased secretion of MMP9 protein	16914095
D014212	Tretinoin	Tretinoin results in decreased expression of MMP9 mRNA	16914095; 21924320;
D014212	Tretinoin	Tretinoin results in increased expression of MMP9 mRNA	16788091
D014212	Tretinoin	[Thiram co-treated with Tretinoin] results in increased activity of MMP9 protein	17332158
D014212	Tretinoin	Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 mRNA]	19357873
D014212	Tretinoin	Tretinoin inhibits the reaction [Doxorubicin results in decreased expression of MMP9 protein]	19357873
D014212	Tretinoin	Tretinoin results in increased expression of MMP9 mRNA	20488242
C032910	triadimefon	triadimefon analog results in decreased expression of MMP9 mRNA	26238599
C011559	tributyltin	tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP9 mRNA]	22749964
C469689	tricetin	tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	28731287
C469689	tricetin	tricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	28731287
C469689	tricetin	tricetin results in decreased expression of MMP9 mRNA	27860196
C469689	tricetin	tricetin results in decreased expression of MMP9 protein	27860196
C012589	trichostatin A	AKT1 protein modified form inhibits the reaction [trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]]	26509796
C012589	trichostatin A	trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 mRNA]	26509796
C012589	trichostatin A	trichostatin A inhibits the reaction [Oxygen deficiency results in increased expression of MMP9 protein]	26509796
C012589	trichostatin A	trichostatin A inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	24429678
C012589	trichostatin A	trichostatin A inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	24429678
D014260	Triclosan	3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP9 protein]	28844962
D014260	Triclosan	Fulvestrant inhibits the reaction [Triclosan results in increased expression of MMP9 protein]	28844962
D014260	Triclosan	[Progesterone co-treated with Triclosan] results in increased expression of MMP9 mRNA	26604029
D014260	Triclosan	Triclosan results in increased expression of MMP9 mRNA	26604029
D014260	Triclosan	Triclosan results in increased expression of MMP9 protein	28844962
D014284	Triiodothyronine	tetrabromobisphenol A inhibits the reaction [Triiodothyronine results in increased expression of MMP9 mRNA]	16678281
D014284	Triiodothyronine	Triiodothyronine results in increased expression of MMP9 mRNA	16678281
D014284	Triiodothyronine	Triiodothyronine results in decreased expression of MMP9 mRNA	17403546
C040533	trimethyltin chloride	trimethyltin chloride results in increased expression of MMP9 mRNA	23000284
D014302	Trinitrobenzenesulfonic Acid	4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
D014302	Trinitrobenzenesulfonic Acid	Prednisolone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
D014302	Trinitrobenzenesulfonic Acid	Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein]	22119283
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in increased activity of and results in increased cleavage of MMP9 protein	22119283
C050414	tripterine	tripterine inhibits the reaction [Bleomycin results in increased expression of MMP9 protein]	26768587
C001899	triptolide	triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C001899	triptolide	triptolide inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C001899	triptolide	triptolide results in decreased expression of MMP9 protein	26420756
D000077288	Troglitazone	Troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	18155510
D000077288	Troglitazone	Troglitazone results in decreased activity of MMP9 protein	18155510
D014414	Tungsten	Tungsten results in decreased expression of MMP9 mRNA	30912803
D014414	Tungsten	Tungsten results in increased expression of and results in increased secretion of MMP9 protein	25324207
C002802	tungsten carbide	[tungsten carbide co-treated with Cobalt] results in decreased expression of MMP9 mRNA	18078969
C113580	U 0126	U 0126 inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MMP9 protein]	22307971
C113580	U 0126	U 0126 inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA]	25724548
C113580	U 0126	U 0126 inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	27087131; 27634460;
C113580	U 0126	U 0126 inhibits the reaction [FGF16 protein results in increased expression of MMP9 mRNA]	24253043
C113580	U 0126	U 0126 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C113580	U 0126	U 0126 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C113580	U 0126	U 0126 inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 mRNA]	29753068
C113580	U 0126	U 0126 inhibits the reaction [perfluorooctanoic acid results in increased expression of MMP9 protein]	29753068
C113580	U 0126	U 0126 inhibits the reaction [sodium arsenite results in increased expression of MMP9 mRNA]	21167264
C113580	U 0126	U 0126 inhibits the reaction [sodium arsenite results in increased expression of MMP9 protein]	21167264
C113580	U 0126	U 0126 inhibits the reaction [sodium arsenite results in increased secretion of MMP9 protein]	15504454
C113580	U 0126	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]	20152819
C113580	U 0126	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	12745093
C113580	U 0126	U 0126 inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein]	22705379
C113580	U 0126	U 0126 results in decreased expression of MMP9 mRNA	19501039; 23566884;
C113580	U 0126	U 0126 results in decreased expression of MMP9 protein	18424783; 22307971;
C113580	U 0126	U 0126 inhibits the reaction [IL6 protein results in increased expression of MMP9 mRNA]	24285838
C113580	U 0126	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 mRNA]	24682241
C113580	U 0126	U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of MMP9 protein]	24682241
C113580	U 0126	U 0126 results in decreased activity of MMP9 protein	19393235; 22326785;
C113580	U 0126	U 0126 results in decreased expression of MMP9 mRNA	19393235; 22326785;
C113580	U 0126	SB 203580 promotes the reaction [U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
C113580	U 0126	U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]	16683234
C113580	U 0126	U 0126 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of MMP9 protein]	16683234; 30980805;
C113580	U 0126	U 0126 inhibits the reaction [RELA protein binds to MMP9 promoter]	23774252
C113580	U 0126	U 0126 inhibits the reaction [Smoke analog results in increased expression of MMP9 mRNA]	19299917
C113580	U 0126	U 0126 inhibits the reaction [Smoke analog results in increased secretion of MMP9 protein]	19299917
C113580	U 0126	U 0126 inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]	23774252
C113580	U 0126	U 0126 inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA]	23774252
C113580	U 0126	U 0126 promotes the reaction [SB 203580 inhibits the reaction [Lipopolysaccharides results in increased activity of MMP9 protein]]	16683234
C113580	U 0126	U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9]	26807887
C062137	U 75302	U 75302 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]	19837106
C062137	U 75302	U 75302 results in increased activity of and results in increased expression of MMP9 protein	19837106
D014520	Urethane	[Urethane co-treated with Freund's Adjuvant] results in decreased expression of MMP9 mRNA	12400877
D014520	Urethane	Urethane results in decreased expression of MMP9 mRNA	12400877
C005466	ursolic acid	ursolic acid results in decreased expression of MMP9 mRNA	21539908
C005466	ursolic acid	2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]]	27274199
C005466	ursolic acid	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of MMP9 protein]	27274199
D014635	Valproic Acid	Valproic Acid affects the expression of MMP9 mRNA	25979313
D014635	Valproic Acid	Valproic Acid results in increased expression of MMP9 mRNA	23179753; 23527032;
D014635	Valproic Acid	Valproic Acid results in increased methylation of MMP9 gene	29154799
D014635	Valproic Acid	Valproic Acid affects the expression of MMP9 mRNA	17963808
D014635	Valproic Acid	Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of MMP9 mRNA]	28184907
D014635	Valproic Acid	Valproic Acid results in decreased expression of MMP9 mRNA	29427782
D000068756	Valsartan	[Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 mRNA	21051829
D000068756	Valsartan	[Valsartan co-treated with Fosinopril] results in decreased expression of MMP9 protein	21051829
D000068756	Valsartan	Valsartan results in decreased expression of MMP9 mRNA	21051829
D000068756	Valsartan	Valsartan results in decreased expression of MMP9 protein	21051829
D014638	Vanadates	Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]	10569804
D014638	Vanadates	Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]	10569804
C066075	vanadium pentoxide	vanadium pentoxide results in increased expression of MMP9 protein	18059072
C545088	varespladib methyl	varespladib methyl inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	19765281
C545088	varespladib methyl	varespladib methyl inhibits the reaction [IL1B protein results in increased secretion of MMP9 protein]	19765281
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of MMP9 mRNA	24982919
D001335	Vehicle Emissions	[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 mRNA	19150882
D001335	Vehicle Emissions	[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 protein	19150882
D001335	Vehicle Emissions	cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 mRNA]	19150882
D001335	Vehicle Emissions	cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [[APOE protein affects the susceptibility to Vehicle Emissions] which results in increased expression of MMP9 protein]	19150882
D001335	Vehicle Emissions	[Vehicle Emissions affects the reaction [APOE gene mutant form affects the susceptibility to Dietary Fats]] which results in increased expression of MMP9 mRNA	19891982
D001335	Vehicle Emissions	Vehicle Emissions promotes the reaction [FOSL1 protein binds to MMP9 promoter]	14565943
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of MMP9 mRNA	14565943; 17065432; 20197249;
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of MMP9 protein	17065432
D001335	Vehicle Emissions	2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in increased expression of MMP9 protein]	24192212
D001335	Vehicle Emissions	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in increased expression of MMP9 protein]]	24192212
D001335	Vehicle Emissions	hydroxysafflor yellow A inhibits the reaction [Vehicle Emissions results in increased expression of MMP9 protein]	24192212
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of MMP9 protein	24192212
D000069470	Venlafaxine Hydrochloride	Venlafaxine Hydrochloride results in decreased expression of MMP9 mRNA	25423262
C573672	VI-14 flavonoid	VI-14 flavonoid results in decreased expression of and results in decreased activity of MMP9 protein	22538171
C573672	VI-14 flavonoid	VI-14 flavonoid results in decreased expression of MMP9 mRNA	22538171
D014757	Viper Venoms	Viper Venoms results in increased expression of MMP9 protein	28245079
D014807	Vitamin D	Vitamin D inhibits the reaction [Particulate Matter results in decreased expression of MMP9 protein]	30698894
D014807	Vitamin D	Vitamin D inhibits the reaction [Silicon Dioxide results in decreased expression of MMP9 protein]	30698894
D014807	Vitamin D	Vitamin D results in increased expression of MMP9 protein	30698894
D024483	Vitamin K 3	Vitamin K 3 results in decreased expression of MMP9 protein	31238027
D000077337	Vorinostat	Vorinostat inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]	27163855
D000077337	Vorinostat	Vorinostat inhibits the reaction [TNF protein results in increased expression of MMP9 protein]	16377638
D000077337	Vorinostat	Vorinostat results in decreased expression of MMP9 mRNA	26238599
D000077337	Vorinostat	Vorinostat results in decreased expression of MMP9 protein	19509267
D000077337	Vorinostat	Vorinostat results in decreased secretion of MMP9 protein	20421217
D000077337	Vorinostat	Vorinostat results in increased expression of MMP9 mRNA	20060208
D000077337	Vorinostat	Vorinostat inhibits the reaction [IL1B protein results in increased expression of MMP9 mRNA]	24429678
D000077337	Vorinostat	Vorinostat inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	24429678
C017967	W 7	W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]	20590612
C017967	W 7	W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	20590612
C070417	Win 55212-2	Win 55212-2 results in decreased activity of MMP9 protein	30776504
C000588914	WJ1376-1	WJ1376-1 inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA]	24727557
C000588914	WJ1376-1	WJ1376-1 inhibits the reaction [TGFB1 protein results in increased expression of MMP9 protein]	24727557
C000588915	WJ1398-1	WJ1398-1 inhibits the reaction [TGFB1 protein results in increased expression of MMP9 mRNA]	24727557
C000588915	WJ1398-1	WJ1398-1 inhibits the reaction [TGFB1 protein results in increased expression of MMP9 protein]	24727557
C085514	wogonin	wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	21295103
C085514	wogonin	wogonin results in decreased expression of and results in decreased activity of MMP9 protein	21295103
C085514	wogonin	wogonin inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased activity of MMP9 protein]	14700523
D000077191	Wortmannin	Wortmannin inhibits the reaction [fucoidan results in decreased expression of MMP9]	24333868
D000077191	Wortmannin	Wortmannin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]	23288142
D000077191	Wortmannin	Wortmannin promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein]	22033475
D000077191	Wortmannin	Wortmannin results in decreased activity of MMP9 protein	22033475
D000077191	Wortmannin	Wortmannin inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]	20195827
D000077191	Wortmannin	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [Wortmannin inhibits the reaction [EGF protein results in increased activity of MMP9 protein]]	23064031
D000077191	Wortmannin	naphtho(1,2-b)furan-4,5-dione inhibits the reaction [Wortmannin inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]	23064031
D000077191	Wortmannin	Wortmannin inhibits the reaction [EGF protein results in increased activity of MMP9 protein]	23064031
D000077191	Wortmannin	Wortmannin inhibits the reaction [EGF protein results in increased expression of MMP9 protein]	23064031
D000077191	Wortmannin	Wortmannin inhibits the reaction [IL1B protein results in increased expression of MMP9 protein]	22936809
C104536	xanthohumol	xanthohumol results in decreased expression of and results in decreased activity of MMP9 protein	23562496
C104536	xanthohumol	xanthohumol results in decreased expression of MMP9 mRNA	23562496
C104536	xanthohumol	xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]	23994090
C528128	xiongshao	xiongshao inhibits the reaction [Dietary Fats results in increased expression of MMP9 mRNA]	21611899
C528128	xiongshao	xiongshao affects the expression of and affects the secretion of MMP9 protein	20694780
C528128	xiongshao	[xiongshao co-treated with huanglian] affects the expression of and affects the secretion of MMP9 protein	20694780
C568790	XMD 8-92	XMD 8-92 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased expression of MMP9 mRNA]	25200491
C568790	XMD 8-92	XMD 8-92 inhibits the reaction [FSL-1 lipoprotein, synthetic results in increased secretion of MMP9 protein]	25200491
C010807	xylosides	xylosides results in decreased secretion of MMP9 protein	14511379
C108830	Y 27632	Y 27632 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]	15728660
C108830	Y 27632	[Y 27632 results in decreased expression of RHOA protein] which results in decreased expression of MMP9 protein	19896475
C087958	YM 529	YM 529 results in decreased expression of and results in decreased activity of MMP9 protein	22326785
C087958	YM 529	YM 529 results in decreased expression of MMP9 mRNA	22326785
C403304	zerumbone	zerumbone analog results in decreased expression of and results in decreased secretion of MMP9 protein	28987329
C403304	zerumbone	zerumbone results in decreased expression of MMP9 mRNA	16007145
D015215	Zidovudine	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]	14662518
D015215	Zidovudine	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]	14662518
D015215	Zidovudine	Zidovudine inhibits the reaction [Lipopolysaccharides results in increased secretion of MMP9 protein]	14662518
C063449	zileuton	zileuton results in decreased activity of MMP9 protein	19309543
C063449	zileuton	zileuton results in decreased expression of MMP9 mRNA	19309543
D015032	Zinc	Zinc binds to MMP9 protein	17137715
D015032	Zinc	Zinc inhibits the reaction [TNF protein results in increased secretion of MMP9 protein]	16606632
D015032	Zinc	Zinc results in decreased expression of MMP9 mRNA	18316168
D015032	Zinc	TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA]	23503329
D015032	Zinc	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of MMP9 mRNA	23503329
D015032	Zinc	[Zinc binds to Curcumin] inhibits the reaction [Acetic Acid results in increased expression of MMP9 mRNA]	23933360
C023616	zinc chromate	zinc chromate results in increased expression of MMP9 protein	20049209
D015034	Zinc Oxide	Zinc Oxide results in increased activity of MMP9 protein	23726862
D015034	Zinc Oxide	Zinc Oxide results in increased secretion of MMP9 protein	23726862
D015034	Zinc Oxide	Zinc Oxide analog promotes the reaction [OVAL protein results in increased expression of MMP9 protein]	25127755
C017803	zinc protoporphyrin	zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]	27829220
C017803	zinc protoporphyrin	zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]	30076913
C017803	zinc protoporphyrin	zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 protein]	30076913
D019287	Zinc Sulfate	Zinc Sulfate inhibits the reaction [TNF protein results in increased secretion of MMP9 protein]	16606632
C028541	zirconium oxide	zirconium oxide results in decreased expression of MMP9 mRNA	14661256
D000077211	Zoledronic Acid	Zoledronic Acid results in decreased expression of and results in decreased activity of MMP9 protein	15343380
C070927	zosterin	zosterin results in decreased expression of MMP9 protein	20465284
C070927	zosterin	zosterin results in decreased expression of MMP9 protein modified form	20465284
D015054	Zymosan	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Zymosan results in increased expression of MMP9 protein]	18557954
D015054	Zymosan	[Zymosan co-treated with 4-aminophenylmercuriacetate] results in increased activity of MMP9 protein	18557954
D015054	Zymosan	Zymosan results in increased expression of MMP9 mRNA	18557954
D015054	Zymosan	Zymosan results in increased expression of MMP9 protein	18557954
D015054	Zymosan	[Lipopolysaccharides co-treated with Zymosan] results in increased activity of MMP9 protein	15259001
D015054	Zymosan	[Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 mRNA	15259001
D015054	Zymosan	[Lipopolysaccharides co-treated with Zymosan] results in increased expression of MMP9 protein	15259001
D015054	Zymosan	MMP9 protein affects the reaction [Zymosan affects the activity of ELANE protein]	19088179
D015054	Zymosan	MMP9 protein affects the reaction [Zymosan affects the expression of ELANE mRNA]	19088179
D015054	Zymosan	NCF1 protein affects the reaction [Zymosan results in increased expression of MMP9 mRNA]	14507659
D015054	Zymosan	Zymosan results in increased activity of MMP9 protein	11839551; 17826846; 18241695;
D015054	Zymosan	Zymosan results in increased expression of MMP9 mRNA	14507659; 17826846; 18241695;
D015054	Zymosan	Zymosan results in increased expression of MMP9 protein	17826846; 18241695;
D015054	Zymosan	Zymosan results in increased secretion of MMP9 protein	17826846

Functional annotations

Keywords

Keyword ID	Keyword Term
KW-0002	3D-structure
KW-0106	Calcium
KW-0177	Collagen degradation
KW-0903	Direct protein sequencing
KW-1015	Disulfide bond
KW-0272	Extracellular matrix
KW-0325	Glycoprotein
KW-0378	Hydrolase
KW-0479	Metal-binding
KW-0482	Metalloprotease
KW-0621	Polymorphism
KW-0645	Protease
KW-1185	Reference proteome
KW-0677	Repeat
KW-0964	Secreted
KW-0732	Signal
KW-0862	Zinc
KW-0865	Zymogen

Interpro

InterPro ID	InterPro Term
IPR000562	FN_type2_dom
IPR036943	FN_type2_sf
IPR000585	Hemopexin-like_dom
IPR036375	Hemopexin-like_dom_sf
IPR018487	Hemopexin-like_repeat
IPR018486	Hemopexin_CS
IPR013806	Kringle-like
IPR033739	M10A_MMP
IPR024079	MetalloPept_cat_dom_sf
IPR001818	Pept_M10_metallopeptidase
IPR021190	Pept_M10A
IPR021158	Pept_M10A_Zn_BS
IPR006026	Peptidase_Metallo
IPR002477	Peptidoglycan-bd-like
IPR036365	PGBD-like_sf
IPR036366	PGBDSf

PROSITE

PROSITE ID	PROSITE Term
PS00546	CYSTEINE_SWITCH
PS00023	FN2_1
PS51092	FN2_2
PS00024	HEMOPEXIN
PS51642	HEMOPEXIN_2
PS00142	ZINC_PROTEASE

Pfam

Pfam ID	Pfam Term
PF00040	fn2
PF00045	Hemopexin
PF00413	Peptidase_M10
PF01471	PG_binding_1

Gene: MMP9

Basic information

Gene expression in different tissues (ENCODE)

Protein structural annotations

3D structure in PDB database

Protein disorder information

Orthologous information

Identified variants/mutations related to cleft phenotype

Other genetic variants/mutations

Disease or phenotype associated information

Gene Ontology (GO)/biological pathways

GO:Molecular Function

GO:Biological Process

GO:Cellular Component

Reactome Pathway

Drugs and compounds information

Functional annotations

Keywords

Interpro

PROSITE

Pfam

Protein-protein interaction

Protein-miRNA interaction